15th Annual Scientific Meeting - Heart Failure Society of America

15th Annual 

Scientific Meeting 

2011 Program 

September 18 – 21, 2011 

Hynes Convention Center 

Boston, MA 

www.hfsa.org

Table of Contents 

President’s Message. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 

About the HFSA .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 

Society Officers and Council. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 

Scientific Program Committee. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 

Meeting Content .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 

General Meeting Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 

Complimentary Food Events.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 

2011 HFSA Satellite/Scientific Program Activity Supporters.. . . . . . 9 

2011 HFSA Corporate Members.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 

Liability Statement .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 

CME Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 

Disclosure Information .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 

Scientific Program Learning Objectives .. . . . . . . . . . . . . . . . . . . . . 11 

2011 Abstract Reviewers.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 

2011 HFSA Faculty.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 

Program-at-a-Glance.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 

September 18: (Sunday) 

Scientific Session .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 

Satellite Symposium .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 

Scientific Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 

Satellite Symposia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 

September 19: (Monday) 

Satellite Symposia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 

Morning Scientific Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 

How To Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 

Oral Abstract Session (Rapid Fire) .. . . . . . . . . . . . . . . . . . . . . . . 44 

Afternoon Scientific Program.. . . . . . . . . . . . . . . . . . . . . . . . . . . 46 

Monday Posters.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 

September 20: (Tuesday) 

Morning Scientific Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 

How To Sessions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 

Oral Abstract Session (Rapid Fire) .. . . . . . . . . . . . . . . . . . . . . . 101 

Award Presentations .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103 

Afternoon Scientific Program.. . . . . . . . . . . . . . . . . . . . . . . . . . 103 

Tuesday Posters .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110 

September 21: (Wednesday) 

Morning Scientific Program .. . . . . . . . . . . . . . . . . . . . . . . . . . . 138 

Exhibit Hall 

Hands-on Workshop (September 19).. . . . . . . . . . . . . . . . . . . . . . . 148 

Product Theater (September 20) .. . . . . . . . . . . . . . . . . . . . . . . . . . 149 

Exhibitors and Exhibit Floor Plan.. . . . . . . . . . . . . . . . . . . . . . . . . 150 

Clinical Trial Row.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152 

Exhibitor Descriptions.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153 

Author Index.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164 

Hynes Convention Center Floor Plans. . . . . . . . . . . . . . . . . . . . . . 202 

Notes.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204 

1

President’s Message 

On behalf of the Executive 

Council and the Program 

Committee of the Heart Failure 

Society of America it is my 

pleasure to welcome you to the 

15th Annual Scientific Meeting. 

The Program Committee, led 

by Lynne W. Stevenson, Steven 

Houser, and Barbara Riegel, 

has put together a very exciting 

and truly novel program, which 

includes content that should 

be of great interest to the 

wide spectrum of attendees. 

Whether you are a clinician or 

researcher, physician, nurse, 

pharmacist, or a trainee, this program will cover topics that will be 

useful in your practice and work. 

The program has been carefully planned to provide state-of-the-art 

information about heart failure for the expert covering the entire field 

from basic science to clinical practice. This year’s program includes 

sessions on fundamental clinical topics, simultaneous symposia, 

how-to sessions, rapid fire abstract sessions, debates, poster sessions, 

and late-breaking clinical trials. Areas where there have been new 

advances and topics, including controversial issues, are highlighted 

as part of the program. Some of the sessions will focus on a benchto-bedside 

approach; it is our hope that you will choose to attend 

sessions out of your main areas of interest and benefit from this unique 

aspect of our meeting which offers a broad view of what is happening 

in heart failure. The Hyde Park session, an HFSA tradition, gives 

the audience an opportunity sit back, relax, enjoy and laugh a little 

while the presenters provide novel insights into important issues and 

controversies in the care of heart failure patients. 

We view our meeting’s success not only by the knowledge gained, but 

also by the enjoyment that attendees have in gaining it. We hope you 

find this year’s program to be informative and rewarding. As always 

we welcome and encourage your feedback. 

I hope you enjoy Boston, leave energized, and take home new ideas 

that will enhance your professional goals. The 2012 Annual Scientific 

Meeting will be held in Seattle, and we look forward to seeing you 

again. 

Barry M. Massie, MD 

President 

Heart Failure Society of America 

2010-2012 

About the HFSA 

The Heart Failure Society of America (HFSA) represents the first 

organized effort by heart failure experts from the Americas to provide 

a forum for all those interested in heart failure research and patient care. 

The HFSA is dedicated to: 

Promoting research related to all aspects of heart failure and to provide 

a forum for presentation of basic, clinical, and population-based research. 

Educating health care professionals through programs, publications 

and other media in the areas of basic science, clinical medicine, patient 

management, and social, ethical and economic issues to enable them to 

diagnose and treat heart failure and concomitant medical conditions more 

effectively. 

Encouraging primary and secondary preventive measures to reduce the 

incidence of heart failure; to serve as a resource for government, private 

industry, and health care providers to facilitate the establishment of 

programs and policies that will better serve the patient. 

Enhancing quality and duration of life in those with heart failure. 

Promoting and facilitating the formal training of physicians, scientists, 

and allied health care providers in the field of heart failure. 

Society Membership Information 

Membership in the Society is open to all health care professionals 

with an interest in cardiovascular medicine. For information about the 

HFSA or to become a member, call or write: 

Heart Failure Society of America, Inc. 

Court International 

Suite 240 South 

2550 University Avenue West 

St. Paul, MN 55114 

phone: 651-642-1633 

fax: 651-642-1502 

e-mail: info@hfsa.org 

Interested participants can also visit the HFSA exhibit booth (#2906) 

or visit the HFSA web site at www.hfsa.org. 

2 3

Officers: 

President: 

Vice-President: 

Secretary: 

Treasurer: 

Immediate Past President: 

Members: 

Ex Officio Members: 

Executive Council 


San Francisco, CA 

Thomas Force, MD 

Philadelphia, PA 

Hani N. Sabbah, PhD 

Detroit, MI 

Mandeep R. Mehra, MD 

Baltimore, MD 

Douglas L. Mann, MD 

St. Louis, MO 

John C. Burnett, Jr., MD 

Rochester, MN 

John Chin, MD 

Sacramento, CA 

Steven R. Houser, PhD 


Sharon A. Hunt, MD 

Stanford, CA 

Mariell L. Jessup, MD 


JoAnn Lindenfeld, MD 

Denver, CO 

Sara C. Paul, RN, MSN, DNP 

Hickory, NC 

Mariann R. Piano, RN, PhD 

Chicago, IL 

Randall C. Starling, MD, MPH 

Cleveland, OH 

James E. Udelson, MD 

Boston, MA 

Michael R. Zile, MD 

Charlotte, SC 

Jay N. Cohn, MD 

Minneapolis, MN 

Allen Farber, Esq 

Washington, DC 

Gary S. Francis, MD 


David A. Lathrop, PhD 

Bethesda, MD 

Isabella Liang, PhD 

Bethesda, MD 

2011 Scientific Program Committee 

Lynne Warner Stevenson, MD (Co-Chair) 

Steven R. Houser, PhD (Co-Chair) 

Barbara J. Riegel, RN, DNSc (Co-Chair) 

Nancy M. Albert, RN, PhD 

Mark E. Anderson, MD, PhD 

Wilson S. Colucci, MD 

James P. Daubert, MD 

Akshay M. Desai, MD 

Justin A. Ezekowitz, MB, BCh 

J. Thomas Heywood, MD 

Corrine Y. Jurgens, RN, PhD 

Annarosa Leri, MD 

Douglas W. Losordo, MD 

Carmelo A. Milano, MD 

Leslie W. Miller, MD 

Mark A. Munger, PharmD 

Ayan R. Patel, MD 

Peipei Ping, PhD 

Stuart D. Russell, MD 

Douglas D. Schocken, MD 


Mark A. Sussman, PhD 

Mary N. Walsh, MD 

Matthew J. Wolf, MD, PhD 

Meeting Content: 

The 2011 HFSA Annual Scientific Meeting provides a forum for 

the open exchange and discussion of research results and scientific 

advancements in the field of heart failure; however HFSA makes no 

representation or warranty as to the truth, originality, or accuracy 

of the information presented. Nor are the views expressed by the 

individual speakers necessarily the views of HFSA. HFSA supports 

the ACCME’s policy on evidence-based content and encourages 

faculty to adhere to these standards when preparing a presentation. 

4 5

General Meeting Information 

Boston, MA 

All activities listed in this program book will take place at the Hynes 

Convention Center. See pages 203-204 for floor plan of meeting 

space. 

CME Accreditation/Registration 


Court International, Suite 240 South 



651-642-1633; fax: 651-642-1502 

Registration Hours 

Meeting Registration Desk, Hynes Convention Center (2nd floor). 

Saturday, September 17: 

9:00 AM-4:00 PM 

Sunday, September 18: 

9:00 AM-4:00 PM 

Monday, September 19: 

7:00 AM-5:00 PM 

Tuesday, September 20: 

7:00 AM-5:00 PM 

Wednesday, September 21: 

7:00 AM-10:00 AM 

What’s Included in Registration Fees 

The registration fee includes admittance to satellite programs, 

scientific sessions, poster sessions, commercial exhibits and activities, 

and the Opening Reception. 

Scientific Meeting Evaluation 

There are two ways to complete the scientific meeting evaluation 

form: (1) complete the evaluation form found in your congress bag 

and return to the Registration Desk (Hynes Convention Center); OR 

(2) complete the form on-line after the meeting (information to be sent 

to attendees by e-mail after the scientific meeting). 

E-Mail From the Exhibit Floor (Booth #2522) 

During the meeting e-mail stations will be available in Exhibit Hall D for 

attendees to check their e-mail. Please note your e-mail account must be 

accessible through a web-based browser, e.g., Internet Explorer. 

No Smoking Policy 

HFSA prohibits smoking in all areas of the meeting and all hotel meeting 

rooms hosting HFSA functions. Thank you for your cooperation. 

Special Needs 

The HFSA strives to hold meetings that are accessible to all. 

Please tell us what you require to help make your participation 

more enjoyable and meaningful. Contact Gudrun Echterhoff, Global 

Meetings & Incentives at gudrun@global-mtgs.com (201-850-7607). 

Speaker Ready Room – Room 309 (Hynes Convention Center) 

Sunday, September 18 

8:00 AM-6:00 PM 

Monday, September 19 

6:30 AM-6:00 PM 

Tuesday, September 20 

6:30 AM-6:00 PM 

Wednesday, September 21 

6:30 AM-NOON 

Press Room – Room 308 (Hynes Convention Center) 


10:00 AM-5:00 PM 


7:00 AM-5:00 PM 


7:00 AM-5:00 PM 


7:00 AM-NOON 

Exhibit Hall Dates and Hours 

The exhibits are located in Exhibit Hall C (2nd level) Hynes 

Convention Center. See page 151 for list of exhibitors and location. 





6:00 PM-8:00 PM 

9:30 AM-7:00 PM 

9:30 AM-7:00 PM 

CLOSED 

Clinical Trial Row: Located in Exhibit Hall D. This provides an 

opportunity for attendees to learn more about ongoing clinical trials 

in heart failure. These boards have been rented by groups supporting 

clinical trials. The HFSA assumes no responsibility or liability for 

information posted about a clinical trial on these boards. 

Hands-on Workshop: Located in Exhibit Hall C. This provides an 

opportunity for hands-on user learning to meeting attendees. 

Product Theater: Located in Exhibit Hall D. This provides an 

opportunity to hold product-related presentations during expo hours. 

Poster Sessions 

Poster Sessions will be held in the Exhibit Hall C (Hynes Convention 

Center) as follows: 

Poster Display: 


9:30 AM-7:00 PM 


Presenters at 

their Posters: 

5:45 PM-6:45 PM 

Annual Business Meeting: 

The Annual Business Meeting of the HFSA will be held on 

Wednesday, September 21, 8:15 AM, Room 311. 

Questions? 

Look for staff wearing golf shirts with the HFSA logo. 

6 7

General Meeting Information (continued) 

Complimentary Food Events 

The following complimentary food events will be offered. All food 

events will take place in the Hynes Convention Center Exhibit Halls C 

and D unless otherwise noted. 

SUNDAY, September 18 

Opening Reception 

(Wine & Hors d’oeuvres) 

MONDAY, September 19 

Continental Breakfast 

Meeting area foyers (3rd Floor) 

Refreshment Break 


Poster Session and Reception 


6:00 PM-8:00 PM 

6:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

2011 HFSA Satellite/Scientific Program 

Activity Supporters 

Actelion 

CardioMEMS 

Medtronic, Inc. 

Otsuka America Pharmaceuticals, Inc. 

Respicardia 

Thoratec Corporation 

2011 HFSA Corporate Members 

Amgen 

Boston Scientific Corporation 

Janssen Pharmaceuticals 


Merck & Co., Inc. 

Otsuka America Pharmaceuticals, Inc. 

St. Jude Medical 

Thoratec Corporation 

TUESDAY, September 20 





Poster Session and Reception 


WEDNESDAY, September 21 





6:45 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

6:45 AM-8:30 AM 

10:00 AM-10:30 AM 

Liability Statement 

Disclaimer: The Heart Failure Society of America (HFSA) cannot accept, 

and hereby specifically disclaims, any liability for death, injury, any loss, 

cost or expense suffered or incurred by any person if such loss is caused 

by, arises from or results from the act, default or omission of any person 

other than an employee or agent of HFSA. In particular, neither HFSA 

nor its agents can accept, and hereby specifically disclaims, any liability 

for losses arising from, caused by, or resulting from, the provision or 

non-provision of services provided by the hotels, companies, or transport 

operators. Neither HFSA nor its agents can accept, and hereby specifically 

disclaims, liability for losses suffered by reason of war including threat of 

war, riots and civil strife, terrorist activity, natural disaster, weather, fire, 

flood, drought, technical, mechanical or electrical breakdown within any 

premises visited by delegates and/or participants in connection with the 

meeting, industrial disputes, government action, regulations or technical 

problems that affect or may affect the services provided in connection 

with the meeting. HFSA is not able to warrant and does not warrant 

that a particular person will appear as a speaker. As a condition to any 

participation in or attendance at the Annual Scientific Meeting or any 

function associated or affiliated herewith, each attendee and participant 

accepts the foregoing disclaimer. 

8 9

CREDIT STATEMENTS 

Scientific Program 

Physicians: The Heart Failure Society of America is accredited by the 

Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. 

The Heart Failure Society of America designates this live activity for a 

maximum of 23.5 AMA PRA Category 1 Credits. Physicians should only 

claim credit commensurate with the extent of their participation in the activity. 

Nurses: This program has been approved by the American Association 

of Critical Care Nurses (AACN) for 23.5 contact hours, Synergy CERP 

Category A, File number 00017263. 

Satellite Symposia: September 18 (Sunday) 

Physicians: The Heart Failure Society of America (HFSA) is accredited 

by the Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. The HFSA designates this 

live activity for a maximum of 2.0 AMA PRA Category 1 Credits. 

Physicians should only claim credit commensurate with the extent of their 

participation in each program. 

Nurses: Each program has been designed to meet Minnesota Board of 

Nursing continuing education requirements and is acceptable for 2.0 

contact hours of continuing education. 

Satellite Symposia: September 19 (Monday) 

Physicians: The Heart Failure Society of America (HFSA) is accredited 

by the Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. The HFSA designates this 

live activity for a maximum of 1.0 AMA PRA Category 1 Credits. 

Physicians should only claim credit commensurate with the extent of their 

participation in this program. 

Nurses: Each program has been designed to meet Minnesota Board of 

Nursing continuing education requirements and is acceptable for 1.0 

contact hour of continuing education. 

CME Certificates Available On-Site 

Presenter/Planner Disclosure Information 

The Heart Failure Society of America has a disclosure policy that 

requires oral presenters to disclose whether or not they have relevant 

financial relationships with any commercial interest and whether or 

not off-label or investigational drug/device use will be discussed. 

All oral and poster presenters’ disclosure information received is 

listed in the HFSA Presenter/Author Disclosure Booklet. A booklet 

is in each meeting congress bag. In addition, each oral presenter will 

have a disclosure slide at the beginning of his/her presentation. 

Scientific Program Learning Objectives 

Following this meeting, participants will be able to: 

1. Describe the epidemiology of HF, including environmental factors, 

and implement strategies for the prevention of HF. 

2. Describe current knowledge about the scientific basis of HF at the 

levels of cardiovascular physiology, neurohormones, tissue factors, 

and molecular biology and genetics. 

3. Identify the findings of basic science and current clinical trials and 

their implications for current and future HF therapy. 

4. Implement optimal guideline-based therapeutic options for HF, 

including pharmacologic agents, non-pharmacologic options, such 

as diet and exercise; and devices. 

5. Manage comorbidities including hypertension, diabetes, and 

cognitive issues. 

6. Demonstrate awareness of psychosocial, economic and ethical 

issues in the treatment of patients with HF. 

7. Implement strategies for effective management of the patient with 

HF, incorporating the family, encouraging self-care, and employing 

the medical home model. 

8. Outline strategies for transitioning patients from impatient to 

outpatient and for reducing hospital readmissions. 

9. Engage in performance measurement and other site-based research. 

Scientific Session and Satellite Symposia learning objectives are 

listed at the end of each session in the program book. 

CME CERTIFICATES (SCIENTIFIC AND SATELLITE 

SESSIONS) WILL BE AVAILABLE ON-SITE. PLEASE 

VISIT THE CME KIOSK IN REGISTRATION AREA TO 

DOWNLOAD AND PRINT YOUR CME CERTIFICATE(S). 

All main entrances to meeting rooms for the scientific sessions 

and the satellite programs will be “gated” to capture attendee 

information. This is the only information that will be used to 

verify attendance for credit certificates. Please make sure you 

enter each session through a gated entrance. 

10 11


Cleveland, OH 

Inder S. Anand, MD, PhD 



Iowa City, IA 

Burns C. Blaxall, PhD 

Rochester, NY 

John P. Boehmer, MD 

Hershey, PA 

Bikyem Bozkurt, MD 

Houston, TX 

Javed Butler, MD, MPH 

Atlanta, GA 

Horng H. Chen, MB, BCh 

Rochester, MN 


Boston, MA 


Durham, NC 

Teresa De Marco, MD 


David DeNofrio, MD 

Boston, MA 


Boston, MA 

Anita Deswal, MD, MPH 

Houston, TX 

Mark H. Drazner, MD 

Dallas, TX 

Justin A. Ezekowitz, MBBCh, MSc 

Edmonton, AB, Canada 

James C. Fang, MD 

Cleveland, OH 

G. Michael Felker, MD 

Durham, NC 

Gregg C. Fonarow, MD 

Los Angeles, CA 

Michael M. Givertz, MD 

Boston, MA 

Steven Goldman, MD 

Tucson, AZ 

Stephen S. Gottlieb, MD 

Baltimore, MD 

2011 Abstract Reviewers 

Roger J. Hajjar, MD 

New York, NY 

Joshua Hare, MD 

Miami, FL 

Paul J. Hauptman, MD 

St. Louis, MO 

Edward P. Havranek, MD 

Denver, CO 

Paul A. Heidenreich, MD 

Palo Alto, CA 

Adrian F. Hernandez, MD 

Durham, NC 

Ray E. Hershberger, MD 

Miami, FL 


La Jolla, CA 

Katherine J. Hoercher, RN 

Cleveland, OH 

Tamara B. Horwich, MD 





Stanford, CA 




Stony Brook, NY 

Michelle M. Kittleson, MD, PhD 

Beverly Hills, CA 

David E. Lanfear, MD 

Detroit, MI 

Terry A. Lennie, RN, PhD 

Lexington, KY 

Ronglih Liao, PhD 

Boston, MA 


Denver, CO 

Kenneth B. Margulies, MD 


Paul J. Mather, MD 


Dennis M. McNamara, MD 

Pittsburgh, PA 

Alan B. Miller, MD 

Jacksonville, FL 


Tampa, FL 

Judith E. Mitchell, MD 

New York, NY 


Salt Lake City, UT 

Myung H. Park, MD 

Baltimore, MD 

Soon J. Park, MD 

Rochester, MN 

Parag C. Patel, MD 

Dallas, TX 

J. Herbert Patterson, PharmD 

Chapel Hill, NC 



Margaret M. Redfield, MD 

Rochester, MN 

Barbara J. Riegel, RN, DNSc 



Baltimore, MD 


Detroit, MI 

Leslie A. Saxon, MD 



Durham, NC 

Marc A. Silver, MD 

Oak Lawn, IL 

John A. Spertus, MD, MPH 

Kansas City, MO 

Francis G. Spinale, MD 

Charleston, SC 

William G. Stevenson, MD 

Boston, MA 


San Diego, CA 

W.H. Wilson Tang, MD 

Cleveland, OH 

Patricia A. Uber, PharmD 

Baltimore, MD 


Indianapolis, IN 

Yibin Wang, PhD 


David J. Whellan, MD 


Suzanne J. Wingate, RN, PhD 

Gaithersburg, MD 


Durham, NC 



12 13

2011 HFSA Faculty 

15th Annual Scientific Meeting 

Keith D. Aaronson, MD, MS 

University of Michigan 

Ann Arbor, MI 

Maha Abdellatif, PhD, MBC 

UMDNJ 

Newark, NJ 

William T. Abraham, MD 

The Ohio State University 

Columbus, OH 

Kirkwood F. Adams, Jr., MD 

University of North Carolina 


Sana M. Al-Khatib, MD 

Duke University 

Durham, NC 


Cleveland Clinic Foundation 

Cleveland, OH 

Larry A. Allen, MD, MHS 

University of Colorado 

Denver, CO 

Susan E. Ammon, RN, MS, FNP 

San Francisco VAMC 


Inder S. Anand, MD, PhD 

Minneapolis VAMC 



University of Iowa 

Iowa City, IA 

Stefan D. Anker, MD, PhD 

Charité Hospital 

Berlin, Germany 

Piero Anversa, MD 

Brigham and Women’s Hospital 

Boston, MA 

J. Malcolm O. Arnold, MD 

University Hospital 

London, ON, Canada 

Denise D. Barnard, MD 

University of California, 

San Diego 

San Diego, CA 

Bradley A. Bart, MD 

Hennepin County Medical Center 


Donald M. Bers, PhD 

University of California, Davis 

Davis, CA 

Emma J. Birks, MD, PhD 

University of Louisville 

Louisville, KY 

Burns C. Blaxall, PhD 

University of Rochester 

Rochester, NY 

John P. Boehmer, MD 

Penn State University 

Hershey, PA 

Roberto Bolli, MD 



Barry A. Borlaug, MD 

Mayo Clinic & Foundation 

Rochester, MN 

Eugene Braunwald, MD 


Boston, MA 

Michael R. Bristow, MD, PhD 


Denver, CO 

Harleah G. Buck, RN, PhD, CHPN 

The Pennsylvania State University 

University Park, PA 

John C. Burnett, Jr., MD 


Rochester, MN 

Javed Butler, MD, MPH 

Emory University 

Atlanta, GA 

Alfred E. Buxton, MD 

Beth Israel Deaconess 

Medical Center 

Boston, MA 

Peter E. Carson, MD 

Washington VAMC 


Horng H. Chen, MB, BCh 


Rochester, MN 

John Chin, MD 

Sutter Memorial Hospital 

Sacramento, CA 

Deepak Chopra, MD 

The Chopra Center for Wellbeing 

Carlsbad, CA 

Jay N. Cohn, MD 

University of Minnesota 


Henry M. Colecraft, PhD 

Columbia University 

New York, NY 


Boston Medical Center 

Boston, MA 

Gianluigi Condorelli, MD, PhD 

National Research Council 

Rome, Italy 

Maria Rosa Costanzo, MD 

Midwest Heart Specialists 

Naperville, IL 

Catherine E. Costello, PhD 

Boston University 

Boston, MA 

Jennifer Cowger, MD 


Ann Arbor, MI 

Laura A. Coyle, RN, MSN, NP 

Advocate Christ Medical Center 

Oak Lawn, IL 



Durham, NC 

Teresa De Marco, MD 


San Francisco 


Prakash C. Deedwania, MD 

VA Central California 

Health Care System 

Fresno, CA 

Frederica del Monte, MD, PhD 



Boston, MA 

David DeNofrio, MD 

Tufts Medical Center 

Boston, MA 



Boston, MA 

14 15 

Victoria V. Dickson, PhD, CRNP 

New York University 

New York, NY 

Lynn V. Doering, RN, DNSc 

UCLA 


Gerald W. Dorn, II, MD 

Washington University 

St. Louis, MO 

Mark H. Drazner, MD 

University of Texas Southwestern 

Dallas, TX 

Samuel C. Dudley, MD, PhD 

University of Illinois 

Chicago, IL 

Jean-Bernard Durand, MD 

University of Texas 

Houston, TX 

Kenneth A. Ellenbogen, MD 

Virginia Commonwealth 

University 

Richmond, VA 

Tonya Elliott, RN, MSN 

Inova Fairfax Hospital 

Falls Church, VA 

Andrew E. Epstein, MD 

University of Pennsylvania 


Jonathan A. Epstein, MD 



Justin A. Ezekowitz, MB, BCh 

University of Alberta 


Michael D. Ezekowitz, MB, PhD 

Lankenau Institute for 

Medical Research 

Wynnewood, PA 

James C. Fang, MD 

Case Western University 

Cleveland, OH 

Arthur M. Feldman, MD, PhD 

Temple University 


G. Michael Felker, MD 


Durham, NC 

Carol Flavell, NP, APRN 


Boston, MA

John S. Floras, MD, PhD 

Mount Sinai Hospital 

Toronto, ON, Canada 

Joshua I. Goldhaber, MD 

Cedars-Sinai Heart Institute 


Ray E. Hershberger, MD 

University of Miami 

Miami, FL 


Stony Brook University 

Stony Brook, NY 

Gregg C. Fonarow, MD 

UCLA 


Samuel Z. Goldhaber, MD 


Boston, MA 


Scripps Clinic 

La Jolla, CA 

Jan Kajstura, PhD 


Boston, MA 

Thomas Force, MD 

Thomas Jefferson University 


Steven Goldman, MD 

VA Medical Center 

Tucson, AZ 

Joseph A. Hill, MD, PhD 


Dallas, TX 

Stuart D. Katz, MD 


New York, NY 

Paul R. Forfia, MD 



Steven R. Goldsmith, MD 



Carolyn Yung Ho, MD 


Boston, MA 

James N. Kirkpatrick, MD 



Majid Fotuhi, MD, PhD 

Neurology Institute for Brain 

Health and Fitness 

Lutherville, MD 

Michael B. Fowler, MD 

Stanford University 

Stanford, CA 

Gary S. Francis, MD 



Robert P. Frantz, MD 


Rochester, MN 

Hasan Garan, MD 


New York, NY 

Carrie A. Geisberg, MD 

Vanderbilt University 

Nashville, TN 

Robert E. Gerszten, MD 

Massachusetts General Hospital 

Charlestown, MA 

Jalal K. Ghali, MD 

Harper University Hospital 

Detroit, MI 

Mihai Gheorghiade, MD 

Northwestern University 

Chicago, IL 

Michele N. Gilbert, RN, MSN 

Charity Health Care System 

Oakland, NJ 

Michael M. Givertz, MD 


Boston, MA 

Lee R. Goldberg, MD, MPH 



Nathan E. Goldstein, MD 

Mount Sinai 

New York, NY 

John Gorcsan, III, MD 

University of Pittsburgh 


Stephen S. Gottlieb, MD 

University of Maryland 

Baltimore, MD 

Kathleen L. Grady, RN, PhD, APN 


Chicago, IL 

Barry H. Greenberg, MD 


San Diego 

San Diego, CA 

Jeffrey L. Greenwald, MD 


Boston, MA 

Roger J. Hajjar, MD 

Mount Sinai School of Medicine 

New York, NY 

Michele A. Hamilton, MD 

Cedars-Sinai Medical Center 


Joshua M. Hare, MD 

University of Miami 

Miami, FL 

Paul J. Hauptman, MD 

St. Louis University 

St. Louis, MO 

Paul A. Heidenreich, MD, MS 

VA/Stanford University 

Palo Alto, CA 

Adrian F. Hernandez, MD 


Durham, NC 


Temple University 


Jonathan G. Howlett, MD 

University of Calgary 

Calgary, AB, Canada 



Stanford, CA 

Claire Hunter, MD 

Creighton University 

Omaha, NE 

Dennis Irwin, MD 

OptumHealth Care Solutions 


Brian Jack, MD 


Boston, MA 

James L. Januzzi, Jr., MD 


Boston, MA 

Shahrokh Javaheri, MD 

Sleepcare Diagnostics 

Mason, OH 




Roy M. John, PhD, MB 


Boston, MA 

Jacob Joseph, MD 

VA Boston Health Care System 

West Roxbury, MA 

Karen E. Joynt, MD 


Boston, MA 

Raj Kishore, PhD 


Chicago, IL 

Michelle M. Kittleson, MD, PhD 



Jon A. Kobashigawa, MD 



Walter J. Koch, PhD 



Todd M. Koelling, MD 


Ann Arbor, MI 

Alan T. Kono, MD 

Dartmouth University 

Lebanon, NH 

Marvin A. Konstam, MD 


Boston, MA 

Bruce A. Koplan, MD 


Boston, MA 

Robert L. Kormos, MD 



Peter R. Kowey, MD 

Lankenau Medical Center 

Wynnewood, PA 

Evangelia G. Kranias, PhD 

University of Cincinnati 

Cincinnati, OH 

Raymond Y. Kwong, MD 


Boston, MA 

16 17

Bonnie Ky, MD, MSCE 



Edward G. Lakatta, MD 

National Institutes of Health 

Baltimore, MD 

Neal Lakdawala, MD 


Boston, MA 

Michael J. Landzberg, MD 

Children’s Hospital 

Boston, MA 

David E. Lanfear, MD 

Henry Ford Health System 

Detroit, MI 

Carl V. Leier, MD 


Columbus, OH 

Daniel J. Lenihan, MD 


Nashville, TN 

Terry A. Lennie, RN, MS, PhD 

University of Kentucky 

Lexington, KY 

Annarosa Leri, MD 


Boston, MA 

Bruce B. Lerman, MD 

Cornell University 

New York, NY 

Eldrin F. Lewis, MD 


Boston, MA 

Gregory D. Lewis, MD 


Boston, MA 

Ronglih Liao, PhD 


Boston, MA 

Peter Libby, MD 


Boston, MA 

Katherine Lietz, MD, PhD 

Loyola University 

Maywood, IL 



Denver, CO 

Mark S. Link, MD 


Boston, MA 

William C. Little, MD 

Wake Forest University 

Winston-Salem, NC 

Peter P. Liu, MD 

University of Toronto 


Barry London, MD, PhD 



Joseph Loscalzo, MD, PhD 


Boston, MA 

Douglas W. Losordo, MD 


Chicago, IL 

Donna M. Mancini, MD 


New York, NY 

Brian F. Mandell, MD, PhD 


Cleveland, OH 

Douglas L. Mann, MD 


St. Louis, MO 

Kenneth B. Margulies, MD 



Ali J. Marian, MD 

University of Texas 

Houston, TX 

Tony Martin, RN, APRN 

Morris Plains, NJ 

Frederick A. Masoudi, MD, MSPH 


Denver, CO 

M. Patricia Massicotte, MD, MHSc 

University of Alberta 




San Francisco 


Paul J. Mather, MD 



Simon Maybaum, MD 

Albert Einstein College 

New York, NY 

Michael A. Mathier, MD 



Kathleen M. McCauley, RN, PhD 


Pennsylvania, PA 

Elizabeth M. McNally, MD, PhD 

University of Chicago 

Chicago, IL 

Dennis M. McNamara, MD 



Mandeep R. Mehra, MD 


Baltimore, MD 

Gregory F. Michaud, MD 


Boston, MA 

Melissa A. Mikelson, RN, BSN 

Marshfield Clinic 

Marshfield, WI 


University of South Florida 

Tampa, FL 

Frank Misselwitz, MD, PhD 

Bayer Schering Pharma AG 

Wuppertal, Germany 

Daria Mochly-Rosen, PhD 


Stanford, CA 

Nicanor Ilie Moldovan, PhD 


Columbus, OH 

Jeffery D. Molkentin, PhD 

Cincinnati Children’s 

Hospital Medical Center 


Stephanie A. Moore, MD 


Boston, MA 

Rohinton J. Morris, MD 

Abington Memorial Hospital 

Abington, PA 

Matthew A. Movsesian, MD 

VA Healthcare System 


Debra K. Moser, RN, DNSc 

University of Kentucky 

Lexington, KY 


University of Utah 


Anju Nohria, MD 


Boston, MA 

Thomas E. Noonan, MD 

CV Institute of New England 

Pawtucket, RI 

John B. O’Connell, MD 

St. Joseph’s Hospital 

Atlanta, GA 

Christopher M. O’Connor, MD 


Durham, NC 

Milton Packer, MD 


Dallas, TX 

Robert Lee Page, PharmD, MSPH 


Denver, CO 

Peter S. Pang, MD 


Chicago, IL 

Myung H. Park, MD 


Baltimore, MD 

Ayan R. Patel, MD 


Boston, MA 

J. Herbert Patterson, PharmD 

University of North Carolina 


Sara C. Paul, RN, MSN, DNP 

Western Piedmont Heart Centers 

Hickory, NC 

Michael G. Petty, CCNS, ACNS 



Marc A. Pfeffer, MD, PhD 


Boston, MA 

Mariann R. Piano, RN, PhD 

University of Illinois 

Chicago, IL 

18 19

Ileana L. Piña, MD 

Albert Einstein College 

Bronx, NY 


UCLA 


Piotr Ponikowski, MD, PhD 

Medical University 

Wroclaw, Poland 

Susan J. Pressler, RN, PhD 


Ann Arbor, MI 

Martha J. Radford, MA, MD 


New York, NY 

Kismet D. Rasmusson, RN, FNP 

Intermountain Medical Center 

Murray, UT 

Lisa D. Rathman, MSN, CRNP 

Lancaster General Hospital 

Lancaster, PA 

Margaret M. Redfield, MD 


Rochester, MN 

Juanita Reigle, RN, MSN, ACNP 

University of Virginia 

Charlottesville, VA 

Michael W. Rich, MD 


St. Louis, MO 

Barbara J. Riegel, RN, DNSc 



Richard J. Rodeheffer, MD 


Rochester, MN 

Joseph G. Rogers, MD 


Durham, NC 

Heather J. Ross, MD 

The Toronto Hospital 



Johns Hopkins University 

Baltimore, MD 


Henry Ford Health System 

Detroit, MI 

20 

Junichi Sadoshima, PhD, MD 

UMDNJ 

Newark, NJ 

Jeffrey E. Saffitz, MD, PhD 



Boston, MA 

Flora Sam, MD 


Boston, MA 

Martin A. Samuels, MD 


Boston, MA 

Douglas B. Sawyer, MD, PhD 


Nashville, TN 

Kristen G. Schaefer, MD 

Dana-Farber Cancer Institute 

Boston, MA 



Durham, NC 

Gerilynn M. Schott, MSN, CRNP 



Christine E. Seidman, MD 

Harvard University 

Boston, MA 

Marc J. Semigran, MD 


Boston, MA 

Monica R. Shah, MD 

National Heart, Lung and 

Blood Institute 

Bethesda, MD 

Ravi V. Shah, MD 


Boston, MA 

Julie B. Shea, RNCS, MS, CCDS 


Boston, MA 

Julie A. Shinn, RN, MA, CCRN 


Stanford, CA 

Marc A. Silver, MD 

Christ Hospital and Medical Center 

Oak Lawn, IL 

Robert D. Simari, MD 


Rochester, MN 

Jagmeet P. Singh, MD, PhD 


Boston, MA 

Mark S. Slaughter, MD 



Mara T. Slawsky, MD, PhD 

Baystate Medical Center 

Springfield, MA 

Andrew L. Smith, MD 

Emory University Hospital 

Atlanta, GA 

Paul A. Sobotka, MD 



Virend K. Somers, MD 

Mayo Clinic and Foundation 

Rochester, MN 

Scott D. Solomon, MD 


Boston, MA 

Pothur R. Srinivas, PhD, MPH 

National Institutes of Health 

Bethesda, MD 

Marshall S. Stanton, MD 


Mounds View, MN 



Cleveland, OH 

Josef Stehlik, MD, MPH 

University of Utah 


Kenneth M. Stein, MD 

Boston Scientific Corporation 

St. Paul, MN 

Lynne Warner Stevenson, MD 


Boston, MA 

Willliam G. Stevenson, MD 


Boston, MA 

Garrick C. Stewart, MD 


Boston, MA 

Wendy Gattis Stough, PharmD 

Campbell University 

Cary, NC 

Benjamin Sun, MD 

Abbott Northwestern Hospital 



San Diego State University 

San Diego, CA 

Karl Swedberg, MD, PhD 

Sahlgrenska University 

Gothenburg, Sweden 

Nancy K. Sweitzer, MD, PhD 

University of Wisconsin 

Madison, WI 

W.H. Wilson Tang, MD 


Cleveland, OH 

David O. Taylor, MD 


Cleveland, OH 

Ryan J. Tedford, MD 

Johns Hopkins University 

Baltimore, MD 

John R. Teerlink, MD 

San Francisco VAMC 


Andre Terzic, MD, PhD 


Rochester, MN 

Jeffrey M. Testani, MD 



Jeffrey J. Teuteberg, MD 



Jeffrey A. Towbin, MD 

Cincinnati Children’s Hospital 



Patricia A. Uber, PharmD 


Baltimore, MD 

James E. Udelson, MD 


Boston, MA 

Anne Marie Valente, MD 


Boston, MA 

Eva van Rooij, PhD 

miRagen Therapeutics 

Boulder, CO 

21

Dirk J. van Veldhuisen, MD, PhD 

University Medical Centre 

Groningen, The Netherlands 

Hector O. Ventura, MD 

Ochsner Medical Center 

New Orleans, LA 

Joseph G. Verbalis, MD 

Georgetown University 



St. Vincent Heart Center of Indiana 

Indianapolis, IN 

Da-Zhi Wang, PhD 


Boston, MA 

Yibin Wang, PhD 

UCLA 


Aaron B. Waxman, MD, PhD 


Boston, MA 

Xander H.T. Wehrens, MD, PhD 

Baylor College 

Houston, TX 

Andrew R. Weintraub, MD 


Boston, MA 

David J. Whellan, MD, MHS 



Connie L. White-Willliams, RN, PhD 

University of Alabama 

Birmingham, AL 

Ronald M. Witteles, MD 


Stanford, CA 

Kelly Wolf, MSW, LCSW 

Newark Beth Israel Medical Center 

Newark, NJ 



Durham, NC 

Clyde W. Yancy, MD, MSc 


Chicago, IL 

James B. Young, MD 


Cleveland, OH 


Medical University of 

South Carolina 


Sunday-September 18, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Room 302 Room 304 Room 311 Room 312 

11:00 AM-1:30 PM Scientific Session 

Clinical Fundamentals: 

Heart Failure Evaluation 

and Medical Therapy 

1:00-3:00 PM Satellite Symposium 

Evaluating the Right 

Ventricle: A Practical 

Guide for the Heart Failure 

Clinician 

3:00-4:00 PM 

Scientific Session 

Excellence in Basic Science 

(featured speaker: Christine 

E. Seidman, MD) 

3:30 - 6:00 PM 

Scientific Session 

Heart Failure and VADs: 

Does Extended Support 

Change the Game? 

(4:30-6:00 PM) 

Satellite Symposium 

Novel Strategies to Enhance 

Response to the Cardiac 

Resynchronization Therapy 

Patient: A Clinician Update 

4:00-6:00 PM Satellite Symposium 

Improving Outcomes in 

Heart Failure Complicated 

by Hyponatremia 

6:00 PM Opening Reception 15 th Annual Scientific Meeting - Poster-Exhibit Area (Exhibit Hall D) Hynes Convention Center 

22 23

Monday-September 19, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Ballroom B Ballroom C Room 302 Room 304 

6:30 AM Continental Breakfast available in foyer areas 

6:45 AM Satellite Symposium 

Addressing the Challenge of 

Central Sleep Apnea in Heart 

Failure 

8:00 AM Welcome/Opening Remarks 

2011 HFSA Lifetime Achievement Award 

8:15 AM Opening Plenary Session 

The Brain Connection 

10:00 AM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

10:30 AM Symposium 

Double Trouble: 

Comorbidities and Cases in 

Heart Failure 

Symposium 

Where Is the Route to Heart 

Failure Recovery? 

Symposium 

Pills or Power? Treatment of 

Arrhythmias 

Satellite Symposium 

Update on Heart Failure 

Device Diagnostics: 

Challenges and Opportunities 

Symposium 

MicroRNA in Cardiovascular 

Disease 

Monday-September 19, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Ballroom B Ballroom C Room 302 Room 304 Room 306 Room 310 Room 312 

NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 38 for Monday posters; visit posters until 7:00 PM 

12:30-1:30 PM How To Sessions 

(4) See page 43 

for locations 

2:00 PM Symposium 

Quality of Care 

and Heart Failure 

Guidelines: 

Progress and 

Controversies 

Symposium 

Fluid and Flow 

3:30 PM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

4:00 PM Late Breaking 

News 

Nursing 

Research Award 

Symposium 

The Problem 

with 

Readmission 

Jay N. Cohn 

New Investigator 

Award: 

Clinical/ 

Integrative 

Physiology 

5:30 PM Wine and Hors d’oeuvres in Poster Area Exhibit Hall (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close (Exhibit Hall re-opens Tuesday 9:30 AM-7:00 PM) 

Symposium 

Inhibitors of 

Cardiac Kinases 

and Phosphatases 

To Treat the 

Failing Heart 

Jay N. Cohn 

New Investigator 

Award: 

Basic Science 

MOC Session 

Advanced 


and Transplant 

Cardiology Part I 

MOC Session 

Advanced 


and Transplant 

Cardiology 

Part II 

Rapid Fire Oral 

Abstract Session 

Symposium 

Are We An 

Ocean Apart for 

Devices? 

24 

25

Tuesday-September 20, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Ballroom C Room 302 Room 304 Room 306 

6:45 AM Continental Breakfast available in foyer areas 

Roundtable 

Centers for VAD/Transplant/ 

Heart Failure: All or None? 

7:00 AM Clinical Fundamentals 

Transplantation/Palliative 

Care 

Symposium 

How Can We Improve Stem 

Cells for Heart Failure 

Therapy? 

Symposium 

What Works to Decrease 

Readmissions? 

Symposium 

Before and After Cardiac 

Transplantation 

Symposium 

Time To Slow Down 


Improving Outcomes after 

Hospitalization for Heart 

Failure: A Call for Action 

26 

10:00 AM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

Symposium 

Genes in the Heart 

Symposium 

Mechanisms to Prevent 

Sudden Death 

Symposium 

Take a Deep Breath 

10:30 AM Case Discussion Symposium 

Implantable Pacing/ 

Defibrillation Devices 

Tuesday-September 20, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Ballroom B Room 302 Room 304 Room 306 Room 312 

NOON Lunch Break – Exhibit Hall opens at 9:30 AM; see page 93 for Tuesday posters; visit posters until 7:00 PM 

Rapid Fire Oral 

Abstract Session 

12:30-1:30 PM How To Sessions (3) 

See page 100 for 

locations 

1:45 PM Announcement of Awards 

Symposium 

Patients Ask About 

Stem Cells: Are We 

Almost There Yet? 

2:00 PM Hyde Park Session Symposium 

Through Thick 

and Thin: Issues in 

Anticoagulation 

27 

3:30 PM Coffee Break – Exhibit Hall (Posters displayed 9:30 AM-7:00 PM) 

Symposium 

Status with Novel 

Proteins and 

Metabolic Markers in 

Characterizing Heart 


Symposium 

Oxidative Stress and 

Uric Acid 

Symposium 

Paradox on the Right 

4:00 PM Debate Session 

How Do You Vote: The Weekly Meeting; 

Risk Stratification Is an Intervention 

5:30 PM Wine and Hors d’oeuvres in poster/exhibit area (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close

Wednesday-September 21, 2011 HFSA 15th Annual Scientific Meeting – September 18-21, 2011 – Boston, MA 

Ballroom A Room 302 Room 304 Room 306 Room 311 

7:00 AM Continental Breakfast available in foyer areas Clinical Fundamentals 

Atrial and Ventricular 

Arrhythmias/Troubleshooting 

CRT/ICD/Mechanical 

Circulatory Support 

8:15 AM HFSA Annual Business 

Meeting 

Symposium 

Cancer Chemotherapy and 

Cardiotoxicity 

Symposium 

The Supported Circulation 

Symposium 

What to Evaluate After the 

Office Visit: To Diagnose, 

Predict or Guide? 

8:30 AM Guideline Session 

Guideline Updates 

2011: What’s Current, 

Controversial, and Coming 

Next 

28 

10:00 AM Coffee Break in meeting foyer areas 

Symposium 

Hope for Heart Failure with 

Preserved Ejection Fraction 

Symposium 

Making Decisions with Level 

of Evidence C 


How Will Therapy Change 

This Year? 

12:00 PM Scientific Meeting adjourned. 16 th Annual Scientific Meeting: September 9-12, 2012, Seattle, WA

Welcome to the 

15th Annual 

Scientific Meeting 

September 18 – 21, 2011 

Hynes Convention Center 

Boston, MA 

www.hfsa.org 

29

Sept. 18 

Sunday 

AM 

SCIENTIFIC SESSION 


11:00 AM-1:30 PM 

Room 312 

SATELLITE SYMPOSIUM 


1:00-3:00 PM 

Room 302 

Sept. 18 

Sunday 

PM 

sundAY 

Clinical Fundamentals: Heart Failure 

Evaluation and Medical Therapy 

Evaluating the Right Ventricle: 

A Practical Guide for the Heart Failure Clinician 

SundAY 

Moderators: Larry A. Allen, Denver, CO 

Akshay M. Desai, Boston, MA 

11:00 Introduction to Clinical Fundamental Curriculum 


11:05 Baseline Evaluation for Etiology of Heart Failure 

Todd M. Koelling, Ann Arbor, MI 

Chair: 

Mandeep R. Mehra, Baltimore, MD 

1:00 Welcome and Introduction 


1:05 Insights into Right Ventricular Failure: 

A Distinctive Pathophysiology 

Paul R. Forfia, Philadelphia, PA 

11:15 Use and Limitation of Classification Systems of Type/ 

Stage and NYHA Class 

Stuart D. Russell, Baltimore, MD 

11:25 Initiation and Titration of ACEI/ARB/Aldosterone 

Antagonists and Beta Blockers 

Jonathan G. Howlett, Calgary, AB, Canada 

1:25 Question and Answers (ARS) 

1:30 Emerging and Establishing Concepts in PAH 

Management: Practical Insights 

Robert P. Frantz, Rochester, MN 


11:45 Indications for CRT/ICD 

Kenneth A. Ellenbogen, Richmond, VA 

12:00 Questions and Answers 

Faculty 

2:00 Adults with Repaired Congenital Heart Defect: 

Not Everything is Free and Clear 

Michael J. Landzberg, Boston, MA 


12:15 Assessment of Hemodynamic Status by Clinical 

Assessment and Indications for Right Heart 

Catheterization 

Mark H. Drazner, Dallas, TX 

12:30 Recognition and Approach to Acute Decompensated 


Mara T. Slawsky, Springfield, MA 

12:45 Adjunctive Therapies: Aldosterone Antagonists, Nitrates, 

Hydralazine Isosorbide Dinitrate 

Jacob Joseph, West Roxbury, MA 

12:55 Use of Diuretics 

Javed Butler, Atlanta, GA 

2:30 Taking Stock of Right and Left Issues: 

The “Politics” of the Horse and the Cart 

Milton Packer, Dallas, TX 

2:50 Question and Answers 

Learning Objectives: 

1. Describe the unique pathology of right ventricle (RV) failure 

2. Use appropriate hemodynamic assessment of the 

identification of RV failure 

3. Describe effective strategies for managing pulmonary 

arterial hypertension (PAH) 

4. Evaluate and manage adult patients with repaired congenital 

heart defects 

5. Effectively assess the differences between right and left 

ventricular failure 


Faculty 

Supported by an educational grant from Actelion 

Pharmaceuticals 

Learning Objective: Describe methods for evaluating acute and 

chronic heart failure and standard drug and device therapy. 

This program is part of the scientific program 

as planned by the HFSA Scientific Program 

Committee. 

This program is not part of the scientific program 


Committee. 

30 

31

Sept. 18 

Sunday 

PM 

SCIENTIFIC SESSIoN 


3:30-6:00 PM 

Room 312 

SCIENTIFIC SESSIoN 


4:30-6:00 PM 

Room 311 

Sept. 18 

Sunday 

PM 

sundAY 

Excellence in Basic Science 

Moderators: Steven R. Houser, Philadelphia, PA 

Matthew J. Wolf, Durham, NC 

3:30* Genetic Bases of Dilated Cardiomyopathy 

5th Distinguished Lecture in Basic Science 

Christine E. Seidman, Boston, MA 

(Award to be presented immediately following lecture) 

4:30* Developmental Defects and Adult Cardiac Disease 

Jonathan A. Epstein, Philadelphia, PA 

Heart Failure and VADs: Does Extended 

Support Change the Game? 

Joint Session of the HFSA and International Consortium of 

Circulatory Assist Clinicians (ICCAC) 

Moderators: Keith D. Aaronson, Ann Arbor, MI 

Tony Martin, Morris Plains, NJ 

4:30* What Role Should Psychosocial Assessment Play in 

Patient Selection? 

Kelly Wolf, Newark, NJ 

SundAY 

5:00* Epigenetics and Heart Failure 

Gerald W. Dorn, II, St. Louis, MO 

5:30* Molecular Genetics and Pathogenesis of Arrhythmogenic 

Right Ventricular Cardiomyopathy 

Ali J. Marian, Houston, TX 

*Includes 5 minute audience discussion 

Learning Objective: Discuss the genetic bases of dilated 

cardiomyopathy and cardiac arrhythmias, the role of 

developmental defects in adult cardiac disease, and the role 

of epigenetics in the study of heart failure. 

4:45* Enhancing Collaboration with Heart Failure Programs: 

The Right Time for Referral 

Maria Rosa Costanzo, Naperville, IL 

5:00* Long-Term Management: Caring for Patients to Keep 

Them at Home 

Laura A. Coyle, Oak Lawn, IL 

5:15* Family Caregivers: Supporting the Support System 

Michael G. Petty, Minneapolis, MN 

5:30* End of Life: When the Heart is Taken out of the 

Equation 

James N. Kirkpatrick, Philadelphia, PA 

5:45 Panel Discussion 

*12 minute presentation, 3 minute audience discussion 

Learning Objective: Describe the role of extended support 

options in the care of patients with heart failure and VADs 



Committee. 



Committee. 

6:00 Opening Reception 

2011 HFSA Annual Scientific Meeting 

Exhibit Hall D 




32 

33

Sept. 18 

Sunday 

PM 



4:00-6:00 PM 

Ballroom A 



4:00-6:00 PM 

Room 304 

Sept. 18 

Sunday 

PM 

sundAY 

Chair: 

Improving Outcomes in Heart Failure 

Complicated by Hyponatremia 

Marvin A. Konstam, Boston, MA 

4:00 Welcome and Introduction 


4:05 Hyponatremia in Heart Failure: Vasopressin Release and 

Other Mechanisms 

Joseph G.Verbalis, Washington, DC 

4:25 Questions and Answers (ARS) 

4:30 Is Hyponatremia a Marker or Mediator of Worsening 

Outcomes in Heart Failure? 

Gregg C. Fonarow, Los Angeles, CA 


4:55 Insights from the Vasopressin Trials 

James E. Udelson, Boston, MA 


5:20 Clinical Implications: Approaches to Managing Patients 

with Heart Failure and Hyponatremia 

Barry H. Greenberg, San Diego, CA 



1. Review the prevalence, pathophysiology and clinical 

implications of hyponatremia in patients with heart failure 

including the relationship between the kidney and heart in 

acute decompensated heart failure (ADHF) 

2. Discuss most recent data on the clinical consequences of 

hyponatremia in heart failure 

3. Identify the role of free water clearance and hyponatremia in 

ADHF and the renal consequences of neurohormonal activation 

4. Discuss the current guidelines and emerging therapeutic 

options for the prevention and treatment of hyponatremia in 

patients with heart failure 

Supported by an educational grant from Otsuka America 

Pharmaceuticals, Inc. 

Chair: 

Novel Strategies to Enhance Response to the 

Cardiac Resynchronization Therapy Patient: A 

Clinician Update 

Jagmeet P. Singh, Boston, MA 

4:00 Introduction and Overview 


4:05 Cardiac Resynchronization Therapy: 

Evidence and Guidelines 



4:30 Imaging of the CRT Patient for Patient Selection and 

Follow-up: Can this Improve Response? 

John Gorcsan, III, Pittsburgh, PA 


4:55 Can We Use Device Diagnostic Information to Optimize 

Medical Management in the Heart Failure Patient? 

John P. Boehmer, Hershey, PA 


5:20 Multidisciplinary Care for the CRT Patient: Will It 

Improve Outcomes? 

Mariell L. Jessup, Philadelphia, PA 




1. Discuss the criteria for selection of HF patients suitable for 

cardiac resynchronization therapy (CRT) 

2. Recognize the challenges in identifying the CRT nonresponder, 

and minimizing non-responses through optimal 

lead placement and CRT programming 

3. Outline the evolving role of aggressive HF management 

based on physiologic data, and discuss the impact of 

multidisciplinary clinics 

4. Review the most recent clinical data regarding the role of 

biventricular (BiV) pacing in improving patient outcomes 

Supported by an educational grant from Medtronic, Inc. 

SundAY 



Committee. 



Committee. 







34 

35

Sept. 19 

Monday 

AM 



6:45-7:45 AM 

Room 302 

OPENING PLENARY SESSION 


8:00-10:00 AM 

Ballrooms A-B 

Sept. 19 

Monday 

AM 

MondAY 

Chair: 

Addressing the Challenge of Central Sleep Apnea 

in Heart Failure 

William T. Abraham, Columbus, OH 

6:45 Welcome and Overview of the Role of Sleep Apnea 

Disorders in Heart Failure 


6:50 Central Sleep Apnea in Heart Failure: Mechanisms of 

Disease and Clinical Impact 

Virend K. Somers, Rochester, MN 

8:00 Welcome and Opening Remarks 

Lynne Warner Stevenson, Boston, MA 

8:05 2011 HFSA Lifetime Achievement Award: 

Kathleen A. Dracup 

Presented by Barbara J. Riegel, Philadelphia, PA 

The Brain Connection 

Moderators: Barry M. Massie, San Francisco, CA 


MondAY 

7:10 Treatment Landscape for Heart Failure Patients with 

Central Sleep Apnea: Current and Evolving Therapies 

Shahrokh Javaheri, Mason, OH 



1. Describe the mechanisms of central sleep apnea (CSA) 

and identify it’s clinical impact with patients with heart 

failure 

2. Discuss current therapeutic options and evolving therapies 

for CSA in patients with heart failure 

Supported by an educational grant from Respicardia 

8:15 Memory: Building and Keeping It 

Majid Fotuhi, Baltimore, MD 

8:40 “Voodoo” Death Revisited: The Modern Lessons of 

Neurocardiology 

Martin A. Samuels, Boston, MA 

9:05 Mindfulness and the Heart/Brain Connection 

Deepak Chopra, Carlsbad, CA 

Learning Objective: Describe the role of the heart/brain 

connection in cardiovascular disease and its implication for 

clinical practice. 


6:45-7:45 AM 

Room 304 

Update on Heart Failure Device Diagnostics: 

Challenges and Opportunities 

Chair: 

David J. Whellan, Philadelphia, PA 

6:45 Heart Failure Diagnostics and Management: 

Framing the Problem 


6:55 What’s New in Technology that Might Improve Patient Care 

Philip B. Adamson, Oklahoma City, OK 

7:15 Data in your Clinical Practice: Obtaining Data, 

Managing Data, and Improving Patient Care 

Nancy M. Albert, Cleveland, OH 


Supported by an educational grant from CardioMEMS 

These programs are not part of the scientific 

program as planned by the HFSA Scientific 

Program Committee. 

10:00 Coffee Break 

Refreshments served in Exhibit Halls C and D 

36 

37

Sept. 19 

Monday 

AM 

POSTERS DISPLAYED 


9:30 AM-7:00 PM 

Exhibit Hall C 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom A 

Sept. 19 

Monday 

AM 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

Double Trouble: Comorbidities and Cases in 


MondAY 

Categories Poster # 

Cardiovascular Physiology 016-035 

Cardiovascular Structure 056-060 

Moderators: Barbara J. Riegel, Philadelphia, PA 

Douglas D. Schocken, Durham, NC 

10:30 Prevalence of Major Comorbidities in Heart Failure Low 

Ejection Fraction and Heart Failure Preserved Ejection 

Fraction 

Robert Lee Page, II, Denver, CO 

MondAY 

Neurohormones/Cytokines 066-082 

10:40 What Do Patients Face? 

Victoria V. Dickson, New York, NY 

Molecular Biology and Genetics 099-106 

10:50 Writing Guidelines to Include Comorbidities 

JoAnn Lindenfeld, Denver, CO 

Surgery, Transplantation, Devices 115-137 

11:00 Drug Dosing for Heart Failure with Comorbidities 

Mark A. Munger, Salt Lake City, UT 

Electrophysiology/Arrhythmias 162-170 

11:10 When Depression Prevents Optimal Medical Therapy 

Lynn V. Doering, Los Angeles, CA 

Clinical Trials 179-187 

Cardiovascular Pharmacology 198-205 

Epidemiology, Prevention 214-220 

Outcomes 228-254 

Clinical Care/Management Strategies 282-318 

11:20 Case Management Problems Around Comorbidity 

Lee R. Goldberg, Philadelphia, PA 

Claire Hunter, Omaha, NE 

Mark A. Munger, Salt Lake City, UT 

Sara C. Paul, Hickory, NC 


Faculty 

Learning Objective: Describe strategies for treating 

comorbidities in patients with heart failure. 

Listing for Monday posters begins on page 58 

Listing for Tuesday posters begins on page 110 



38 

39

Sept. 19 

Monday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom C 

SYMPOSIUM 


10:30 AM-NOON 

Room 302 

Sept. 19 

Monday 

AM 

Where Is the Route to Heart Failure Recovery? 

Pills or Power? Treatment of Arrhythmias 

Moderators: Douglas L. Mann, St. Louis, MO 

Hani N. Sabbah, Detroit, MI 

Moderators: Alfred E. Buxton, Boston, MA 

Barry London, Pittsburgh, PA 

MondAY 

10:30* Is There a “Right” Stem Cell To Repair the 

Failing Heart? 

Mark A. Sussman, San Diego, CA 

10:48* Gene Therapy for the Failing Heart 

Roger J. Hajjar, New York, NY 

10:30 Arrhythmias in Heart Failure Low Ejection Fraction 

vs. Preserved Ejection Fraction 

Alfred E. Buxton, Boston, MA 

10:45 Ablation vs. Drug Suppression of Atrial Fibrillation 

Gregory F. Michaud, Boston, MA 

MondAY 

11:06* How Can We Recognize Recovery? 

Scott D. Solomon, Boston, MA 

11:24* Ventricular Assist Devices to Support Recovery 

Emma J. Birks, Louisville, KY 

11:42* Inducing Stem Cells to the Cardiovascular Lineage with 

Biomaterials 

Nicanor I. Moldovan, Columbus, OH 


Learning Objective: Describe emerging methods for 

promoting heart failure recovery. 

11:00 AV Node Ablation for Atrial Fibrillation: 

When and How to Pace 

James P. Daubert, Durham, NC 


Alfred E. Buxton, Boston, MA 



11:30* Current State of Drugs vs. Ablation for 

Ventricular Tachycardia 

William G. Stevenson, Boston, MA 

11:45* Ventricular Arrhythmias Before and After 

Ventricular Assist Devices 

Hasan Garan, New York, NY 


Learning Objective: Assess options for the treatment of 

arrhythmias in patients with heart failure. 

40 

41

Sept. 19 

Monday 

AM 

MondAY 

SYMPOSIUM 


10:30 AM-NOON 

Room 304 

MicroRNA in Cardiovascular Disease 

Moderators: Steven Goldman, Tuscon, AZ 

Jeffery D. Molkentin, Cincinnati, OH 

10:30* MicroRNA and Heart Failure Diagnosis 

Joseph A. Hill, Dallas, TX 

10:48* MicroRNA and Cardioprotection 

Maha Abdellatif, Newark, NJ 

11:06* MicroRNA and Pathological Cardiac Hypertrophy 

Gianluigi Condorelli, Rome, Italy 

11:24* MicroRNA and Congenital Heart Disease 

Da-Zhi Wang, Boston, MA 

11:42* MicroRNA as Therapeutic Targets in Ischemic 

Heart Disease 

Eva van Rooij, Boulder, CO 

*15 minute presentation, 2-3 minute audience discussion 

Learning Objective: Describe the role of microRNA in 

cardiovascular disease and its implications for heart failure 

therapy. 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

1. Tools for End-of-Life Discussion: Finding the Words, Room 302 

Dosing the Drugs 

Nathan E. Goldstein, New York, NY 

Juanita Reigle, Charlottesville, VA 

Kristen G. Schaefer, Boston, MA 

Learning Objective: Describe strategies for effective 

end-of-life discussion with heart failure patients and 

their families. 

2. Don’t Miss Causes of Heart Failure Room 304 

Neal Lakdawala, Boston, MA 

Dennis M. McNamara, Pittsburgh, PA 

Learning Objective: Identify important, but sometimes 

overlooked, causes of heart failure. 

3. What Reviewers Look for in Your Articles Room 306 

Gary S. Francis, Minneapolis, MN 

Debra K. Moser, Lexington, KY 


Learning Objective: Outline the features of successful 

journal article submissions. 

Sept. 19 

Monday 

PM 

4. Reading the ICD Print Out Room 311 

Bruce A. Koplan, Boston, MA 

Gerilynn M. Schott, Philadelphia, PA 

Julie B. Shea, Boston, MA 

MondAY 

Learning Objective: Describe what to look for in an 

ICD print out and what the implications are for treatment. 

42 

43

Sept. 19 

Monday 

PM 

ORAL ABSTRACT SESSION 


12:30-1:45 PM 

Room 312 



12:30-1:45 PM 

Room 312 

Sept. 19 

Monday 

PM 

Rapid Fire Abstracts 

Rapid Fire Abstracts (cont.) 

MondAY 

Moderators: Carl V. Leier, Columbus, OH 

Peter P. Liu, Toronto, ON, Canada 

12:30* The Swanz-Ganz Catheter and UNOS IA Patients: 287 

The Routine Change Challenge 

Jason A. Gluck, Roja Mulamalla, Joseph Radojevic, Justin 

Lundbye, Detlef Wencker, Hartford Hospital, Hartford, CT 

12:36* Who Wants an LVAD for Ambulatory Heart Failure? 118 

Garrick C. Stewart, Michelle M. Kittleson, Jennifer A. 

Cowger, Frances L. Johnson, Chetan B. Patel, Maria M. 

Mountis, Parag Patel, Eduardo Rame, Maya E. Guglin, 

Jeffrey J. Teuteberg, Lynne W. Stevenson, Brigham and 

Women’s Hospital, Boston, MA 

12:42* Hemodynamic Predictors of Renal Function 122 

Following Left Ventricular Assist Device 

Implantation 

Gabriel T. Sayer, Shiela Sahni, Kimberly Ashley, Rachel 

Flynn, Ajith P. Nair, Anelechi C. Anyanwu, Michael J. 

Domanski, Sean P. Pinney, Mount Sinai Medical Center, 

New York, New York 

12:48* A Multimarker Panel lmproves Risk Prediction 066 

in Chronic Heart Failure 

Bonnie Ky, Benjamin French, James C. Fang, Nancy 

K. Sweitzer, Wayne C. Levy, Alan H.B. Wu, Lee R. 

Goldberg, Marriel Jessup, Thomas P. Cappola, University 

of Pennsylvania, Philadelphia, PA 

12:54* The Intermountain Risk Score Stratifies Mortality 235 

Risk in Heart Failure Patients Receiving an ICD 

Based on Pre-Implant Laboratory Values 

Kimberly D. Brunisholz, Benjamin D. Horne, Roberta 

James, Kyle D. Balling, Kismet D. Rasmusson, Deborah 

Budge, Rami Alharethi, Dylan P. Nelson, Joseph M. Tuinel, 

Abdallah G. Kfoury, Intermountain Medical Center, Salt 

Lake City, UT 

1:00* Development and Prospective Validation of 229 

Pediatric Heat Failure Risk-Prediction Model for 

30-Day Mortality in US Children Listed for Heart 


Christopher S. Almond, Kimberlee Guavreau, Charles 

E. Canter, Gary E. Piercey, T.P. Singh, Children’s 

Hospital, Boston, MA 

(continued next page) 

*3 minutes to present, 2 minute discussion 

1:06* The Impact of Prior Heart Failure Hospitalization 233 

on Long-Term Mortality Differs by Baseline Risk 

of Death 

Scott L. Hummel, Naga V.A. Kommuri, Todd M. 

Koelling, Detroit Medical Center, Ann Arbor, MI 

1:12* Changes in Galectin-3 Levels Over Time Predict 294 

Mortality and Morbidity in Chronic HF 

Rudolf A. de Boer, Dirk J. van Veldhuisen, Lars Gullestad, 

Thor Ueland, Pal Aukrust, Yu Guo, Aram S. Adourian, 

Pieter Muntendam, University Medical Center, Groningen, 

Netherlands 

1:18* Natriuetic Peptide Receptor 3 Genotype is 198 

Associated with Altered Pharmacokinetics During 

Nesiritide Infusion 

David E. Lanfear, James Yang, Karen Leszczynski, Hani N. 

Sabbah, Henry Ford Hospital, Detroit, MI 

1:24* Treatment with CBA-NP a Novel Chimeric 068 

Natruiretic Peptide Attenuates Cardiorenal Fibrosis 

and Improves Diastolic Dysfunction in Diabetic Rat 

Model 

Syed Ameenuddin, Elise A. Oehler, John C. Burnett, Jr., 

Hong H. Chen, Mayo Clinic, Rochester, MN 

1:30* Chronic Cardiac Gene Delivery of proBNP in 067 

Experimental Progressive Hypertensive Heart 

Disease Improves Survival 

Alessandro Cataliotti, Jason M. Tonne, Diego Bellavia, 

Fernando L. Martin, Sarah Mangiafico, John C. Burnett, 

Yasuhiro Ikeda, Mayo Clinic, Rochester MN 

1:36* HF Assessment with BNP in the Home: Primary 289 

Results of the Multicenter HABIT Trial 

Alan S. Maisel, Denise Barnard, Brian Jaski, Geir Frivold, 

John Marais, Barry H. Greenberg, San Diego VA Medical 

Center, San Diego, CA 


Learning Objective: Discuss findings from recent clinical 

research in heart failure. 

To learn more about these studies, visit their posters during 

the poster presentation session in the Exhibit Hall this 

afternoon. 

MondAY 

44 

45

Sept. 19 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom A 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom C 

Sept. 19 

Monday 

PM 

MondAY 

Quality of Care and Heart Failure Guidelines: 

Progress and Controversies 

Moderators: Frederick A. Masoudi, Denver, CO 

Michael W. Rich, St. Louis, MO 

2:00 Quantitating the Improvement in the Use of Guideline 

Therapies 

Gregg C. Fonarow, Los Angeles, CA 

2:15 A for One and A for All? Differences in the Level of 

Evidence Between Subgroups 

G. Michael Felker, Durham, NC 


2:45 Current Status of Heart Failure Quality of Care in the 

United States 

Martha J. Radford, New York, NY 

3:00 If We Pay for Performance, What Will We Get? 

Jalal K. Ghali, Detroit, MI 


Learning Objective: Describe the role of guidelines in the 

treatment of heart failure. 

Fluid and Flow 

Moderators: John C. Burnett, Jr., Rochester, MN 

Steven R. Goldsmith, Minneapolis, MN 

2:00 Hormonal Regulation of Fluid Balance 

Margaret M. Redfield, Rochester, MN 

2:10 Kidney Output: Quality as well as Quantity 


2:20 Circulating Markers of Renal Function and Injury 

James L. Januzzi, Jr., Boston, MA 

2:30 Venous Pressure and Renal Function 

W.H. Wilson Tang, Cleveland, OH 

2:40 Hemoconcentration with Diuretics: Good or Bad? 

Jeffrey M. Testani, Philadelphia, PA 

2:50 Hemoconcentration With Ultrafiltration: Good or Bad? 

Bradley A. Bart, Minneapolis, MN 

3:00 Limits for Salt and Fluid Intake 

Terry A. Lennie, Lexington, KY 

3:10 Discussion: Will Diuresis Be Different Next Year? 

Faculty 

3:20 Release the Kidney: Effects of Denervation 

Paul A. Sobotka, Minneapolis, MN 

Learning Objective: Describe the role of the kidney and 

contrast differing strategies for fluid management in the care 

of patients with heart failure. 

MondAY 





46 

47

Sept. 19 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 304 

SYMPOSIUM 


2:00-3:30 PM 

Room 312 

Sept. 19 

Monday 

PM 

The Problem with Readmission 

Are We An Ocean Apart for Devices? 

MondAY 

Moderators: Peter E. Carson, Washington, DC 

David DeNofrio, Boston, MA 

2:00 Can We Really Adjust for Risk? 

Larry A. Allen, Denver, CO 

2:15 Only Half of Readmissions Are for Heart Failure 

Prakash C. Deedwania, Fresno, CA 

2:30 Under-served Populations at Risk 

Karen E. Joynt, Boston, MA 

2:45 Readmissions Can Be Decreased by Increasing Length of 

Stay or Death 

Adrian F. Hernandez, Durham, NC 

3:00 Differences Between the USA and Canada 

J. Malcolm O. Arnold, London, ON, Canada 


Learning Objective: Discuss issues in measurement of 

readmissions and strategies for reducing readmissions 

(Joint Session: HFSA and HFA of the ESC) 

Moderators: Stefan Anker, Berlin, Germany 

Barry M. Massie, San Francisco, CA 

Challenge Presenter: Piotr Ponikowski, Wroclaw, Poland 

Panel: 

Karl Swedberg¸ Gothenburg, Sweden 

Dirk J. Van Veldhuisen, Groningen, The Netherlands 

David Taylor, Cleveland, OH 

Sana M. Al-Khatib, Durham, NC 

2:00 Case 1: ICD in 63 yr old Class II pt with LVED 30, 

non-ischemic, 5 yr diagnosis, on good therapy. 

Does he need a device? 

2:22 Case 2: 82 yr old woman living alone at home with QRS 

170 LBBB, Class III HF symptoms, EF 26, LV Dimension 

7.2, moderate MR, serumcreatinine 1.9. 

Should she have CRT or CRD-D? 

2:45 Case 3: 73 yr old male, 5 yr history of ischemic HF and 

diabetic vascular disease, 5 hospitalizations in past yr, last one 

complicated by 2 ICD shocks for PMVT with hypokalemia. 

Returns to clinic and wants ICD turned off. 

What happens now? 

3:08 Case 4: 68 yr old with new diagnosis HF w/o obvious 

etiology, LVEF 27, LVD 6.2, LBBB QRS 125, presented 

with orthopnea resolved on furosemide. 

How long to wait before considering a device? 

Learning Objective: Discuss the use of devices in selected 

heart failure patients from the European and North American 

perspective. 

MondAY 





48 

49

Sept. 19 

Monday 

PM 

MOC SESSION 


2:00-3:30 PM 

Room 310 

SYMPOSIUM 


2:00-3:30 PM 

Room 306 

Sept. 19 

Monday 

PM 

MondAY 

HFSA Study Session for MOC: Advanced Heart 

Failure and Transplant Cardiology Part I 

(10 Knowledge Points: Must attend both sessions to earn points) 

Moderators: Ileana L. Piña, Bronx, NY 

Marc J. Semigran, Boston, MA 

HFSA has developed an ABIM-approved Self-Evaluation 

of Medical Knowledge Module on Advanced Heart Failure 

and Transplant Cardiology worth 10 points towards 

Maintenance of Certification (MOC). This two-part 

session will review the 25 questions in that module. 

In order to receive MOC points, the module must be 

purchased at www.hfsa.org and successfully completed 

online. CME credit is also granted upon completion of the 

module. There is no CME credit for the review sessions. 

It is not necessary to be board certified in Advanced Heart 

Failure and Transplant Cardiology to complete the module 

or attend these sessions. 

Although there is no additional registration fee to attend 

this session, attendee must be preregistered in order to 

enter the session. 

Learning Objective: Discuss key questions in the 

epidemiology, pathophysiology, and treatment of patients 

with advanced heart failure. 

Inhibitors of Cardiac Kinases and Phosphatases 

To Treat the Failing Heart 

Moderators: Michael R. Bristow, Denver, CO 

Jeffery D. Molkentin, Cincinnati, OH 

2:00* Inhibiting Phosphatases in the Failing Heart 

Yibin Wang, Los Angeles, CA 

2:18* CamKII Inhibition to Improve Cardiac Function 

Mark E. Anderson, Iowa City, IA 

2:36* Phosphatase Inhibition to Improve Myocyte Calcium 

Handling 

Evangelia G. Kranias, Cincinnati, OH 

2:54* PKC Inhibition to Protect the Heart 

Daria Mochly-Rosen, Stanford, CA 

3:12* GRK2 Is More than a Target: An Emerging Clinical 

Biomarker for Heart Failure 

Walter J. Koch, Philadelphia, PA 


Learning Objective: Describe the role of inhibitors of 

cardiac kinases and phosphatases in treating the failing 

heart. 

MondAY 





50 

51

Sept. 19 

Monday 

PM 

LATE BREAKING NEWS 


4:00-5:30 PM 

Ballroom B 

LATE BREAKING NEWS 


4:00-5:30 PM 

Ballroom B 

Sept. 19 

Monday 

PM 

Late Breaking News 

Late Breaking News (cont.) 

Moderators: Eugene Braunwald, Boston, MA 

Jay N. Cohn, Minneapolis, MN 

5:04* Details for this clinical trial where not available at the time 

of printing. Information will be provided on-site. 

MondAY 

4:00* Treatment of ADHF with Soluble Guanylate Cyclase 

Activator Cinaciguat: The COMPOSE Program: Three 

Randomized, Controlled, Phase IIb Studies 

Mihai Gheorghiade, Erland Erdmann, Roberto Ferrari, 

Gerasimos Filippatos, Philip D. Levy, Aldo Maggioni, 

Alexandre Mebazaa, Christina Nowack, Northwestern 

University, Chicago, IL 

4:10 Commentary: 

John C. Burnett, Jr., Rochester, MN 

5:14 Commentary 

5:19 Audience Questions 

*22 minutes allotted: 10 minute presentation, 5 minute 

commentary, 7 minute audience questions 

Learning Objective: Describe the results of recent trials and 

discuss their implications for the care of patients with heart 

failure. 

MondAY 


4:22* Clinical Outcomes at 180 Days in the ASCEND-HF Trial: 

Double-Blind, Placebo-Controlled, Multicenter Acute 

Study of Clinical Effectiveness of Nesiritide in Subjects 

with Decompensated HF 

Randall C. Starling, Adrian F. Hernandez, Christopher M. 

O’Connor, Paul W. Armstrong, Kenneth Dickstein, Daniel 

Gennivois, Vic Hasselblad, Gretchen M. Heizer, Michel 

Komajda, Barry M. Massie, John JV McMurray, Markku 

Nieminen, Karl Swedberg, Robert M. Califf, Cleveland Clinic, 

Cleveland, OH 


William C. Little, Winston-Salem, NC 


4:42 Surgical Treatment of Ischemic HF Trial (STICH) 

Daniel Mark, J. David Knight, Eric J. Velazquez, Jaroslaw 

Wasilewski, Jonathan G. Howlett, Peter K. Smith, Miroslaw 

Rajda, Rakesh Yadav, Baron L. Hamman, Marcin Malinowski, 

Ajay Naik, Gena Rankin, Tina M. Harding, Laura A. Drew, 

Patrice Desvigne-Nickens, Kevin J. Anstrom for the STICH 

Investigators, Duke University, Durham, NC 


Paul A. Heidenreich, Stanford, CA 



5:30 Poster Session and Reception 

Exhibit Halls C and D 

Presenters at their Posters 5:45-6:45 PM 

Refreshments and Hors d’oeuvres served 





52 

53

Sept. 19 

Monday 

PM 

NURSING INVESTIGATOR AWARD 


4:00-5:30 PM 

Room 302 

JNC NEW INVESTIGATOR SESSION 


4:00-5:30 PM 

Room 304 

Sept. 19 

Monday 

PM 

MondAY 

Nursing Research Award 

Moderators: Mariann R. Piano, Chicago, IL 

Susan J. Pressler, Ann Arbor, MI 

4:00* Regular Monitoring of Lower Extremity Edema 011 

Predicts Cardiac Event-Free Survival in Patients 

with Heart Failure 

Kyoung Suk Lee, Terry A. Lennie, Sandra B. Dunbar, Susan 

J. Pressler, Seongkum Heo, Debra K. Moser, University of 

Kenntucky, Lexington, KY 

4:18* Comfort and Symptom Burden Associated with 012 

Health-Related Quality of Life in Older Women 

with Advanced Heart Failure and Preserved 

Systolic Function 

Bonita L. Huiskes, J. Thomas Heywood, Kathleen Dracup, 

Azusa Pacific University, Azusa, CA 

4:36* “I Just Can’t Do It Anymore”: Patterns of Physical 013 

Activity and Cardiac Rehabilitation Referral in 

African Americans with Heart Failure 

Margaret M. McCarthy, Alexandra Howe, Judith Schipper, 

Jaime Gonzalez, Stuart Katz, Victoria V. Dickson, New 

York University, New York, NY 

4:54* Is Cognitive Impairment Associated with Medication 014 

Adherence in Outpatients with Heart Failure? 

Lee Ann Hawkins, Shirley Kilian, Michael Kashner, 

Anthony Firek, Christopher J. Firek, Elena V. Perez, Helme 

Silvet, VA Loma Linda Healthcare System, Loma Linda, 

CA 

5:12* Bio-Feedback Relaxation Intervention Improve 015 

Heart Failure Patients’ Long-Term Disease Outcomes 

Tsuey-Yuan Huang, Shiow-Li Hwang, Terry A. Lennie, 

Ming-Feng Tsai, Debra K. Moser, Chang Gung Institute of 

Technology, Taoyuan, Taiwan 


Learning Objective: Discuss results of recent nursing 

research and its implications for the care of patients with 

heart failure. 





54 

Jay N. Cohn New Investigator Award: 

Clinical/Integrative Physiology 

Moderators: Justin A. Ezekowitz, Edmonton, AB, Canada 

Marc A. Pfeffer, Boston, MA 

4:00* Increase in Left Ventricular Pro-Fibrotic Genes with 006 

LVAD Therapy and Potential Anti-Fibrotic Therapeutic 

Properties of the Novel Designer Natriuretic Peptide 

CD-NP in Cultural Human Cardiac Fibroblasts 

Tomoko Ichiki, John A. Shirger, Frank C. Brozovich, Brenda 

K. Huntley, S. Jeson Sangaralingham, Paul M. McKie, Soon 

J. Park, John C. Burnett, Jr., Mayo Clinic, Rochester, MN 

4:18* Ventricular Assist Device Implantation Corrects 007 

Skeletal Muscle Function, Oxidative Capacity and 

Local Expression of Insulin-Like Growth Factor-1 in 

Patients with Advanced Heart Failure 

Tuba Khawaja, Tomoko Kato, Aalap Chokshi, Michael 

Chew, Hirokazu Akashi, Raffay Khan, Faisal Cheema, 

Meaghan Jones, Ulrich Jorde, Daniel Forman, Hiroo 

Takayama, Yoshifumi Naka, Donna Mancini, P. Christian 

Schulze, Columbia University New York, NY 

4:36* Elevated Mid-Region Pro-Adrenomedullin is 008 

Associated with Increased Mortality in Stable 

Outpatients with Diastolic Dysfunction 

Yang Xue, Pam Taub, Navaid Iqbal, Hugh Nguyen, 

Paul Clopton, Lori Daniels, Alan Maisel, VA San Diego 

Healthcare System, San Diego, CA 

4:54* Effects of the Sodium-Restricted DASH Diet 009 

in Hypertensive Heart Failure with Preserved 

Ejection Fraction 

Scott L. Hummel, E. Mitchell Seymour, Samar S. Sheth, 

Hannah R. Rosenblum, Robert D. Brook, Joanna M. Wells, 

Alan B. Weder, University of Michigan, Ann Arbor, MI 

5:12* Single Breath Exhaled Gas Analysis by Selected 010 

Ion-Flow Tube Mass-Specrometry (SIFT-MS) in 

Patients with Acute Decompensated Heart Failure 

Michael A. Samara, Kelly M. Paschke, W.H. Wilson Tang, 

Raed A. Dweik, Cleveland Clinic, Cleveland, OH 


Learning Objective: Discuss results of recent research and 

their implications for the treatment of heart failure. 





55 

MondAY

Sept. 19 

Monday 

PM 

JNC NEW INVESTIGATOR SESSION 


4:00-5:30 PM 

Room 306 

MOC SESSION 


4:00-5:30 PM 

Room 310 

Sept. 19 

Monday 

PM 

MondAY 

Jay N. Cohn New Investigator Award: 

Basic Science 

Moderators: Burns C. Blaxall, Rochester, NY 

Michael R. Zile, Charleston, SC 

4:00* Ca2+ Oscillations Regulate Growth and 001 

Commitment of Stem Cells in the Developing Heart 

Joao Ferreira-Martins, Sergio Signore, Francesco Cappetta, 

Barbara Ogorek, Elisabeth Steadman, Justin A. Korn, 

Noriko Ide-Iwata, Claudia Fiorini, Fumihiro Sanada, 

Hanqiao Zheng, Toru Hosoda, Annarosa Leri, Piero 

Anversa, Jan Kajstura, Marcello Rota, Brigham & Women’s 


4:18* Presenilin Mediated Ca2+ Changes and 002 

Protein Quality Control in Heart Failure 

Cristina Balla, Davide Gianni, Khaushik Subramanian, 

Bernhard Haring, Nicole Koulisis, Eduward Goihberg, 

Massimo Volpe, Federica del Monte, Beth Israel Deaconess 

Medical Center, Boston, MA 

4:36* Role of Cardiac mTOR in Ischemic Injury 003 

Toshinori Aoyagi, Yuichiro Kusakari, Chunyang Xiao, 

Brendan T. Inouye, Anthony Rosenzweig, Takashi Matsui, 

University of Hawaii, Honolulu, HI 

4:54* Cardiomyocyte Autophagy: Therapeutic 004 

Titration in Pathological Cardiac Remodeling 

Dian J. Cao, Wang V. Zhao, Pavan K. Battiprolua, 

Thomas G. Gillette, Joseph A. Hill, University of Texas 

Southwestern, Dallas, TX 

HFSA Study Session for MOC: Advanced Heart 

Failure and Transplant Cardiology Part II 

(10 Knowledge Points: Must attend both sessions to earn points) 

Moderators: Ileana L. Piña, Bronx, NY 

Marc J. Semigran, Boston, MA 

HFSA has developed an ABIM-approved Self-Evaluation 

of Medical Knowledge Module on Advanced Heart Failure 

and Transplant Cardiology worth 10 points towards 

Maintenance of Certification (MOC). This two-part 

session will review the 25 questions in that module. 

In order to receive MOC points, the module must be 

purchased at www.hfsa.org and successfully completed 

online. CME credit is also granted upon completion of the 

module. There is no CME credit for the review sessions. 

It is not necessary to be board certified in Advanced Heart 

Failure and Transplant Cardiology to complete the module 

or attend these sessions. 

Although there is no additional registration fee to attend 

this session, attendee must be preregistered in order to 

enter the session. 

Learning Objective: Discuss key questions in the 

epidemiology, pathophysiology, and treatment of patients 

with advanced heart failure. 

MondAY 

5:12* Intact T and B Cell Responses are Required 005 

for Full Expression of Acute Non-Ischemic 

Cardiomyopathy 

Andrea Cordero-Reyes, Keith A. Youker, Jose Flores- 

Arredondo, Alejandro Trevino, Jerry D. Estep, Carlos M. 

Orrego, Guillermo Torre-Amione, The Methodist Hospital, 

Houston, TX 


Learning Objective: Discuss the results and implications of 

basic science research in heart failure. 





56 





57

Sept. 19 

Monday 

Posters 

Posters 

Cardiovascular Physiology 

Posters 


Sept. 19 

Monday 

Posters 

MondAY 

016 Interferon Regulatory Factor-3 (IRF-3) as a Potential 

Therapeutic Target To Prevent Myocyte Apoptosis and 

Promote Angiogenesis in Post-Myocardial Infarction 

Remodeling 

Geoffrey de Couto 1 , William Stanford 1 , Scott Heximer 1 , Jeffrey 

Medin 1 , Peter Liu 1 ; 1 University of Toronto, Toronto, ON, Canada 

017 Impaired Dobutamine Augmentation of Early Diastolic 

Suction in Diastolic Dysfunction 

Takahiro Ohara 1 , Cassie L. Niebel 2 , Kelley C. Stewart 2 , John J. 

Charonko 2 , Pamela R. Burgess 1 , Min Pu 1 , Pavlos P. Vlachos 2 , 

William C. Little 1 ; 1 Cardiology Section, Wake Forest University 

School of Medicine, Winston-Salem, NC; 2 Department of 

Mechanical Engineering, Virginia Tech, Blacksburg, VA 

018 The GRK2 Inhibitor βARKct Enhances β2-Adrenergic 

Receptor-Dependent Cardiac Contractility In Vivo by 

Opposing Receptor Interaction with Phosphodiesterase 

Type 4D 

Anastasios Lymperopoulos 1,2 , Giuseppe Rengo 2,3 , Erhe Gao 2 , 

Walter J. Koch 2 ; 1 Pharmaceutical Sciences/College of Pharmacy, 

Nova Southeastern University, Fort Lauderdale, FL; 2 Center 

for Translational Medicine, Thomas Jefferson University, 

Philadelphia, PA; 3 University Federico II, Naples, Italy 

019 Diminished Global Arginine Bioavailability as a 

Metabolic Defect in Chronic Heart Failure in the Setting 

of Preserved Renal Function 

Kevin Shrestha 1 , Zhili Shao 1 , Allen G. Borowski 1 , Richard W. 

Troughton 2 , Allan L. Klein 2 , W.H. Wilson Tang 1 ; 1 Cleveland 

Clinic, Cleveland, OH; 2 Christchurch School of Medicine and 

Health Sciences, Christchurch, New Zealand 

020 TWIST-1 and Its Target, the miR 199/214 Cluster, Are 

Down-Regulated in Dilated Cardiomyopathy Resulting 

in Increased Proteasome Activity in Human Myocardium 

Anna Baumgarten 1 , Claudia Bang 2 , Reinhard Pregla 3 , Anika 

Tschirner 1 , Volker Adams 4 , Rudolf Meyer 3 , Thomas Thum 2 , 

Roland Hetzer 3 , Stefan D. Anker 1 , Jochen Springer 1 ; 1 Applied 

Cachexia Research, CCR, Charite Medical School, Berlin, 

Germany; 2 Institute for Molecular and Translational Therapeutic 

Strategies, Medical School Hannover, Hannover, Germany; 

3 

DHZB, Berlin, Germany; 4 Heart Center Leipzig, Leipzig, 

Germany 

021 Nebulette Mutations Augment Cardiomyocyte Calcium 

Signaling through Modification of the Thin Filament in 

Preclinical Inherited Dilated Cardiomyopathy 

Kathryn M. Rafferty 1 , Evangalia G. Kranias 2 , Jeanne James 1 , 

Jeffrey A. Towbin 1 , Enkhsaikhan Purevjav 1 ; 1 The Heart Institute, 

Cincinnati Childrens Hospital Medical Center, Cincinnati, OH; 

2 

Department of Pharmacology Cell Biophysics, University of 

Cincinnati, Cincinnati, OH 

58 

022 Association between VE-VCO2 Slope and Resting 

Hemodynamic Measurements in Ambulatory Heart 

Failure (HF) Patients: An Analysis from the Duke 

Advanced HF Database 

C. Patel 1 , R.J. Mentz 1 , J. Suarez 1 , A.F. Hernandez 1 , G.M. Felker 1 , 

C.M. O’Connor 1 , J.G. Rogers 1 ; 1 Duke University, Durham, NC 

023 Obese Patients with Equivalent NYHA Have Less 

Cardiac Impairment Than Non-Obese Counterparts 

Shanmugakumar Chinnappa 1 , Nigel Lewis 1 , David Goldspink 2 , 

Diane Barker 1 , Lip-Bun Tan 1 ; 1 Leeds Teaching Hospitals NHS 

Trust, Leeds, United Kingdom; 2 University of Leeds, Leeds, 

United Kingdom 

024 Fat Measurement and Functional Characteristics in 

Heart Failure Patients 

A. Zavin 1 , K. Allsup 1 , D.R. Gagnon 6,7 , R. Arena 4 , S. Davis 1 , J. 

Joseph 1,2 , S. Lecker 2 , A. Lazzari 1,3 , P.C. Schulze 5 , D.E. Forman 1,2 ; 

1 

VA Boston Healthcare System, Boston; 2 Harvard Medical 

School, Boston, MA; 3 Boston University School of Medicine, 

Boston, MA; 4 University of New Mexico, Albuquerque, 

NM; 5 Columbia University Medical Center, New York, NY; 

6 

Boston University SPH, Boston, MA; 7 VA Cooperative Studies 

Program, Boston, MA 

025 Pacing from a Novel Quadripolar LV Lead Improves LV 

Synchrony in CRT Patients 

Gery F. Tomassoni 1 , Melody Muir 1 , Erin O’Brien 2 , Kyungmoo 

Ryu 2 , Aaron Hesselson 1 ; 1 Lexington Cardiology Consultants, 

Lexington, KY; 2 St. Jude Medical, Sylmar, CA 

026 Hematological Malignancies Are Associated with 

Significant Elevations in N-Terminal Pro Brain 

Natriuretic Peptide 

Jesal Popat 1 , Abel Rivero 1 , Maya Guglin 1 ; 1 Department of 

Cardiovascular Medicine, University of South Florida, Tampa, 

FL 

027 In Vitro and In Vivo Actions of a Novel ANP Genetic 

Variant: Unique Actions on Human Endothelial Cells 

Valentina Cannone 1 , Brenda K. Huntley 1 , Guido Boerrigter 1 , 

Alessandro Cataliotti 1 , Denise M. Heublein 1 , John C. Burnett, 

Jr. 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, Rochester, 

MN 

028 Left Atrial Diastolic Dysfunction, an Underappreciated 

Cause of Pulmonary Venous Hypertension and 

Decompensated Heart Failure 

Hemal H. Kadakia 1 , Soheni Channah 1 , James T. Heywood 1 , 

Allen D. Johnson 1 , Douglas N. Gibson 1 , Michael R. Smith 1 , 

Tariq Khan 1 ; 1 Cardiology, Scripps Clinic, San Diego, CA 

59 

MondAY

Sept. 19 

Monday 

Posters 

Posters 


Posters 

Cardiovascular Structure 

Sept. 19 

Monday 

Posters 

MondAY 

029 Cardiac Wasting in Experimental Cancer Cachexia: 

Prevention by Bisoprolol and Spironolactone 

Jochen Springer 1 , Anika Tschirner 1 , Arash Haghika 2 , Aleksandra 

Grzesiak 3 , Elena Kaschina 3 , Hind Lal 4 , Stefan von Haehling 1 , 

Denise Hilfiker-Kleiner 2 , Thomas Force 4 , Stefan D. Anker 1 ; 

1 

Cachexia Research, Charite Medical School, Berlin, 

Germany; 2 Dept of Cardiology and Angiology, Medical School 

Hannover, Hannover, Germany; 3 Institute of Pharmacology, 

Charite Medical School, Berlin, Germany; 4 Thomas Jefferson 

University, Philadelphia, PA 

030 Effects of Left Ventricular Stimulation Site on Diastolic 

Function in Cardiac Resynchronization Therapy 

Dusan Z. Kocovic, Scott Cox, Nancy Britton, Mark Heimann; 

Cardiology/Electrophysiology, Lankenau Hospital, Wynnewood, 

PA 

031 The Right Ventricular Contractile Pattern Is Markedly 

Different in Transplanted Compared to Normal Hearts. 

Implications for RV Function Assessment Post Cardiac 

Transplant 

Anjali V. Fields 1 , Amresh Raina 1 , Susan V. Chambers 1 , Paul 

R. Forfia 1 ; 1 Medicine/Cardiology, University of Pennsylvania, 


032 Echocardiographic Estimation of the Left Ventricular 

End Diastolic Pressure Volume Relationship Predicts 

Survival in Congestive Heart Failure 

Justin A. Karl 1 , Daniel Spevack 1 , Neeraja Yedlapati 2 , Mario 

J. Garcia 1 , Ythan Goldberg 1 ; 1 Medicine, Montefiore Medical 

Center, Bronx, NY; 2 Medicine, North Central Bronx Hospital, 

Bronx, NY 

033 Hemodynamic and Neurochemical Determinates of 

Renal Function in Heart Failure 

John D. Parker 1 , Cameron Gilbert; 1 Medicine, University of 

Toronto, Toronto, ON, Canada 

034 Ejection Fraction: A Predictor for Types of Cognitive 

Deficit in HF Patients 

Ponrathi R. Athilingam 1 ; 1 College of Nursing, University of 

South Florida, Tampa, FL 

035 Withdrawn 

056 Role of T Lymphocytes in Leptin-Mediated Myocardial 

Fibrosis 

Sherma Zibadi 1,2 , Douglas F. Larson 1 , Ronald R. Watson 1,2 ; 

1 

Sarver Heart Center, The University of Arizona, Tucson, AZ; 

2 

College of Public Health, The University of Arizona, Tucson, 

AZ 

057 Renal Remodeling Post Myocardial Infarction: The 

Modulating Actions of Aging 

S. Jeson Sangaralingham 1 , Tomoko Ichiki 1 , Fernando L. 

Martin 1 , Paul M. McKie 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiovascular Diseases, Mayo Clinic, Rochester, MN 

058 The Characterization of Myocardial Fibrosis by Cardiac 

MRI in Association with Renal Dysfunction 

Sanjay Dandamudi 1 , James F. Glockner 1 , Joshua P. Slusser 1 , 

David O. Hodge 1 , Horng H. Chen 1 ; 1 Mayo Clinic, Rochester, 

MN 

059 Echocardiography To Screen for Central Sleep Apnea in 


Andrew D. Calvin 1 , Virend K. Somers 1 , Christelle van der Walt 1 , 

Lyle J. Olson 1 ; 1 Division of Cardiovascular Diseases, Mayo 

Clinic, Rochester, MN 

060 Do Ischemic Cardiomyopathy and Cardiac Allograft 

Vasculopathy Have Unique Myocardial Remodeling 

Characteristics? 

Divya Ratan Verma 1 , Stavros G. Drakos 1 , Monica P. Revelo 1 , 

Abdallah G. Kfoury 1 , Farman Khan 1 , Feras Bader 1 , Deborah 

Budge 1 , Rami Alharethi 1 , Craig Selzman 1 , Edward Gilbert 1 , 

Elizabeth Hammond 1 , Dylan Miller 1 , Dean Y. Li 1 , Josef Stehlik 1 ; 

1 

UTAH Cardiac Transplant Program, Salt Lake City, UT 

Neurohormones/Cytokines 

066 A Multimarker Panel Improves Risk Prediction in 

Chronic Heart Failure 

Bonnie Ky 1 , Benjamin French 1 , James C. Fang 2 , Nancy K. 

Sweitzer 3 , Wayne C. Levy 4 , Alan H.B. Wu 5 , Lee R. Goldberg 1 , 

Mariell Jessup 1 , Thomas P. Cappola 1 ; 1 Cardiovascular Institute, 

University of Pennsylvania School of Medicine, Philadelphia, 

PA; 2 Cardiovascular Medicine, Case Western University, 

Cleveland, OH; 3 Cardiovascular Medicine, University of 

Wisconsin, Madison, WI; 4 Cardiovascular Medicine, University 

of Washington, Seattle, WA; 5 Department of Laboratory 

Medicine, University of California at San Francisco, San 

Francisco, CA 

MondAY 

60 

61

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

067 Chronic Cardiac Gene Delivery of proBNP in 

Experimental Progressive Hypertensive Heart Disease 

Improves Survival 

Alessandro Cataliotti 1 , Jason M. Tonne 2 , Diego Bellavia 1 , 

Fernando L. Martin 1 , Sarah Mangiafico 1 , John C. Burnett 1 , 

Yasuhiro Ikeda 2 ; 1 Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN; 2 Molecular Medicine, Mayo Clinic, Rochester, 

MN 

073 Interaction of Elevated Copeptin (CT-proVasopressin, 

a Surrogate Marker of Arginine Vasopressin), B-Type 

Natriuretic Peptide, and Hyponatremia in Predicting 

Outcome in Chronic Heart Failure 

Wayne L. Miller 1 , Diane E. Grill 1 , Mary A. Phelps 1 , Joachim 

Struck 2 , Allan S. Jaffe 1 ; 1 Mayo Clinic, Rochester, MN; 

2 

BRAHMS Aktiengesellschaft (Part of ThermoFisher Scientific), 

Hennigsdorf, Germany 

MondAY 

068 Treatment with CBA-NP a Novel Chimeric Natriuretic 

Peptide Attenuates Cardiorenal Fibrosis and Improves 

Diastolic Dysfunction in Diabetic Rat Model 

Syed Ameenuddin 1 , Elise A. Oehler 1 , John C. Burnett, Jr. 1 , 

Horng H. Chen 1 ; 1 Division of Cardiovascular Diseases, Mayo 


074 NGAL Is Independently Associated with Cardiovascular 

Death and All-Cause Mortality in Community-Dwelling 

Older Adults with Stage A Heart Failure 

Lori B. Daniels 1 , Paul Clopton 2 , Elizabeth Barrett-Connor 1 , Alan 

S. Maisel 2 ; 1 University of California, San Diego, La Jolla, CA; 

2 

VA San Diego Healthcare System, La Jolla, CA 

MondAY 

069 Validation of a Formula Combining ST2 and NT-proBNP 

Enhancing Prognostic Accuracy in Patients with Heart 


J. Snider 1 , T. Breidthardt 2 , M. Noveanu 2 , M. Potocki 2 , T. 

Socrates 2 , N. Arenja 2 , C. Heinisch 2 , B. Drexler 2 , C. Mueller 2 ; 

1 

Critical Diagnostics, San Diego, CA; 2 Departement Innere 

Medizin, Universitätsspital Basel, Basel, Switzerland 

070 The Prohormone of B-Type Natriuretic Peptide, 

proBNP1-108, Is Secreted by the Failing and Non-Failing 

Human Heart 

Elizabeth C. Costello 1 , Harald Lapp 2 , Amir Lerman 1 , Guido 

Boerrigter 1 , Fima Macheret 1 , Fernando Martin 1 , Alexander Bufe 3 , 

Catherine Larue 4 , Denise M. Heublein 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiovascular Research, Mayo Clinic, Rochester, MN; 2 Helios 

Clinic, Erfurt, Germany; 3 Helios Clinic, Wuppertal, Germany; 

4 

BioRad, Marnes-la-Coquette, France 

071 Prognostic Value of Natriuretic Peptide in Heart Failure 

with Atrial Fibrillation 

Jin-Oh Choi 1 , Sung-Ji Park 1 , Jae-Joong Kim 2 , Eun-Seok Jeon 1 , 

Sang Hoon Lee 1 ; 1 Internal Medicine, Samsung Medical Center, 

Sungkyunkwan University School of Medicine, Seoul, Korea; 

2 

Internal Medicine, Asan Medical Center, University of Ulsan 

College of Medicine, Seoul, Korea 

072 Elevated Cystatin C Predicts Long-Term Adverse 

Cardiac Events in Patients with Heart Failure 

Independent of Natriuretic Peptide Levels and 

Creatinine Clearance 

Matthias Dupont 1 , Earl B. Britt, Jr. 2 , Yuping Wu 3 , Stanley L. 

Hazen 2 , Wilson W.H. Tang 1 ; 1 Department of Cardiovascular 

Medicine, Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH; 2 Center for Cardiovascular 

Diagnostics and Prevention, Cleveland Clinic Foundation, 

Cleveland, OH; 3 Department of Mathematics, Cleveland State 

University, Cleveland, OH 

62 

075 Impaired HDL Function Predicts Subclinical Myocardial 

Necrosis in Patients at Risk of Developing Heart Failure 

Zhili Shao 1 , Yuping Wu 2 , Yi Lu 1 , Stanley L. Hazen 1 , W.H. 

Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland 

State University, Cleveland, OH 

076 Soluble Angiotensin Converting Enzyme 2 Activity 

Levels Is Associated with Cardiopulmonary Functional 

Impairment in Chronic Systolic Heart Failure 

Andres Schuster 1 , Zhili Shao 1 , Allen G. Borowski 1 , Akanksha 

Thakur 2 , W.H. Wilson Tang 1 ; 1 Department of Cardiovascular 

Medicine, Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH; 2 Case Western Reserve School of 

Medicine, Case Western Reserve University, Cleveland, OH 

077 Rise in Urinary Neutrophil Gelatinase-Associated 

Lipocalin (NGAL) Following Intravenous Diuretic 

Therapy Predicts Development of Worsening Renal 

Function in Acute Decompensated Heart Failure 

Matthias Dupont 1 , Adiveh Awad 1 , Mario Scarcipino 1 , Cynthia 

Kovach 1 , Anjli P. Maroo 1 , Wilson W.H. Tang 1 ; 1 Department 

of Cardiovascular Medicine, Heart and Vascular Institute, 

Cleveland Clinic Foundation, Cleveland, OH 

078 Heterogeneity of ProBNP1-108 to BNP and ProBNP1-108 

to Nt-proBNP Ratios in Congestive Heart Failure 

Damien Gruson 1 , Sylvie A. Ahn 1 , Jean-Marie Ketelslegers 1 , 

Michel F. Rousseau 1 ; 1 Division of Cardiology Dept of 

Laboratory Medicine, University of Louvain, Brussels, Belgium 

079 Galectin-3 as a New Remodeling Marker in Heart 

Failure: Comparison to Other Neurohumoral 

Biomarkers 

Damien Gruson 1 , Sylvie A. Ahn 1 , Jean-Marie Ketelslegers 1 , 

Michel F. Rousseau 1 ; 1 Division of Cardiology Dept of 

Laboratory Medicine, University of Louvain, Brussels, Belgium 

63

Sept. 19 

Monday 

Posters 

Posters 


Posters 

Molecular Biology and Genetics 

Sept. 19 

Monday 

Posters 

MondAY 

080 Predicting Cardiac Dysfunction during Breast Cancer 

Chemotherapy 

Carrie Geisberg 1 , Amy Dickey 1 , Holly M. Smith 1 , Brenda White 1 , 

Darla Freehardt 1 , Sawyer Douglas 1 ; 1 Cardiovascular Medicine, 

Vanderbilt University, Nashville, TN 

081 Plasma Renin Activity (PRA) Predicts Diuretic 

Resistance in Acute Heart Failure Patients: An Ancillary 

Study of the Diuretic Optimization Strategies Evaluation 

in Acute Heart Failure (DOSE-AHF) 

Tomohito Ohtani 1 , G. Michael Felker 2 , Steven E. McNulty 2 , 

Martin M. LeWinter 3 , Eugene Braunwald 4 , Margaret M. 

Redfield 1 ; 1 Mayo Clinic, Rochester, MN; 2 Duke University, 

Durham, NC; 3 Univ of Vermont, Burlington, VT; 4 Brigham and 

Women’s Hospital, Boston, MA 

082 Italian RED Study Sub-Analysis: 30-Day Post-Discharge 

BNP Levels Predict 6-Month All-Cause Mortality and 

Cardiac Events 

Giorgio Zampini 1 , Kevin S. Shah 2 , Laura Magrini 1 , Alan 

S. Maisel 2 , Salvatore DiSomma 1 ; 1 Emergency Medicine 

Department, Medical School University La Sapienza, 

Sant’Andrea Hospital, Rome, Via di Grottarossa, Italy; 

2 

Cardiology, Veterans Affairs San Diego Healthcare System, San 

Diego, CA 


099 Isolation of Cardiovascular Progenitors from Human 

Embryonic Stem Cells Capable of Integration into 

Human Fetal Hearts 

Reza Ardehali 1,2 , Shah R. Ali 2 , Micha Drukker 2 , Irvig L. 

Weissman 2 ; 1 Division of Cardiovascular Medicine, Stanford 

University School of Medicine, Stanford, CA; 2 Institute for Stem 

Cell Biology and Regenerative Medicine, Stanford University 

School of Medicine, Stanford, CA 

100 Placental Growth Factor (PlGF) and Soluble fms-Like 

Tyrosine Kinase-1 (SFLT-1) Predict Mortality in Stable 

Patients with Heart Failure with Preserved Ejection 

Fraction 

Michael A. Samara 1 , Stanley L. Hazen 2 , W.H. Wilson Tang 1 ; 

1 

Cardiovascular Medicine, Heart and Vascular Institute, 

Cleveland Clinic, Cleveland, OH; 2 Center for Cardiovascular 

Diagnostics and Therapy, Lerner Research Institute, Cleveland 

Clinic, Cleveland, OH 

101 Ca2+/Calmodulin Dependent Protein Kinase II 

Phosphorylation of RyR2 Alters the Force-Frequency 

Relationship in Mice 

Mark D. McCauley 1,2 , Tiannan Wang 1 , Sameer Ather 1 , Na Li 1 , 

Biykem Bozkurt 1 , Xander Wehrens 1 ; 1 Department of Medicine 

(Cardiology), Baylor College of Medicine, Houston, TX; 

2 

Department of Cardiology, Texas Heart Institute, St. Luke’s 

Episcopal Hospital, Houston, TX 

102 Beta-Adrenergic Receptor Polymorphisms in 

Susceptibility, Response to Treatment and Prognosis in 


Sabrina B. Pereira 1 , Monica W. Veloso 1 , Sergio Chermont 1 , 

Monica Quintao 1 , Wolney Andrade 1 , Humberto Villacorta 1 , 

Luiza Contarato 1 , Maria Luiza G. Rosa 1 , Antonio Claudio L. 

Nobrega 1 , Evandro T. Mesquita 1 , Georgina S. Ribeiro 1 ; 1 Federal 

Fluminense University, Niterói, Brazil 

103 Chronic Treatment with Mineralocorticoid Receptor 

Antagonists Reverses Salt-Induced Transcriptional 

Effects in Aorta of Dahl Salt Sensitive Rats 

Sheng Gao 1 , Jun Li 1 , Xiaoyan Zhou 1 , Patricia Brown 1 , Oscar 

Puig 1 , Maarten Hoek 1 , Michael Forrest 1 , Sophie Roy 1 , Martin 

Crook 1 ; 1 Cardiovascular Diseases, MRL, Merck Co., Rahway, 

NJ 

104 The Natriuretic Peptide Receptors NPR-A and NPR-B 

Are Differentially Regulation by Extracellular Matrix 

Proteins 

Brenda K. Huntley 1 , Tomoko Ichiki 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiorenal Research, Mayo Clinic, Rochester, MN 

105 NGAL Lacks Specificity for Acute Kidney Injury in 

Acute Heart Failure Syndrome 

Mridula Rai 1,2 , Cara Statz 1 , Aleksandra Ras 1 , Jennifer Rahn 1 , 

Lynn O’Bara 1 , Faisal Zaeem 1 , Roja Mulamalla 1 , Jonathan 

Hammond 1 , Detlef Wencker 1 ; 1 Heart Failure and Transplant 

Center, Hartford Hospital, Hartford, CT; 2 University of 

Connecticut Health Center, Farmington, CT 

106 Circulating microRNA Patterns in Ischemic and 

Idiopathic Heart Failure 

Oxana Galenko 1 , Samin Panahi 1 , Staci Gunter 1 , Kimberly D. 

Brunisholz 1 , Benjamin D. Horne 1,2 , John Carlquist 1,3 , Jeffrey L. 

Anderson 1,3 ; 1 Cardiology, Intermountain Medical Center, Murray, 

UT; 2 Genetic Epidemiology, University of Utah, Salt Lake City, 

UT; 3 Cardiology, University of Utah, Salt Lake City, UT 

MondAY 

64 

65

Sept. 19 

Monday 

Posters 

Posters 

Surgery, Transplantation, Devices 

Posters 


Sept. 19 

Monday 

Posters 

MondAY 

115 Assessment of Intrinsic Cardiac Function, Myocardial 

Blood Flow and Metabolism in Patients Supported on 

Mechanical Circulatory Assist Devices 

Patricia Campbell 1 , Hicham Skali 1 , Leslie Griffin 1 , Colleen 

Smith 1 , Michael M. Givertz 1 , Marc A. Pfeffer 1 , Scott D. 

Solomon 1 , Marcelo F. Di Carli 1 ; 1 Cardiovascular Division, 

Brigham and Women’s Hospital, Boston, MA 

116 Aortic Valve Opening at Hospital Discharge 

after HeartMate II Left Ventricular Assist Device 

Implantation Is Associated with Improved Renal 

Function at 3 Months 

David R. Fermin 1 , Soon J. Park 2 , Yan Topilsky 1 , John C. Burnett, 

Jr. 1 , Tal Hasin 1 , Sudhir S. Kushwaha 1 , Brooks S. Edwards 1 , 

Horng H. Chen 1 , Tomoko Ichiki 1 , Barry A. Boilson 1 , Lyle Joyce 2 , 

Richard Daly 2 , John A. Schirger 1 ; 1 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN; 2 Cardiovascular Surgery, Mayo 


117 Mechanical Unloading Via Left Ventricular Assist Device 

Implantation Ameliorates Adipose Tissue Inflammation 

and Increases Adipocyte Size in Patients with Advanced 


Raffay S. Khan 2 , Aalap Chokshi 1 , Collette R. Harris 1 , Shuiqing 

Yu 1 , Gissette Reyes-Soffer 2 , Daniel E. Forman 1 , Yoshifumi 

Naka 3 , Donna Mancini 1 , P. Christian Schulze 1 ; 1 Division of 

Cardiology, Columbia University, New York, NY; 2 Division 

of Preventive Medicine Nutrition, Columbia University, New 

York, NY; 3 Division of Cardiothoracic Surgery, Columbia 

University, New York, NY 

118 Who Wants an LVAD for Ambulatory Heart Failure? 

Garrick C. Stewart 1 , Michelle M. Kittleson 2 , Jennifer A. 

Cowger 3 , Frances L. Johnson 4 , Chetan B. Patel 5 , Maria M. 

Mountis 6 , Parag Patel 7 , J. Eduardo Rame 8 , Maya E. Guglin 9 , 

Jeffrey J. Teuteberg 10 , Lynne W. Stevenson 1 ; 1 Brigham and 

Women’s Hospital, Boston, MA; 2 Cedars-Sinai Heart Institute, 

Los Angeles, CA; 3 University of Michigan, Ann Arbor, MI; 

4 

University of Iowa, Iowa City, IA; 5 Duke University, Durham, 

NC; 6 Cleveland Clinic, Cleveland, OH; 7 University of Texas 

Southwestern, Dallas, TX; 8 University of Pennsylvania, 

Philadelphia, PA; 9 University of South Florida, Tampa, FL; 10 , 

University of Pittsburgh, Pittsburgh, PA 

119 Are LVAD Support and Cardiac Transplantation 

Approaching Equipoise? 

Robert M. Adamson 1 , Brian Jaski 2 , Peter Hoagland 2 , Joseph 

Chammas 1 , Sam Baradarian 1 , Vanjah Norman 1 , Walter P. 

Dembitsky 1 ; 1 Cardiothoracic Surgery, Sharp Memorial Hospital, 

San Diego, CA; 2 Cardiology, Sharp Memorial Hospital, San 

Diego, CA 

120 Scaffold Delivery of Neonatal Cardiomyocyte Results in 

Prolonged Cellular Survival and Improvements in Left 

Ventricular Function in Rats with Chronic Heart Failure 

Jordan J. Lancaster 1 , Elizabeth Juneman 1 , Nicholle M. Johnson 1 , 

Joseph J. Bahl 1 , Steven Goldman 1 ; 1 Cardiology, Southern 

Arizona VA Health Care System, Tucson, AZ 

121 Survival of INTERMACS Profile 4-6 Patients after 

Left Ventricular Assist Device Implant Is Improved 

Compared to Seattle Heart Failure Model Estimated 

Survival 

Peter Eckman 1 , Andrew Rosenbaum 1 , Haree Vongooru 2 , 

Jagroop Basraon 3 , Forum Kamdar 1 , Ranjit John 1 , Wayne Levy 4 ; 

1 

University of Minnesota, Minneapolis, MN; 2 University 

of Louisville, Louisville, KY; 3 UCSF-Fresno, Fresno, CA; 

4 

University of Washington, Seattle, WA 

122 Hemodynamic Predictors of Renal Function Following 

Left Ventricular Assist Device Implantation 

Gabriel T. Sayer 1 , Sheila Sahni 2 , Kimberly Ashley 1 , Rachel 

Flynn 1 , Ajith P. Nair 1 , Anelechi C. Anyanwu 3 , Michael J. 

Domanski 1 , Sean P. Pinney 1 ; 1 Cardiology, Mount Sinai Medical 

Center, New York, NY; 2 Medicine, Mount Sinai Medical Center, 

New York, NY; 3 Cardiothoracic Surgery, Mount Sinai Medical 

Center, New York, NY 

123 Use of Antigen Microarrays To Detect Non-HLA 

Antibodies in Patients with Heart Transplant Rejection 

Andrzej Chruscinski 1 , Jongsung Lim-Shon 1 , Vivek Rao 1 , Gary 

Levy 1 , Heather Ross 1 ; 1 Multi-Organ Transplant, Toronto General 

Research Institute, Toronto, ON, Canada 

124 Reliability of a Novel Slow Cuff-Deflation System for 

Non-Invasive Blood Pressure Monitor in Out-Patients 

with Continuous-Flow Left Ventricular Assist Devices 

Gregg Lanier 1 , Khristine Orlanes 2 , Ryan T. Demmer 1 , Yacki 

Hayashi 1 , Jennifer Murphy 2 , Margaret Flannery 2 , Rosie Te-Frey 2 , 

Nir Uriel 1 , Donna M. Mancini 1 , Yoshifumi Naka 2 , Hiroo 

Takayama 2 , Ulrich P. Jorde 1 , Paolo C. Colombo 1 ; 1 Department of 

Medicine, Columbia University, New York, NY; 2 Department of 

Surgery, Columbia University, New York, NY 

125 Reverse Remodeling with Combined Maximal Medical 

Therapy and Continuous Flow LVAD Support 

Snehal R. Patel 1 , Vivek Bhatia 1 , Pauline Edwards 1 , Cecelia 

Nucci 1 , David Dallesandro 1 , Daniel Goldstein 1 , Simon 

Maybaum 1 ; 1 Center for Advanced Cardiac Therapy, Montefiore 

Medical Center, Albert Einstein College of Medicine, Bronx, 

NY 

MondAY 

66 

67

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

MondAY 

126 Pilot Evaluation of a Novel Intra-Atrial Valved-Shunt 

(V-Wave Device) for Pressure-Dependent Cardiac 

Unloading in a Chronic Model of Ischemic Heart Failure 

Patrick I. McConnell 1 , Carlos L. del Rio 2 , Yaacov Nitzan 3 , Yukie 

Ueyama 2 , Pedro Vargas 2 , Adriana Pedraza 2 , Meni Jacoby 3 , Robert 

L. Hamlin 2,4 , Gad Keren 3 , William T. Abraham 4 , Stefan Verheye 3 ; 

1 

Nationwide Children’s Hospital, Columbus, OH; 2 QTest Labs, 

Columbus, OH; 3 V-Wave, Hod Hasahron, Israel; 4 The Ohio State 

University, Columbus, OH 

127 Left Ventricular Assist Devices Improve Functional Class 

but Fail To Normalize Peak Oxygen Consumption 

Casey R. Benton 1 , Gabriel Sayer 2 , Kimberly Ashley 2 , Rachel 

Flynn 2 , Ajith P. Nair 2 , Michael J. Domanski 2 , Anelechi C. 

Anyanwu 3 , Sean P. Pinney 2 ; 1 Medicine, The Mount Sinai 

Medical Center, New York, NY; 2 Cardiology, The Mount Sinai 

Medical Center, New York, NY; 3 Cardiothoracic Surgery, The 

Mount Sinai Medical Center, New York, NY 

128 Use of Luminex Antibody Testing and Virtual 

Crossmatching To Enhance Donor Heart Availability for 

Sensitized Heart Transplant Candidates: A Single Center 

Experience 

Robert L. Scott 1 , Diane L. Kasper 1 , Riccardo Valdez 1 , Francisco 

A. Arabia 1 , Carol S. Bachtel 1 , Patrick A. DeValeria 1 , D. Eric 

Steidley 1 , Louis A. Lanza 1 , Dawn E. Jaroszewski 1 , Radha 

S. Gopalan 1 , Anantharam V. Kalya 1 , Scott T. Stoll 1 , Octavio 

E. Pajaro 1 , Stacie M. Attig 1 ; 1 Heart Failure and Cardiac 

Transplantation, Mayo Clinic Arizona, Phoenix, AZ 

129 Development of a Long-Term Superficial Device for 

Partial Circulatory Support 

R. Dowling 1 , P. Spence 1 , S. Warren 1 , L. Tompkins 1 , M. 

Sandoval 1 , G. Giridharan 2 , L. Sherwood 2 , E. Gratz 4 , G. 

Spanier 4 , C. Lederer 5 , S. Bruck 5 , M. Slaughter 3 , S. Koenig 2 ; 

1 

SCR, Inc, Louisville, KY; 2 Bioengineering and Surgery, 

Cardiovascular Innovation Institute, Louisville, KY; 3 Thoracic 

and Cardiovascular Surgery, U Louisville, Louisville, KY; 

4 

Abiomed, Danvers, MA; 5 LB Technology, Louisville, KY 

130 Increased Levels of Osteopontin Are Associated 

with Development of Right Ventricular Failure after 

Ventricular Assist Device Implantation in Patients with 

Advanced Heart Failure 

Tomoko S. Kato 1 , Aalap Chokshi 1 , Tuba Khawaja 1 , Faisal H. 

Cheema 1 , Hirokazu Akashi 1 , Jonathan Yang 2 , Hiroo Takayama 2 , 

Yoshifumi Naka 2 , MaryJane Farr 1 , Donna Mancini 1 , P. Christian 

Schulze 1 ; 1 Department of Medicine, Division of Cardiology, 

Columbia University Medical Center, New York, NY; 

2 

Department of Surgery, Division of Cardiothoracic Surgery, 

Columbia University Medical Center, New York, NY 

131 Total Depletion and Abnormal Composition of 

Myocardial Free Fatty Acid Stores in Patients with 

Advanced Heart Failure 

Ruiping Ji 1 , Tuba Khawaja 1 , Hongfeng Jiang 2 , Shuiqing 

Yu 1 , Raffay Khan 2 , Donna Mancini 1 , P. Christian Schulze 1 ; 

1 

Cardiology, Columbia University, New York, NY; 2 Preventive 

Medicine & Nutrition, Columbia University, New York, NY 

132 Ventricular Restraint Improves Outcomes in HF Patients 

with CRT 

Russell J. Ivanhoe 1 , Maria Rosa Costanza 2 , William T. Abraham 3 , 

PEERLESS HF Investigators, Barry K. Rayburn 4 ; 1 Paracor 

Medical, Inc., Sunnyvale, CA; 2 Heart Failure Program, Midwest 

Heart Foundation, Naperville, IL; 3 Cardiovascular Medicine, 

The Ohio State University, Columbus, OH; 4 Cardiovascular 

Partners, Birmingham, AL 

133 The Impact of Technology Dependency on Device 

Acceptance and Quality of Life in Persons with 

Implantable Cardioverter Defibrillators 

Kimberly A. Udlis 1 ; 1 College of Nursing, University of 

Wisconsin Oshkosh, Oshkosh, WI 

134 Persistent Anemia in Patients Supported with the 

Total Artificial Heart: Hemolysis and Ineffective 

Erythropoiesis 

Anit K. Mankad 1 , Maureen Flattery 1 , Daniel G. Tang 1 , William 

Clark 1 , Suzanne Harton 1 , Gundars J. Katlaps 2 , Michael L. Hess 1 , 

Vigneshwar Kasirajan 1 , Keyur B. Shah 1 ; 1 Internal Medicine, 

Division of Cardiovascular Disease, Virginia Commonwealth 

University/Medical College of Virginia, Richmond, VA; 

2 

Cardiothoracic Surgery, Hunter Holmes Mcguire Veterans 

Hospital, Richmond, VA 

135 Predictors of Worsening Renal Function in Patients 

with Decompensated Heart Failure Treated with 

Ultrafiltration 

Nicholas Haglund 1 , Joan Mack 2 , Melissa Lederer 2 , Ioana 

Dumitru 1 , John Windle 1 , Eugenia Raichlin 1 ; 1 Cardiology, 

University of Nebraska Medical Center, Omaha, NE; 2 Nursing, 

Nebraska Medical Center, Omaha, NE 

136 Powering a Ventricular Assist Device over Meter 

Distances Wirelessly: The Free-Range Resonant 

Electrical Energy Delivery (FREE-D) System 

Benjamin Waters 1 , Alanson Sample 1 , Robert Kormos 3 , Joshua 

Smith 1,2 , Pramod Bonde 3 ; 1 Department of Electrical Engineering, 

University of Washington, Seattle, WA; 2 Department of 

Computer Science and Engineering, University of Washington, 

Seattle, WA; 3 Cardiothoracic Surgery, University of Pittsburgh 

Medical Center, Pittsburgh, PA 

MondAY 

68 

69

Sept. 19 

Monday 

Posters 

Posters 


Posters 

Electrophysiology/Arrhythmias 

Sept. 19 

Monday 

Posters 

MondAY 

137 Predicting Acute Cardiac Allograft Rejection Using 

Donor and Recipient Gene Expression 

Zsuzsanna Hollander 1,2 , Virginia Chen 2 , David Lin 1 , Raymond T. 

Ng 2,3 , Robert Balshaw 2,4 , Andrew Ignaszewski 5 , Gabriela Cohen 

Freue 2,4 , Janet Wilson-McManus 2 , Robert W. McMaster 2,6 , Paul 

Keown 1,2,5 , Bruce M. McManus 1,2,5 ; 1 Pathology and Laboratory 

Medicine, The University of British Columbia, Vancouver, 

Canada; 2 NCE CECR PROOF Centre of Excellence, Vancouver, 

Canada; 3 Computer Science, The University of British 

Columbia, Vancouver, Canada; 4 Statistics, The University 

of British Columbia, Vancouver, Canada; 5 Medicine, The 

University of British Columbia, Vancouver, Canada; 6 Medical 

Genetics, The University of British Columbia, Vancouver, 

Canada 


162 Temporal Association between Fluid Accumulation and 

Atrial and Ventricular Tachyarrhythmias: An Analysis of 

46,696 CRT-D and ICD Patients 

John Andriulli 1 , Hans J. Moore 2 , James Johnson 3 , Vinod Sharma 3 , 

Douglas A. Hettrick 3 , Steven M. Markowitz 4 ; 1 Cooper University 

Hospital, Camden, NJ; 2 Washington Veterans Affairs Medical 

Center, Washington, DC; 3 Medtronic, Inc., Minneapolis, MN; 

4 

Cornell University Medical Center, New York, NY 

163 ICD and CRT-D Heart Failure Patients with an 

Intrathoracic Impedance Fluid Index Threshold 

Crossing Have Significantly Increased Risk of 

Ventricular Tachyarrhythmias 

John A. Andriulli 1 , J. Thomas Heywood 2 , Roy Small 3 , Wilson 

Tang 4 , Douglas Hettrick 5 , Clayton T. Miller 6 ; 1 Cooper University 

Hospital, Camden, NJ; 2 Scripps Clinic, La Jolla, CA; 3 Lancaster 

Medical Center, Lancaster, PA; 4 Cleveland Clinic, Cleveland, 

OH; 5 Medtronic Inc., Medtronic Inc., MN; 6 Medtronic Inc., 

Medtronic Inc., MN 

164 Clinical Predictors of Chronic Cardiac 

Resynchronization Pacing Efficacy in the Failing 

Congenital Heart 

Yamuna Sanil 1 , Lakshmi Nagaraju 1 , Kathleen Zelin 1 , Harinder 

R. Singh 1 , Peter P. Karpawich 1 ; 1 Section of Pediatric Cardiology, 

The Children’s Hospital of Michigan, Detroit Medical Center, 

Detroit, MI 

165 Clinical Predictors of Early Adverse Outcomes Recieving 

Cardiac Resynchronization Therapy: Large Scale Single 

Center Experience 

Clay A. Cauthen 1 , John Rickard 1 , Bruce L. Wilkoff 1 , W.H. 

Wilson Tang 1 ; 1 Departmenmt of Cardiovascular Medicine, 


70 

166 Extending Wearable Cardiac Defibrillator Use in Heart 

Failure Patients beyond the ICD Waiting Period 

Nicole R. Bianco 1 , Steven J. Szymkiewicz 1 ; 1 Zoll, Pittsburgh, PA 

167 Increased Durability of Fidelis Leads in 

Resynchronization Systems 

Susan R. Vishneski 2 , Ashley C. Branch 1 , James F. Paulson 2 , 

Linette R. Klevan 1 , John M. Herre 1 ; 1 Sentara Cardiovascular 

Research Institute, Norfolk, VA; 2 Eastern Virginia Medical 

School, Norfolk, VA 

168 Characteristics of Implantable Cardioverter- 

Defibrillator Recipients for the Primary and Secondary 

Prevention of Sudden Cardiac Death in the Outcomes 

among Veterans with Implantable Defibrillators (OVID) 

Registry 

David F. Katz 1 , Ryan G. Aleong 1 , Lauren Pointer 2 , Cara N. 

Pelligrini 4 , William H. Sauer 1 , Russell R. Heath 1 , Joseph 

Schuller 1 , Duy T. Nguyen 1 , Paul A. Heidenreich 5 , Barry M. 

Massie 4 , Paul D. Varosy 1,2,3 ; 1 Division of Cardiology, University 

of Colorado, Aurora, CO; 2 Division of Cardiology, VA Eastern 

Colorado Health Care System, Denver, CO; 3 Colorado 

Cardiovascular Outcomes Research, Denver, CO; 4 Division of 

Cardiology, San Francisco VA Medical Center, San Francisco, 

CA; 5 Division of Cardiology, Palo Alto VA Medical Center, Palo 

Alto, CA 

169 Impact of Scar Burden on Outcomes of Cardiac 

Resynchronization Therapy 

Kelly L. Brooke 1 , Tracy L. Webster 1 , Yi-Zhou Xu 1 , Panithaya 

Chareonthaitawee 1 , Yong-Mei Cha 1 ; 1 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN 

170 Chronic Follow-Up of Comprehensive Pacemaker 

Optimization: LV-Only Pacing as an Available Option 

Ryan M. Gage 1 , Kevin V. Burns 1 , Daniel B. Vatterott 1 , Spencer 

H. Kubo 1 , Alan J. Bank 1 ; 1 Research Division, United Heart 

Vascular Clinic, St. Paul, MN 

Clinical Trials 

179 Effects of CRT Interval Optimization on Continuous 

Left Atrial Pressure Waveforms in Ambulant Heart 

Failure Patients and Inter-Patient Repeatability 

Wandy Chan 1 , Richard Troughton 1 , Andreas Blomqvist 2 , Iain 

Melton 1 , Ian Crozier 1 , Kjell Noren 2 ; 1 Christchurch Hospital, 

Christchurch, New Zealand; 2 St Jude Medical AB, Sweden 

71 

MondAY

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

MondAY 

180 Tafamidis Stabilizes Transthyretin and Improves Clinical 

Outcomes in Transthyretin Amyloid Cardiomyopathy 

Rodney Falk 1 , Matthew Maurer 2 , Savitri Fedson 3 , Daniel 

Judge 4 , Steven Zeldenrust 5 , Arshed Quyyumi 6 , Arian Pano 7 , 

Jeff Packman 7 , Donna Grogan 7 ; 1 Harvard Vanguard Medical 

Associates, Boston, MA; 2 Columbia University College of 

Physicians and Surgeons, New York, NY; 3 University of 

Chicago Hospital, Chicago, IL; 4 Johns Hopkins University, 

Baltimore, MD; 5 Mayo Clinic College School of Medicine, 

Rochester, MN; 6 Emory University School of Medicine, Atlanta, 

GA; 7 FoldRx Pharmaceuticals, Inc., Cambridge, MA 

181 NT-proBNP-Guided Preemptive Treatment of 

Outpatients with Chronic Heart Failure Followed in a 

Out Hospital Clinic 

Michael Shochat 1 , Avraham Shotan 1 , Iris Dahan 1 , Ilia Shochat 1 , 

Yaniv Levy 1 , Aya Asif 1 , Mark Kazatsker 1 , David Blondheim 1 , 

Simcha Meisel 1 ; 1 Cardiology, Hillel Yaffe, Hadera, Israel 

182 Shock Reduction Remains an Opportunity in Current 

Practice for ICD and CRT-D Patients 

Brett J. Peterson 1 , Grant Simons 4 , Scott Sakaguchi 3 , Christian 

Machado 5 , Michael O. Sweeney 2 , Fang Yang 1 ; 1 Medtronic, 

Mounds View, MN; 2 Brigham and Women’s Hospital, Boston, 

MA; 3 University of Minnesota, Minneapolis, MN; 4 Englewood 

Hospital and Medical Center, Englewood, NJ; 5 Providence 

Hospital and Medical Centers, Southfield, MI 

183 Relationship between Change in Ventricular Size 

and Function and BNP in Patients Undergoing CRT 

Therapy: MADIT-CRT 

Patricia Campbell 1 , Madoka Takeuchi 1 , Mikhail Bourgoun 1 , Scott 

McNitt 2 , Ilan Goldenberg 2 , Wojciech Zareba 2 , Arthur J. Moss 2 , 

Marc A. Pfeffer 1 , Scott D. Solomon 1 ; 1 Cardiovascular Division, 

Brigham and Women’s Hospital, Boston, MA; 2 Cardiology 

Division, University of Rochester, Rochester, NY 

184 A Novel Method Using the Valsalvagram in the Diagnosis 

of Heart Failure 

Herbert J. Semler 1 , Barry A. Borlaug 2 ; 1 Cardiovascular Medicine, 

Oregon Health Science University, Portland, OR; 2 Cardiology, 

Mayo Clinic, Rochester, MN 

185 Elevated Troponin Is Associated with Increased 

Mortality in Patients with Acute Dyspnea 

Yang Xue 1 , Paul Clopton 1 , Alan Maisel 1 ; 1 Cardiology, VA San 

Diego Healthcare System, San Diego, CA 

186 Safety and Efficacy of Ixmyelocel-T, an Expanded 

Patient-Specific Mixed Cell Product, in Dilated 

Cardiomyopathy (IMPACT-DCM) 

Amit N. Patel 1 , Baron L. Hamman 2 , Brian Bruckner 3 , Omar 

M. Lattouf 4 , Nicholas G. Smedira 5 , Cara East 2 , David A. Bull 1 ; 

1 

University of Utah, Salt Lake City, UT; 2 Baylor University 

Medical Center, Dallas, TX; 3 Methodist DeBakey Heart Center, 

Houston, TX; 4 Emory Crawford Long Hospital, Atlanta, GA; 

5 


187 Cystatin C as a Biomarker of Worsening Renal Function 

in Acute Heart Failure: Insights from the DOSE Study 

Raquel L. Bennett-Gittens 1,2 , Javed Butler 2 , Steve E. McNulty 3 , 

Anekwe Onwuanyi 1 , Adefisayo Oduwole 1 , Mike Felker 3 , Adrian 

F. Hernandez 3 , Kerry L. Lee 3 , Brenda Lankford 1 , Elizabeth O. 

Ofili 1 ; 1 Internal Medicine-Cardiology Division, Morehouse 

School of Medicine, Atlanta, GA; 2 Internal Medicine-Cardiology 

Division, Emory University, Atlanta, GA; 3 Data Coordinating 

Center, Duke University, Durham, NC 

Cardiovascular Pharmacology 

198 Natriuretic Peptide Receptor 3 Genotype Is Associated 

with Altered Pharmacokinetics during Nesiritide 

Infusion 

David E. Lanfear 1 , James Yang 2 , Karen Leszczynski 1 , Hani N. 

Sabbah 1 ; 1 Heart and Vascular Institute, Henry Ford Hospital, 

Detroit, MI; 2 Public Health Sciences, Henry Ford Hospital, 

Detroit, MI 

199 Cellular Basis for Angiotensin-(1-7)-Induced Positive 

Modulation on Cardiac Contractile Performance in 


Che Ping Cheng 1 , Peng Zhou 1 , Heng-Jie Cheng 1 ; 1 Internal 

Medicine-Cardiology, Wake Forest University School of 

Medicine, Winston-Salem, NC 

200 Cardiorenal Actions of the Designer Natriuretic Peptide, 

CD-NP, in a Severe Heart Failure Model Treated with 

Furosemide 

Elizabeth C. Costello 1 , Guido Boerrigter 1 , Sarah Mangiafico 1 , 

Alessandro Cataliotti 1 , John C. Burnett, Jr. 1 ; 1 Cardiovascular 

Research, Rochester, MN 

201 Atorvastatin Attenuates Atrial Remodeling by Its Anti- 

Oxidant and Anti-Inflammatory Action 

Y. Li, J. Shi, W.M. Li, Y.T. Gong, N. Yang; Harbin Medical 

University, Harbin, China; Harbin Medical University, Harbin, 

China; Harbin Medical University, Harbin, China; Harbin 

Medical University, Harbin, China; Harbin Medical University, 

Harbin, China 

MondAY 

72 

73

Sept. 19 

Monday 

Posters 

Posters 


Posters 

Epidemiology/Prevention 

Sept. 19 

Monday 

Posters 

MondAY 

202 Therapeutic Window for Cardioprotection by 

Recombinant Human Erythropoietin (rhEPO) in the Rat 

Model of Ischemia-Reperfusion: Implications for Clinical 

Trial Design 

Ismayil Ahmet 1 , Edward G. Lakatta 1 , Mark I. Talan 1 ; 1 Labratory 

of Cardiovascular Sciences, NIA/NIH, Baltimore, MD 

203 Biological Membrane Sealant Poloxamer 188 Improves 

Left Ventricular Function in Rats with Chronic Heart 


Elizabeth Juneman 1 , Laith Saleh 1 , Tariq Niazi 1 , Jordan J. 

Lancaster 1 , Hoang Thai 1 , Bruce Markham 2 , Steven Goldman 1 ; 

1 

Cardiology, Southern Arizona VA Health Care System, Tucson, 

AZ; 2 University of Michigan, Ann Arbor, MI 

204 TRV120027, a Novel Beta-Arrestin Biased Ligand at the 

Angiotensin II Type I Receptor, Unloads the Heart and 

Maintains Renal Function When Added to Furosemide 

in Experimental Heart Failure 

Guido Boerrigter 1 , David G. Soergel 2 , Michael W. Lark 2 , John C. 

Burnett, Jr. 1 ; 1 Mayo Clinic, Rochester, MN; 2 Trevena, Inc., King 

of Prussia, PA 

205 Discharge Prescription of Angiotensin II Receptor 

Blockers and All-Cause Mortality in Hospitalized 

Medicare Beneficiaries with Heart Failure and Preserved 

Ejection Fraction: A Propensity-Matched Study of the 

OPTIMIZE-HF 

Ali Ahmed 1,2 , Yan Zhang 1 , Marjan Mujib 1 , Pushkar P. Pawar 1 , 

Tarun Arora 1 , Meredith Kilgore 1 , Inmaculada Aban 1 , Thomas 

Love 3 , Richard Allman 2,1 , Gregg Fonarow 4 ; 1 UAB, Birmingham, 

AL; 2 VA Medical Center, Birmingham, AL; 3 Case Western 

Reserve University, Cleveland, OH; 4 Cardiology, UCLA, Los 

Angeles, CA 


214 Crystal Methamphetamine Associated Heart Failure 

among Native Hawaiians and Pacific Islanders 

Ann E. Leonard 1 , Beth Blackburn 1 , Marjorie K. Mau 2 , May 

Vawer 1 , Todd B. Seto 1 ; 1 The Queen’s Medical Center, Honolulu, 

HI; 2 Native Hawaiian Health, John A. Burns School of 

Medicine, Honolulu, HI 

215 Vaccination Rates in Heart Failure: Are We Missing the 

Target? 

Imran Khan 1 , Kiran Anna 1 , Mark E. Dunlap 2 ; 1 Medicine, 

MetroHealth Campus of Case Western Reserve, Cleveland, OH; 

2 

Cardiology, MetroHealth Campus of Case Western Reserve, 

Cleveland, OH 

216 The Prevalence and Predictors of Left Ventricular 

Systolic Dysfunction in Patients with Renal Artery 

Stenosis 

Eric E. Morgan 1,2 , Mujeeb Sheikh 2 , Christopher Cooper 2 , 

Samer Khouri 2 ; 1 Department of Physiology and Pharmacology, 

University of Toledo College of Medicine, Toledo, OH; 

2 

Department of Medicine, University of Toledo Medical Center, 

Toledo, OH 

217 Anger Proneness Increases Risk of Heart Failure 

Anna Kucharska-Newton 1 , Patricia Chang 1 , Carla Dupree 1 , 

Janice Williams 1 , Thomas Mosley 2 , Saul Blecker 3 , Sally Stearns 1 ; 

1 

University of North Carolina, Chapel Hill, NC; 2 University 

of Mississippi, Jackson, MS; 3 Johns Hopkins University, 

Baltimore, MD 

218 Ethnic Differences in Risk Prediction for Heart Failure 

Rehospitalization 

Ma Wai Wai Zaw 1 , Shaw Yang Chia 2 , Ling Ling Sim 2 , Bernard 

Kwok 2 , Carolyn Lam 1 ; 1 National University Health System 

(NUHS), Singapore, Singapore; 2 National Heart Centre (NHC), 

Singapore, Singapore 

219 Post Traumatic Stress Disorder Is Associated with 

Increased Mortality in Stable Outpatients with Elevated 

B-Type Natriuretic Peptide 

Yang Xue 1 , Laura Redwine 2 , Pam Taub 1 , Paul Clopton 1 , Navaid 

Iqbal 1 , Arrash Fard 1 , Murray Stein 2 , Alan Maisel 1 ; 1 Cardiology, 

VA San Diego Healthcare System, San Diego, CA; 2 Psychiatry, 

VA San Diego Healthcare System, San Diego, CA 

220 The Value of Optimal Blood Pressure Control in 

Reducing Functional and Structural Cardiovascular 

Abnormalities 

Mahfouz El Shahawy 1 , Miglena Entcheva 1 ; 1 Cardiovascular 

Disease Assessment Center, Sarasota Memorial Hospital, 

Sarasota, FL 

Outcomes 

228 Consequences of Hyponatremia on Intensive Care Unit 

Cost and Length of Stay in Heart Failure Patients 

Alpesh Amin 1 , Steven Deitelzweig 2 , Jay Lin 3 , Kathy Belk 4 , 

Dorothy Baumer 4 , Timothy Lowe 4 ; 1 University of California, 

Irvine, Irvine, CA; 2 Ochsner Health System, New Orleans, LA; 

3 

Novosyshealth, Flemington, NJ; 4 Premier, Inc., Charlotte, NC 

MondAY 

74 

75

Sept. 19 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 19 

Monday 

Posters 

MondAY 

229 Development and Prospective Validation of a 

Pediatric Heart Failure Risk-Prediction Model for 

30-Day Mortality in US Children Listed for Heart 


Christopher S. Almond 1 , Kimberlee Gauvreau 1 , Charles E. 

Canter 2 , Gary E. Piercey 1 , T.P. Singh 1 ; 1 Children’s Hospital 

Boston, Boston, MA; 2 Pediatric Cardiology, St. Louis Children’s 

Hospital, St. Louis, MO 

230 International Variation in Use of Anticoagulation among 

Heart Failure Patients with Atrial Fibrillation 

Jorge Suarez 1 , Jonathan P. Piccini 1 , Li Liang 1 , John J. Atherton 2 , 

Christopher S. Haywood 3 , Renato D. Lopes 1 , Adrian F. 

Hernandez 1 ; 1 Cardiology, Duke Clinical Research Institute, 

Durham, NC; 2 Cardiology, Royal Brisbane and Women’s 

Hospital, Brisbane, Queensland, Australia; 3 Cardiology, St 

Vincent’s Hospital, Sydney, New South Wales, Australia 

231 Serum Sodium Levels Have Strong Prognostic Value in 

Patients Admitted for Heart Failure and a Preserved 

Ejection Fraction 

Noah Moss 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore Medical 

Center, Bronx, NY 

232 Mortality in Pulmonary Hypertension Stratified by 

Sedimentation Rate 

Baruch Popovtzer 1 , Jason N. Salamon 1 , Jeremy Mazurek 1 , 

Muhammad Sardar 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore 

Medical Center, Bronx, NY 

233 The Impact of Prior Heart Failure Hospitalizations on 

Long-Term Mortality Differs by Baseline Risk of Death 

Naga V.A. Kommuri 1 , Todd M. Koelling 2 , Scott L. Hummel 2,3 ; 

1 

Department of Internal Medicine, Detroit Medical Center: 

Sinai-Grace Hospital, Detroit, MI; 2 Division of Cardiovascular 

Medicine, University of Michigan, Ann Arbor, MI; 3 Staff 

Cardiologist, Ann Arbor Veterans’ Affairs Medical Center, Ann 

Arbor, MI 

234 Hemodynamic and Laboratory Correlations of 

Symptoms in Patients with Heart Failure 

Maya Guglin 1 , Catherine Law 1 ; 1 Cardiology, University of South 

Florida, Tampa, FL 

235 The Intermountain Risk Score Stratifies Mortality Risk 

in Heart Failure Patients Receiving an ICD Based on 

Pre-Implant Laboratory Values 

Kimberly D. Brunisholz 1 , Benjamin D. Horne 1 , Roberta James 1 , 

Kyle D. Balling 1 , Kismet D. Rasmusson 1 , Deborah Budge 1 , 

Rami Alharethi 1 , Dylan P. Nelson 1 , Joseph M. Tuinei 1 , Abdallah 

G. Kfoury 1 ; 1 Heart Failure Prevention and Treatment Program, 

Intermountain Medical Center, Salt Lake City, UT 

236 Do Doppler/Echo Variables Improve the Performance of 

the Seattle Heart Failure Model in Predicting Outcomes? 

Omar F. Abouezzeddine 1 , Sultan A. Mirzoyev 1 , Wayne C. 

Levy 2 , Margaret M. Redfield 1 ; 1 Mayo Clinic, Rochester, MN; 

2 


237 Severity of Left Atrial Enlargement Does Not Predict 

Mortality in Heart Failure Patients 

Ramesh Chandra 1 , Daniel Spevack 1 ; 1 Division of Cardiology, 

Montefiore Medical Center, Albert Einstein College of 

Medicine, Bronx, NY 

238 Right Bundle Branch Block Is a Prognostic Marker for 

Cardiovascular Events in Patients Hospitalized with 

Acute Heart Failure: Data from KorHFR (Korean Acute 

Heart Failure Registry) 

Jaewon Oh 1 , Seok-Min Kang 1 , Sung Jin Hong 1 , Namki Hong 1 , 

Hoyoun Won 1 , Sungha Park 1 , Yangsoo Jang 1 ; 1 Cardiology, Yonsei 

University Medical College, Seoul, Korea 

239 Alcohol Cardiomyopathy Is Associated with Worse Graft 

Survival after Cardiac Transplant 

Douglas M. Brinkley 1 , Edward M. Geltman 1 ; 1 Medicine, 

Washington University School of Medicine, St. Louis, MO 

240 Barriers and Facilitators to Implementing the 2010 

Veteran’s Administration (VA) CHF QUERI Hospital to 

Home (H2H) Initiative 

Nancy L. Oliva 1,2 , Anju Sahay 1 , Parisa Gholami 1 , Paul A. 

Heidenreich 1,3 ; 1 VA Chronic Heart Failure QUERI Center, 

VA Palo Alto Health Care System, Palo Alto, CA; 2 Geriatric 

Research, Education Clinical Center (GRECC), VA Palo Alto 

Health Care System, Palo Alto, CA; 3 Center for Primary Care 

Outcomes Research, Stanford University, Stanford, CA 

241 MELD Score at the Time of Surgery Does Not Predict 

Post-Operative Outcomes in Orthotopic Heart 

Transplant 

Maria M. Patarroyo 1 , Cesar A. Simbaqueba 1 , W.H. Wilson 

Tang 2 , Randall Starling 2 , David O. Taylor 2 ; 1 Internal Medicine, 

Cleveland Clinic Foundation, Cleveland, OH; 2 Cardiovascular 

Medicine, Cleveland Clinic Foundation, Cleveland, OH 

242 Symptom Profiles in Advanced Heart Failure with 

Marked Differences in Quality-of-Life 

Christopher S. Lee 1 , Antony Y. Kim 1 , Jennifer Green 1 , Anne 

Rosenfeld 1 ; 1 Oregon Health Science Univ., Portland, OR 

MondAY 

76 

77

Sept. 19 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 19 

Monday 

Posters 

MondAY 

243 Impact of Hyponatremia on Inpatient Mortality and 

Hospital Readmission Rates in Hospitalized Patients 

with Heart Failure 

Steven Deitelzweig 1 , Alpesh Amin 2 , Jay Lin 3 , Kathy Belk 4 , 

Dorothy Baumer 4 , Timothy Lowe 4 ; 1 Ochsner Health System, 

New Orleans, LA; 2 University of California, Irvine, Irvine, CA; 

3 

Novosyshealth, Flemington, NJ; 4 Premier, Inc., Charlotte, NC 

244 Red Blood Cell Distribution Width Predicts In-Hospital 

Mortality in Acute Dyspnea Patients with or without 

Acute Heart Failure: Data from YONDER (YONsei 

Dyspnea on Emergency Department Registry) Study 

Namki Hong 1 , Seok-Min Kang 1 , Jaewon Oh 1 , Soo-Young Kim 1 , 

Hoyoun Won 1 , Sungha Park 1 , Yangsoo Jang 1 ; 1 Cardiology, Yonsei 

University Medical College, Seoul, Korea 

245 The PROTECT In-Hospital Risk Model: 7-Day Outcome 

in Patients Hospitalized with Acute Heart Failure (AHF) 

and Renal Dysfunction 

R.J. Mentz 1 , M. Fiuzat 1 , K. Chiswell 1 , D. Wojdyla 1 , B. Davison 2 , 

J. Cleland 3 , H.C. Dittrich 4 , M.M. Givertz 5 , G. Mansoor 4 , P. 

Ponikowski 6 , J.R. Teerlink 7 , A.A. Voors 8 , G. Cotter 2 , M. Metra 9 , 

B.M. Massie 7 , C.M. O’Connor 1 ; 1 Duke, Durham; 2 Momentum 

Res, Durham; 3 Univ of Hull, Hull, United Kingdom; 4 Merck 

Res, Rahway; 5 BWH, Boston; 6 Med Univ, Wroclaw, Poland; 

7 

UCSF SF VAMC, San Francisco; 8 Univ Med Ctr, Groningen, 

Netherlands; 9 Univ Brescia, Brescia, Italy 

246 A Blended Facilitation To Implement the VA Hospital-to- 

Home (H2H) Initiative: CHF QUERI 

Anju Sahay 1 , Paul A. Heidenreich 1 ; 1 CHF QUERI, Dept of 

Veterans Affairs, Palo Alto, CA 

247 Association of Heart Failure Symptoms Identified by 

Home Monitoring with Long-Term Mortality and Shock 

Incidence 

Paul A. Heidenreich 1 , John P. Boehmer 2 , David L. Hayes 3 , F.R. 

Gilliam 4 , John D. Day 5 , Milan Seth 6 , Leslie A. Saxon 7 ; 1 VA Palo 

Alto Health Care System, Palo Alto, CA; 2 Penn State, Hershey, 

PA; 3 Mayo Clinic, Rochester, MN; 4 Cardiology Associates of 

NE Arkansas, Jonesboro, AR; 5 Intermountain Health System, 

Salt Lake City, UT; 6 Boston Scientific, St. Paul, MN; 7 USC, Los 

Angeles, CA 

248 True Biventricular Pacing Favors Outcomes of Cardiac 

Resynchronization 

Kelly L. Brooke 1 , Tracy A. Webster, Heather Wiste, Samuel J. 

Asirvatham, David L. Hayes, Yong-Mei Cha; 1 Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

249 Peripartum Cardiomyopathy – Is the Current Definition 

Too Restrictive? 

Kismet Rasmusson 1 , Kim Brunisholz 1 , Deborah Budge 1 , Rami 

Alharethi 1 , Jenny Connolly 1 , Benjamin Horne 1 , Kurt Jensen 1 , 

Josef Stehlik 2 , Abdallah Kfoury 1 ; 1 Heart Failure Prevention and 

Treatment Program, Intermountain Medical Center, Salt Lake 

City, UT; 2 Heart Failure and Transplant, University Hospital, 


250 Resource Use and Medical Costs by Cause of Death in 

HF-ACTION 

Yanhong Li 1 , David J. Whellan 2 , Mark E. Dunlap 3 , William 

E. Kraus 1 , Gregory Samsa 1 , Kevin A. Schulman 1 , Michael 

Zile 4 , Shelby D. Reed 1 ; 1 Duke Clinical Research Institute, 

Duke University, Durham, NC; 2 Jefferson Medical Center, 

Philadelphia, PA; 3 Case Western Reserve University, Cleveland, 

OH; 4 Medical University of South Carolina, Charleston, OH 

251 Regadenoson Stress SPECT MPI for Prediction of 

Outcomes in Patients with Impaired Left Ventricular 

Function: A Comparison with Adenosine Stress 

Salvador Borges-Neto 1 , Linda K. Shaw 1 , Mona Fiuzat 1 , Robert 

Pagnanelli 1 , Christopher M. O’Connor 1 ; 1 Medicine/Cardiology, 

Duke University, Durham, NC 

252 Aggressive Diuresis as a Predictor of Hospital 

Readmission Due to Acute Heart Failure Exacerbations 

in Elderly Patients 

Shirley Wong 1 , Norela Ocampo 1 , Rebecca Cheung 1 , Jun Chiong 1 ; 

1 

Department of Pharmacotherapy and Outcomes Science, Loma 

Linda University, Loma Linda, CA 

253 Improved Heart Failure Outcomes through Family 

Involvement 

Patricia E. Briggs 1 ; 1 Nursing, Christiana Care Health Services, 

Newark, DE 

254 Risk Scoring in Cardiac Failure and eCPR Patients 

Requiring ECMO Support 

Richard K. Cheng 1 , Chi-hong Tseng 2 , Richard Shemin 3 , W. Robb 

MacLellan 1 ; 1 Cardiology, UCLA, Los Angeles, CA; 2 General 

Internal Medicine, UCLA, Los Angeles, CA; 3 Cardiothoracic 

Surgery, UCLA, Los Angeles, CA 

Clinical Care/Management Strategies 

282 Pulse Pressure Widening Is a Determinant of Diastolic 

Dysfunction 

Mahazarin Ginwalla 1 , Florian Rader 1 , Tilak Pasala 1 , Jeremy 

Johnson 1 , Mark Dunlap 1 ; 1 Cardiology, Metrohealth Medical 

Center/CWRU, Cleveland, OH 

MondAY 

78 

79

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

MondAY 

283 Impact of a Heart Failure “Teach to Goal” Intervention 

in Low Literacy Patients 

Aurelia Macabasco-O’Connell 1 , Adriana Mendez 1 , Michael 

Pignone 2 ; 1 School of Nursing, University of California Los 

Angeles, Los Angeles, CA; 2 Department of Medicine, University 

of North Carolina-Chapel Hill, Chapel Hill, NC 

284 Different Features of the Apical and Non-Apical Types of 

Stress-Induced Cardiomyopathy 

Sun Hwa Lee 1 , Won Ho Kim 1 , Jae Ki Ko 1 , Yun Ji Park 1 , Lae 

Young Jung 1 , Min Ju Song 1 , Hae Eun Yun 1 ; 1 Cardiology, 

Chonbuk National University Medical School, Jeonju, Korea 

285 Significant Barriers Exist in the Appropriate Utilization 

of Echo Contrast Agents in the Heart Failure Population 

Sara L. Partington 1 , Shelley Hurwitz 1 , Judy R. Mangion 1 ; 

1 

Non-Invasive Cardiovascular Imaging, Brigham and Women’s 


286 Ketamine-Induced Ventricular Remodeling: Pathological 

Consequences and Protective Effects of Metoprolol 

Y. Li, J. Shi, B.F. Yang, Z.H. Gong, W.M. Li; Harbin Medical 

University, Harbin, China; Harbin Medical University, Harbin, 

China; Harbin Medical University, Harbin, China; Harbin 

Medical University, Harbin, China; Harbin Medical University, 

Harbin, China 

287 The Swan-Ganz Catheter and UNOS IA Patients: The 

Routine Change Challange 

Jason A. Gluck 1 , Roja Mulamalla 1 , Joseph Radojevic 1 , Justin 

Lundbye 1 , Detlef Wencker 1 ; 1 Cardiology, Hartford Hosptial, 

Hartford, CT 

288 Are Telemonitoring and Structured Telephone Support 

More Effective in Younger or Older Heart Failure 

Patients? A Sensitivity Analysis from a Cochrane Review 

Sally C. Inglis 1 , Robyn A. Clark 2 , Simon Stewart 3 , Finlay A. 

McAlister 4 , John G.F. Cleland 5 ; 1 University of Technology, 

Sydney, Australia; 2 Queensland University of Technology, 

Brisbane, Australia; 3 Baker IDI Heart and Diabetes Institute, 

Melbourne, Australia; 4 University of Alberta, Edmonton, 

Canada; 5 Castle Hill Hospital, East Yorkshire, United Kingdom 

289 HF Assessment with BNP in the Home: Primary Results 

of the Mulitcenter HABIT Trial 

Alan S. Maisel 1 , Denise Banard 2 , Brian Jaski 3 , Geir Frivold 4 , 

John Marais 5 , Barry Greenberg 2 ; 1 Medicine, San Diego VA 

Medical Center, San Diego, CA; 2 University of California San 

Diego, San Diego, CA; 3 San Diego Sharp Medical Center, San 

Diego, CA; 4 Loma Linda Medical Center, Loma Linda, CA 

290 Fatigue Correlates to Functional Status Better Than 

Dyspnea or Orthopnea 

Jesal Popat 1 , Maya Guglin 1 ; 1 Department of Cardiovascular 

Medicine, University of South Florida, Tampa, FL 

291 Utilisation of Telehome Monitoring in Patients over the 

Age of 75 with Complex Heart Failure; Does Age Make 

Any Difference? 

Genevieve Lemay 1 , Nahid Azad 2 , Christine Struthers 3 ; 1 Internal 

Medicine, University of Ottawa, Ottawa, Canada; 2 Geriatric 

Medicine, The Ottawa Hospital, Ottawa, Canada; 3 The Heart 

Institute, Ottawa, Canada 

292 Biofeedback Training in Patients with Advanced Heart 


Dana L. Frank 1 , Matthew Baumann 1 , Michael Liebenstein 1 , 

Lamees Khorshid 1 , Gregory J. Bolwell 1 , Jerome Kiffer 1 , W.H. 

Wilson Tang 1 , James B. Young 1 , Randall C. Starling 1 , Michael G. 

McKee 1 , Christine S. Moravec 1 ; 1 Cleveland Clinic, Cleveland, 

OH 

293 Lack of Association of Changes in BNP with Cardiorenal 

Syndrome during Treatment of Acute Decompensated 


Sameer Ather 1 , Mark D. McCauley 1 , Amandeep Dhaliwal 1 , Anita 

Deswal 1,2 , Wenyaw Chan 3 , David Aguilar 1,2 , Allison M. Pritchett 1 , 

Kumudha Ramasubbu 1,2 , Xander H.T. Wehrens 1 , Biykem 

Bozkurt 1,2 ; 1 Baylor College of Medicine, Houston, TX; 2 Michael 

E DeBakey VA Hospital, Houston, TX; 3 UT School of Public 

Health, Houston, TX 

294 Changes in Galectin-3 Levels over Time Predict 

Mortality and Morbidity in Chronic HF 

Rudolf A. de Boer 2 , Dirk J. van Veldhuisen 2 , Lars Gullestad 3 , 

Thor Ueland 3 , Pal Aukrust 3 , Yu Guo 1 , Aram S. Adourian 1 , 

Pieter Muntendam 1 ; 1 BG Medicine Inc., Waltham, MA; 

2 

University Medical Centre Groningen, Groningen, Netherlands; 

3 

Rikshospitalet University Hospital, Oslo, Norway 

295 Emergency Department Diuretic Dosing in Acute 

Decompensated Heart Failure and Its Effect on Length 

of Stay and Re-Admission Rate 

Jacqueline Fearon-Clarke 1 , Simarta Brennan 1 , Rami Bustami 1 , 

Betty Merveil-Ceneus 1 , Bernardo Vargas 1 , Rosmery Montesino 1 , 

Steven Sheris 1 ; 1 Cardiology, Gagnon Cardiovascular Institute at 

Overlook Hospital, Atlantic Health, Summit, NJ 

296 A Multi-Disciplinary Hospital to Home Initiative To 

Reduce Heart Failure Readmissions 

Zachary L. Cox 1,2 , Brittany L. Cunningham 1 , Thomas DiSalvo 1 ; 

1 

Vanderbilt University Medical Center, Nashville, TN; 

2 

Lipscomb University College of Pharmacy, Nashville, TN 

MondAY 

80 

81

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

MondAY 

297 Plasma Galectin-3 Is Associated with Near-Term 

Rehospitalization in Heart Failure: A Meta-Analysis 

Rudolf A. de Boer 1 , Dirk J. van Veldhuisen 1 , Christopher 

deFilippi 2 , Pieter Muntendam 3 , Aram S. Adourian 3 , Yu Guo 3 , 

James L. Januzzi 4 ; 1 University Medical Centre Groningen, 

Groningen, Netherlands; 2 Division of Cardiology, University 

of Maryland, Baltimore, MD; 3 BG Medicine Inc., Waltham, 

MA; 4 Division of Cardiology, Massachusetts General Hospital, 

Boston, MA 

298 Design, Feasibility, and Clinical Characteristics of a 

Novel Heart Failure with Preserved Ejection Fraction 

Program 

Sanjiv J. Shah 1 , Michael A. Burke 1 , Deepak Gupta 1 , Venkatesh 

Anjan 1 , John B. O’Connell 1 , Mihai Gheorghiade 1 , Robert O. 

Bonow 1 ; 1 Medicine, Northwestern University Feinberg School of 

Medicine, Chicago, IL 

299 Medical Management Guided by Pulmonary Artery 

Pressures in NYHA Functional Class III Heart Failure 

Patients 

Maria Rosa Costanzo 1 , William T. Abraham 2 , Philip B. 

Adamson 3 , Pam A. Cowart 4 , Kevin M. Corcoran 4 , Greg L. 

Ginn 4 ; 1 Cardiology, Midwest Heart Foundation, Naperville, IL; 

2 

Cardiology, Ohio State University, Columbus, OH; 3 Cardiology, 

Oklahoma Foundation for Cardiovascular Research, Oklahoma 

City, OK; 4 CardioMEMS Inc, Atlanta, GA 

300 Medication Management Strategies of Community Heart 

Failure Programs in Australia 

Alexandra A. Bennett 1,2 , Deborah Tong 1 , Patricia M. Davidson 3 , 

Andrew M. McLachlan 1,2 ; 1 Faculty of Pharmacy, The University 

of Sydney, Sydney, NSW, Australia; 2 Centre for Education and 

Research on Ageing, The University of Sydney and Concord 

General Repatriation Hospital, Sydney, NSW, Australia; 3 Curtin 

Health Innovation Research Institute, Curtin University, Sydney, 

NSW, Australia 

301 Does the Interpretation of Fluid Threshold Crossings 

Differ between Heart Failure and Non Heart Failure 

Centers? Analysis from the OptiVol Care Pathway Study 

Roy S. Small 1 , John Andriulli 2 , W.H. Wilson Tang 3 , J. Thomas 

Heywood 4 , Clayton Miller 5 ; 1 Cardiology, The Heart Group 

of Lancaster General Health, Lancaster, PA; 2 Cardiology, 

University of Medicine and Dentistry New Jersey, Voorhees, 

NJ; 3 Cardiovascular Medicine, Cleveland Clinic, Cleveland, 

OH; 4 Cardiology, Scripps Clinic Torrey Pines, La Jolla, CA; 

5 

Research, Medtronic, Mounds View, MN 

302 Total Body Water Measured with BIVA (Bioelectrical 

Impedance Vector Analysis) Predicts Outcome in 

Patients Hospitalized with Acute Heart Failure 

Carolyn Haunschild 1 , Paul Clopton 2 , Yang Xue 1 , Alan S. Maisel 1 ; 

1 

Cardiology, University of California San Diego, San Diego, 

CA; 2 Cardiology, San Diego Veteran Affairs Healthcare System, 

San Diego, CA 

303 NT-proBNP Guided Therapy Improves the Quality of 

Life in Patients with Chronic Heart Failure. Results 

from the ProBNP Outpatient Tailored Chronic Heart 

Failure Therapy Study 

Anju Bhardwaj 1 , Shafiq U. Rehman 1 , Asim A. Mohammed 1 , 

Han-na Kim 1 , Linda Barajas 1 , Justine Barajas 1 , Stephanie A. 

Moore 1 , Dorothy Sullivan 1 , James L. Januzzi 1 ; 1 Cardiology, 

Massachusetts General Hospital, Boston, MA 

304 Cardiomyopathy Characterized by Normal 

Interventricular Septal Thickness in Amyloidosis: 

Description of a New Entity 

Rahul Suresh 1 , Patricia A. Pellikka 2 , Angela Dispenzieri 2 , 

Naveen L. Pereira 2 ; 1 Mayo Medical School, Mayo Clinic, 

Rochester, MN; 2 Medicine, Mayo Clinic, Rochester, MN 

305 H1N1 and De Novo Cardiac Dysfunction or 

Exacerbation of Existing Cardiac Disease in Patients 

Admitted to Hospital 

Courtney A. Young, Sayeh Zielke, Debra L. Isaac; University of 

Calgary, Calgary, AB 

306 Correlation of Weight Change and Net Fluid Status as 

Markers of Diuretic Efficacy 

Zachary Cox 1,2 , Thomas DiSalvo 1 ; 1 Vanderbilt University 

Medical Center, Nashville, TN; 2 Lipscomb University College 

of Pharmacy, Nashville, TN 

307 Symptom-Monitoring and Treatment-Seeking Behaviors 

in Japanese Patients with Heart Failure: A Multicenter 

Study 

Naoko Kato 1 , Koichiro Kinugawa 1 , Etsuko Nakayama 2 , 

Akiko Hatakeyama 2 , Yumiko Kumagai 2 , Taro Shiga 1 , Masaru 

Hatano 1 , Atsushi Yao 1 , Chikako Miura 2 , Masayoshi Nagayama 3 , 

Tetsuya Sumiyoshi 3 , Ryozo Nagai 1 ; 1 Cardiovascular Medicine, 

The University of Tokyo Hospital, Tokyo, Japan; 2 Nursing, 

Sakakibara Heart Institute, Tokyo, Japan; 3 Cardiology, 

Sakakibara Heart Institute, Tokyo, Japan 

MondAY 

82 

83

Sept. 19 

Monday 

Posters 

Posters 


Posters 


Sept. 19 

Monday 

Posters 

308 Ultrafiltration Is Associated with Worsening Renal 

Function, and Electrolyte Abnormalities in Patients 

with Diuretic Refractory Heart Failure and Renal 

Dysfunction 

Shailesh C. Shirolkar 1 , G. Michael Felker 1 , Susanna R. Stevens 1 , 

Minnie P. Blackwell 1 , Shelley L. Thompson 1 , Joseph G. Rogers 1 , 

Christopher M. O’Connor 1 , Sandesh Dev 1 ; 1 Duke Clinical 

Research Institute, Durham, NC 

315 Nutritional Supplementation with Amino Acids 

in Ambulatory Patients with Idiophatic Dilatated 

Cardiomyophaty 

Carlo Lombardi 1 , Metra Marco 1 , Maiandi Cristian 1 , Filippo 

Quinzani 1 , Giovanni Cuminetti 1 , Anna Isotta Castriani 1 , Federica 

Guidetti 1 , Nodari Savina 1 , M. Gheorghiade 2 , Dei Cas Livio 1 ; 

1 

Cardiology, University of Brescia, Brescia, Italy; 2 Northwestern 


MondAY 

309 Mortality in Primary Pulmonary Arterial Hypertension 

Stratified by Hemoglobin Levels 

Baruch Popovtzer 1 , Jason N. Salamon 1 , Jeremy Mazurek 1 , 

Muhammad Sardar 1 , Ronald Zolty 1 ; 1 Cardiology, Montefiore 

Medical Center, Bronx, NY 

316 Heart Failure in Cancer: Is Interactive Voice Response 

System (IVRS) Feasible for Symptom Management? 

Anecita P. Fadol, Tito Mendoza, Pankil Shah, Charles Cleeland; 

Cardiology, MD Anderson Cancer Center, Houston, TX; 

Symptom Research, MD Anderson Cancer Center, Houston, TX 

MondAY 

310 Racial Disparities in Patients Selected for Advanced 

Heart Failure Therapies 

Neelima Nadella 1 , Sevan S. Karadolian 2 , Mohamed Ahmed 2 , 

Celeste Williams 1 , Henry E. Kim 1 ; 1 Cardiovascular Medicine, 

Henry Ford Hospital, Detroit, MI; 2 Department of Internal 

Medicine, Henry Ford Hospital, Detroit, MI 

317 Short and Long-Term Outcome of Impedance-Guided 

Preemptive Therapy Provided To Prevent Acute Heart 

Failure in the Course of Acute Myocardial Infarction 

Michael Shochat 1 , Avraham Shotan 1 , Ilia Shochat 1 , Iris Dahan 1 , 

Aya Asif 1 , David Blomdhaim 1 , Simcha Meisel 1 ; 1 Cardiology, 

Hillel Yaffe Medical Center, Hadera, Israel 

311 Bioimpedance Improves the Diagnostic Accuracy for 

Acute Heart Failure in the Emergency Department 

Tertius Tuy 1 , Lori Fiessinger 2 , Asha Talati 3 , Jieun Kim 1 , W. Frank 

Peacock 4 ; 1 Duke-NUS Graduate Medical School, Singapore, 

Singapore; 2 Case Western Reserve University SOM, Cleveland, 

OH; 3 Cleveland Clinic Lerner College of Medicine, Cleveland, 

OH; 4 Cleveland Clinic, Cleveland, OH 

318 New Discoveries Regarding the Limitations of 

Impedance Monitoring for Heart Failure Management 

Chris Charles 1 , Miriam Rademaker 1 , Iain Melton 1 , Jeff Siou 2 , 

Riddhi Shah 2 , Fujian Qu 2 , Neal Eigler 2 , Dan Gutfinger 2 , Richard 

Troughton 1 ; 1 Christchurch Cardioendocrine Research Group, 

University of Otago, Christchurch, New Zealand; 2 Cardiac 

Rhythm Management Division, St Jude Medical, Sylmar, CA 

312 Can Echocardiographic Characteristics Help Predict 

Response to Echo-Guided Biventricular Pacemaker 

Optimization? 

Salima Qamruddin 1 , Reza Rafie 1 , Tasneem Z. Naqvi 1 ; 1 Non 

Invasive Lab, Division of Cardiology, Department of Medicine, 

University of Southern California, Los Angeles, CA 

313 History Taking Differences in Acute Heart Failure 

Patients by Emergency Medicine and Internal Medicine 

Physicians Leads to Differing Initial Management 

Ankitkumar K. Patel 1 , Kevin Curl 2 , Sajjad Sabir 1 , Foluso 

Fakorede 1 , Walid Saad 1 , Dany Gaspard 1 , Elias Iliadis 1 ; 

1 

Cardiology, Cooper University Hospital, Robert Wood Johnson 

Medical School, Camden, NJ; 2 Penn State College of Medicine, 

Hershey, PA 

314 Clinical Characteristics and Outcomes of Patients with 

Improvement in Renal Function during the Treatment of 


Jeffrey M. Testani 1 , Brian D. McCauley 1 , Jennifer Chen 1 , Steven 

G. Coca 2 , Thomas P. Cappola 1 , Stephen E. Kimmel; 1 Medicine, 

University of Pennsylvania, Philadelphia, PA; 2 Medicine, Yale 

University, New Haven, CT 

84 

85

Sept. 20 

Tuesday 

AM 

ROUNDTABLE 


7:00-8:15 AM 

Room 304 

CLINICAL FUNDAMENTALS 


7:00-8:15 AM 

Room 302 

Sept. 20 

Tuesday 

AM 

Roundtable: Centers for VAD/Transplant/Heart 

Failure: All or None? 

Clinical Fundamentals: Transplantation/ 

Palliative Care 

TuesdAY 

Moderator: Clyde W. Yancy, Chicago, IL 

7:00 Heart Failure Management 

John B. O’Connell, Atlanta, GA 

7:10 Patient Selection within Centers of Excellence 

Dennis Irwin, Minneapolis, MN 

7:20 Discussion 

7:35 VAD Over Transplant 

Maria Rosa Costanzo, Naperville, IL 

7:45 VAD with Transplant 

Robert L. Kormos, Pittsburgh, PA 

8:00 Discussion 

Learning Objective: Outline the important issues 

surrounding certification of centers for heart transplantation 

of VAD implantation. 

Moderators: Kismet D. Rasmusson, Murray, UT 


7:00 Identifying Patients Who Have Failed Optimal Medical 

Therapy 


7:10 Selection, Priority, Early and Late Outcomes with 


David O. Taylor, Cleveland, OH 

7:20 Current Immunosuppression Regimens and Rejection 

John Chin, Sacramento, CA 

7:35 The Rest of the Regimen and Why 

Connie L. White-Williams, Birmingham, AL 

7:45 Allograft Vasculopathy 

Stephanie A. Moore, Boston, MA 

7:55 Changing Goals of Care in Advanced Disease 

James N. Kirkpatrick, Philadelphia, PA 


Faculty 

Learning Objective: Describe strategies for identifying and 

treating patients with advanced heart failure appropriate for 

transplantation or palliative care. 

TuesdAY 

86 

87

Sept. 20 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom A 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom C 

Sept. 20 

Tuesday 

AM 

TuesdAY 

Improving Outcomes after Hospitalization for 

Heart Failure: A Call for Action 

Moderators: Mihai Gheorghiade, Chicago, IL 

Kenneth M. Stein, St. Paul, MN 

8:30 Introduction and Background 

Mihai Gheorghiade, Chicago, IL 

8:40 NIH View 

Monica R. Shah, Bethesda, MD 

8:50 View from Pharma 

Frank Misselwitz, Wuppertal, Germany 

9:00 View from the Device Arena 

Marshall S. Stanton, Mounds View, MN 

9:10 Measuring Hospital Performance 

Frederick A. Masoudi, Denver, CO 

9:20 The Hospitalist 

Jeffrey L. Greenwald, Boston, MA 

9:30 The ED 

Peter S. Pang, Chicago, IL 


Learning Objective: Outline strategies for improving 

outcomes for heart failure patients following hospitalization. 

Time To Slow Down 

Moderators: Wilson S. Colucci, Boston, MA 

David E. Lanfear, Detroit, MI 

8:30 To Shift from Beta Blockers 

Karl Swedberg, Gothenburg, Sweden 

8:50 Calcium Fluxes in the Myocyte 

Joshua I. Goldhaber, Los Angeles, CA 

9:10 The Biology of Cardiac Pacemakers 

Edward G. Lakatta, Baltimore, MD 

9:30 Cardiomyopathy Related to Tachycardia or PVC Burden 

Bruce B. Lerman, New York, NY 

9:45 Should Beta Blocker Therapy be Titrated to Heart Rate? 

Stephen S. Gottlieb, Baltimore, MD 

Learning Objective: Describe the role of heart rate in the 

pathogenesis and treatment of heart failure. 

TuesdAY 





88 

89

Sept. 20 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 302 

SYMPOSIUM 


8:30-10:00 AM 

Room 304 

Sept. 20 

Tuesday 

AM 

Before and After Cardiac Transplantation 

What Works to Decrease Readmissions? 

Moderators: Michelle M. Kittleson, Los Angeles, CA 

Paul J. Mather, Philadelphia, PA 

Moderators: Mary N. Walsh, Indianapolis, IN 


8:30 Waiting For Better or Worse: Listing and De-Listing 

Mariell L. Jessup, Philadelphia, PA 

8:30 How Can We Tell What Works? 

Andrew R. Weintraub, Boston, MA 

TuesdAY 

8:45 Impact of Priority System on Hospital and Family 

Resource Utilization 

Julie A. Shinn, Stanford, CA 

8:55 Double-Organ Transplantation: Who and Why 

Jon A. Kobashigawa, Los Angeles, CA 


9:15 Beyond Levels: How Can We Tailor 

Immunosuppression? 

Josef Stehlik, Salt Lake City, UT 

9:25 Timing and Impact of Renal Rescue 

David O. Taylor, Cleveland, OH 


9:40 Graft Arteriosclerosis vs. Native Atherosclerosis: 

Contrasts and Commonalities 

Peter Libby, Boston, MA 

8:45 Education Strategies 

Michele N. Gilbert, Oakland, NJ 

8:57 Transition of Care from Inpatient to Outpatient 

Kathleen M. McCauley, Philadelphia, PA 

9:09 Value of IV Diuretics in Clinic 

Lisa D. Rathman, Lancaster, PA 

9:21 Project Red 

Brian Jack, Boston, MA 

9:33 European Approach to Decreasing Readmissions 

Stefan D. Anker, Berlin, Germany 


Learning Objective: Describe current approaches to 

reducing readmissions in heart failure patients. 

TuesdAY 

Learning Objective: Discuss key clinical issues in pre- and 

post-care of the transplant patient and identify appropriate 

care strategies. 





90 

91

Sept. 20 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 306 

POSTERS DISPLAYED 


9:30 AM-7:00 PM 


Sept. 20 

Tuesday 

AM 

How Can We Improve Stem Cells for Heart 

Failure Therapy? 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

Moderators: Annarosa Leri, Boston, MA 

Kenneth B. Margulies, Philadelphia, PA 

8:30* Stem Cells and Cardiomyogenesis: Overview of Stem 

Cell Biology 

Piero Anversa, Boston, MA 

Categories Poster # 

Cardiovascular Physiology 036-055 

Cardiovascular Structure 061-065 

8:52* Inflammation Modulates Cardiac Repair via Stem Cells 

Ronglih Liao, Boston, MA 

Neurohormones/Cytokines 083-098 

TuesdAY 

9:15* Epigenetic Modulation of Endothelial Progenitor Cells 

for Cardiomyogenesis 

Raj Kishore, Chicago, IL 

9:37* Directed Differentiation of Progenitor Cells 

Andre Terzic, Rochester, MN 

Molecular Biology and Genetics 107-114 

Surgery, Transplantation, Devices 138-161 

TuesdAY 

*20 minute presentation, 2-3 minute audience discussion 

Electrophysiology/Arrhythmias 171-178 

Learning Objective: Describe the current and potential role 

of stem cells in heart failure therapy. 

Clinical Trials 188-197 

Cardiovascular Pharmacology 206-213 

Epidemiology, Prevention 221-227 

Outcomes 255-281 

Clinical Care/Management Strategies 319-355 

Listing for Monday posters begins on page 58 

Listing for Tuesday posters begins on page 110 





92 

93

Sept. 20 

Tuesday 

AM 

CASE DISCUSSION 


10:30 AM-NOON 

Ballroom A 

CASE DISCUSSION 

Sept. 20 

Tuesday 

AM 

TuesdAY 

Case Presenters: Akshay M. Desai, Boston, MA 

James C. Fang, Cleveland, OH 

Panelists: 

Roy M. John, Boston, MA 

Alan T. Kono, Lebanon, NH 

Rohinton J. Morris, Abington, PA 

J. Herbert Patterson, Chapel Hill, NC 

Kismet D. Rasmusson, Murray, UT 

10:30 Case 1: A 61 yo diabetic man with a longstanding history of 

atrial fib presents with a 6 mo history of progressive lower 

extremity edema and exertional dyspnea. His exam is notable 

for blood pressure of 144/80 mm Hg, irregular pulse of 75 

beats/min, and prominent temporalis muscle wasting. The 

jugular veins are distended to the angle of the jaw seated upright 

and the lungs are clear to auscultation. The cardiac exam is 

notable for a prominent P2 but no gallop, and grade 2/6 systolic 

murmurs at both the lower left sternal border and the apex. The 

liver edge is firm and palpable four fingerbreadths below the 

right costal margin. There is pitting edema to the thighs with 

normal muscular strength and bulk in the extremities. ECG is 

notable for atrial fib with low limb lead voltage. Echo reveals 

concentric LV hypertrophy (posterior wall thickness 18 mm), 

marked biatrial enlargement, and moderate tricuspid and mitral 

valve regurg. The lateral mitral annular relaxation velocity is 8 

cm/s. How would you approach the management of this patient 

with ‘diastolic’ heart failure? 

10:52 Case 2: A 75 yo woman with recurrent episodes of ADHF is 

referred for management of PH. She underwent aortic valve 

replacement and coronary artery bypass grafting several yrs ago 

for symptomatic aortic stenosis and coronary artery disease. 

Her additional history is notable for type 2 diabetes mellitus, 

hypertension, and atrial fib. On exam, she weighs 275 lbs and is 55 

tall with BP 150/80 and pulse 50 beats/min. She has jugular venous 

distention to the jaw, dullness to percussion at both lung bases, 

and a stable sternum. There is a prominent RV heave and S3; P2 is 

increased and there is a systolic murmur typical of tricuspid regurg, 

but no diastolic murmur is audible. The abdomen is distended and 

obese with 3+ pitting edema of the lower extremities with skin 

changes of venous stasis. Echo reveals mild mitral stenosis, severe 

tricuspid regurgitation, and moderate RV enlargement/dysfunction. 

The LV EF is normal. Labs reveal creatinine 2.5 mg/dL with BUN 

55 mg/dL. Right heart cath reveals right atrial pressure 24 mm Hg, 

pulmonary artery pressure of 68/24 mm Hg (mean 38 mm Hg) and 

pulmonary capillary wedge pressure of 20 mm Hg with V-waves 

to 26 mm Hg; aortic pressure is 156/72 mm Hg. The pulmonary 

artery 02 saturation is 49% and systemic arterial saturation is 90% 

generating cardiac index 2.3 L/min/m2, cardiac output of 4.7 L/min 

by the Fick method; the calculated pulmonary vascular resistance 

is 339 dynes/sec/cm5 and systemic vascular resistance is 1256 

dynes/sec/cm5. How would you manage this patient with heart 

failure, pulmonary hypertension, tricuspid regurgitation, and renal 

insufficiency? 

11:14 Case 3: A 74 yo man is self referred for consideration of ‘stem 

cell’ therapy. He suffered an inferior MI over 20 yrs ago and 

for the last 5 yrs has been noted to have severe LVdysfunction. 

His functional capacity is currently NYHA III and for the 

last yr he has noted a left arm ache with exertion. He denies 

resting symptoms of HF. One year ago, he received a CRT-D 

system without clinical improvement. He is currently treated 

with losartan 50 mg daily, carvedilol CR 40 mg daily, and 

aspirin 325 mg daily. On exam, he is a pleasant elderly man 

in no acute distress. He is 5’10” and 197 lbs with body mass 

index of 28 kg/m2. His BP is 116/61 mm Hg in the right arm 

and 110/64 mm Hg in the left, with pulse 50 beats/min. The 

head and neck exam are unremarkable and filling pressures 

are low. The carotid upstrokes are brisk without bruits. The 

lungs are clear to auscultation and percussion bilaterally. 

Cardiac auscultation is notable for an S4 gallop, increased P2, 

and LV heave, but no murmur. There is no hepatomegaly or 

ascites. The distal extremities are warm with good pulses and 

no edema. ECG reveals an A-sensed V-paced rhythm with 

unclear resynchronization (leftward axis rather than rightward 

axis). Labs are notable for creatinine 1.3 mg/dL, NA of 136 

meq/L, BUN of 21 mg/dL, HDL 23 mg/dL, LDL 74 mg/dL, 

triglycerides 375 mg/dL, BNP 887 pg/mL, hemoglobin 13 g/dL, 

and hemoglobin A1c 6.6%. Echo reveals LV EF 10-15% with 

end diastolic dimension 7.7 cm, mild mitral regurg, and normal 

RV function w/o minimal tricuspid valve regurg. RV systolic 

pressure is estimated at 59 mm Hg based on the tricuspid jet 

velocity. MIBI perfusion images reveal an enlarged LV with 

inferior scar, but apparent ‘viability’ in the other territories. 

What therapies would you offer? 

11:36 Case 4: A 60 yr old man with stage III chronic kidney 

disease, nonobstructive CAD, and dilated cardiomyopathy with 

implanted dual chamber defibrillator presents for evaluation of 

progressive exertional dyspnea (NYHA III). His exam is notable 

for BP of 100/82 mm Hg, a pulse of 75 beats/min, normal 

jugular venous pressure, clear lungs, and a paradoxically split 

second heart sound with a laterally displaced apical impulse in 

the anterior axillary line. There is no hepatomegaly or ascites 

and the extremities are well perfused without peripheral edema. 

ECG reveals sinus rhythm with left bundle branch block and 

QRS duration 192 ms. Echo reveals a markedly dilated LVIDD 

10 cm with severely reduced function and estimated EF of 

15-20% with moderate mitral regurg. Adenosine-PET perfusion 

study reveals a small region of scar in the mid-basal inferior 

wall with minimal reversibility. Cardiopulmonary exercise 

testing reveals peak VO2 11 cc/kg/min at a RER of 1.1. What 

would you do next? 

Learning Objective: Using practice guidelines, research 

findings and clinical experience, make decisions about the 

management of difficult cases in heart failure. 

TuesdAY 


94 

95

Sept. 20 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 302 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom C 

Sept. 20 

Tuesday 

AM 

Take a Deep Breath 

Implantable Pacing/Defibrillation Devices 

Moderators: Kirkwood F. Adams, Jr., Chapel Hill, NC 

Hector O. Ventura, New Orleans, LA 

Moderators: Hasan Garan, New York, NY 

William G. Stevenson, Boston, MA 

TuesdAY 

10:30 Should We Sleep Sitting UP? 

John S. Floras, Toronto, ON, Canada 

11:00* How Do We Measure Decongestion at Discharge? 

J. Thomas Heywood, La Jolla, CA 

11:15* Ventilatory Parameters During Exercise 


11:30* Selecting Beta Blockers for Patients with Pulmonary 

Disease 

Myung H. Park, Baltimore, MD 

10:30 Durability of Cardiac Resynchronization Therapy 

Benefit 

Andrew L. Smith, Atlanta, GA 

10:45 Who Should NOT Get an ICD? 

Andrew E. Epstein, Philadelphia, PA 

10:55 Preparing for Death with a Device 

Paul J. Hauptman, St. Louis, MO 

11:05 Do “Out of the Box” Settings Need to Be Changed? 

Mark S. Link, Boston, MA 

TuesdAY 

11:45* Should We Teach Patients How to Breathe? 

Patricia A. Uber, Baltimore, MD 

11:15 Re-Evaluation after the First Shock 



Learning Objective: Describe the importance of adequate 

assessment and control of breathing in the therapy of heart 

failure. 

11:25 Future Physiologic Heart Failure Monitoring 



Learning Objective: Describe the role of implantable 

pacing and defibrillation devices and monitoring during the 

treatment of heart failure. 

96 

97

Sept. 20 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 304 

SYMPOSIUM 


10:30-NOON 

Room 306 

Sept. 20 

Tuesday 

AM 

Mechanisms to Prevent Sudden Death 

Genes in the Heart 

Moderators: Frederica del Monte, Boston, MA 

Joshua I. Goldhaber, Los Angeles, CA 

Moderators: Ray E. Hershberger, Miami, FL 

Neal Lakdawala, Boston, MA 

TuesdAY 

10:30* Are There Any Novel Antiarrhythmic Agents on the 

Horizon? 

Peter R. Kowey, Wynnewood, PA 

10:48* Sarcoplasmic Reticulum Calcium Release as a Target for 

Ventricular Arrhythmias 

Donald M. Bers, Davis, CA 

11:06* The Ryanodine Receptor is the Final Common Mediator 

of Lethal Arrhythmias 

Xander H.T. Wehrens, Houston, TX 

11:24* Calcium Channels as a Target for Ventricular 

Arrhythmias 

Henry M. Colecraft, New York, NY 

11:42* Device Therapy for Cardiac Arrhythmias: Is the Day of 

Antiarrhythmic Agents Over? 

Barry London, Pittsburgh, PA 

10:30 Desmosomes 

Jeffrey E. Saffitz, Boston, MA 

10:50 Dystrophin Defects: Inherited and Acquired 

Elizabeth M. McNally, Chicago, IL 

11:10 When Are Viral Genomes Pathogenic in the Heart? 

Jeffrey A. Towbin, Cincinnati, OH 

11:30 How Should We Counsel and Follow the Carrier? 

Carolyn Yung Ho, Boston, MA 


Learning Objective: Describe the role of genetics in heart 

failure and genetic counseling in the management of heart 

failure. 

TuesdAY 


Learning Objective: Describe the mechanisms of sudden 

death and potential interventions to prevent it in heart failure 

patients. 

98 

99

Sept. 20 

Tuesday 

PM 

TuesdAY 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

5. Clinical Practice Careers in Heart Failure Room 306 

Michele A. Hamilton, Los Angeles, CA 

Thomas E. Noonan, Pawtucket, RI 

Mary N. Walsh, Indianapolis, IN 

Learning Objective: Describe the variety of potential 

practice opportunities for specialists in heart failure. 

6. Following Patients on the Transplant List Room 304 

(Frequency, Testing, Re-Evaluation, Status Changes) 

Tonya Elliott, Falls Church, VA 

Michael B. Fowler, Stanford, CA 

Learning Objective: Identify key clinical issues in 

following heart failure patients on the transplant list. 

7. Select the Test: MRI/Nuclear/Echo Room 302 

Raymond Y. Kwong, Boston, MA 

Ayan R. Patel, Boston, MA 


Learning Objective: Use evaluation methods appropriate 

to the diagnostic or treatment situation. 



12:30-1:30 PM 

Room 312 

Rapid Fire Abstracts 

Moderators: Arthur M. Feldman, Philadelphia, PA 

Mark A. Sussman, San Diego, CA 

Sept. 20 

Tuesday 

PM 

12:30* Early Enalapril Therapy on Long-Term Mortality 255 

in Patients with Asymptomatic Left Ventricular 

Systolic Dysfunction: A 22-Year Follow-up of SOLVD 

in Belgium 

Philip Jong, Sylvie A. Ahn, Michel F. Rousseau, University 

of Louvain, Brussels, Belgium 

12:36* Exercise Induced Pulmonary Hypertension: 320 

Comparison of Stress Echocardiography to Right 

Heart Catheterization 

Karthik Gujia, Deepika Misra, Christine Roncari, Roxana 

Sulica, Beth Israel Medical Center, New York, NY 

12:42* Comparison of Rest and Peak Exercise Exhaled 083 

Nitric Oxide in Determining Underlying Pulmonary 

Vascular Dysfunction in Heart Failure 

Andres Schuster, Allen G. Borowski, Akanksha Thakur, 

W.H. Wilson Tang, Cleveland Clinic, Cleveland, OH 

TuesdAY 

12:48* Fms-Like Tyrosine Kinase 3 Protects Cardiomyocytes 084 

Against Oxidative Stress-Induced Apoptosis 

Otmar Pfister, Vera Lorenz, Stephanie P. Hauselmann, 

Katrin Buhler, Aleksandra Woodnar-Filipowicz, Gabriela 

M. Kuster, University of Hospital, Basel, Switzerland 

12:54* Treatment of Functional Mitral Regurgitation 138 

by Percutaneous Annuloplasty Results I Durable 

Clinical Efficacy Through 18 Months 

David G. Reuter, Michael Haude, Tomasz Siminiak, Jezy 

Sadowski, Janusz Lipiecki, Jean Fajadet, Uta C. Hoppe, 

Seattle Children’s Hospital and Cardiac Dimensions, 

Seattle, WA 

1:00* Genotype and Phenotypic Characteristics of Persons 221 

with Cardiac Amyloidosis from the Multinational 

Transthyretin Amyloidosis Outcomes Survey 

(THAOS) Registry 

Kumar Dharmarajan, Say Salomon, Stephen Helmke, 

Sergio Tereyua, Claudio Rapezzi, Rodney Falk, Mathew S. 

Maurer, Columbia University, New York, NY 



100 

101

Sept. 20 

Tuesday 

PM 



12:30-1:30 PM 

Room 312 

HYDE PARK 


2:00-3:30 PM 

Ballrooms A-B 

Sept. 20 

Tuesday 

PM 

TuesdAY 

Rapid Fire Abstracts (cont.) 

1:06* Requests for ICD and Pacemaker Deactivation: 171 

Characteristics of Affected Patients and Outcomes 

Tracy L. Webster, Lillian C. Buchhalter, Abigale L. 

Ottenberg, Keith M. Swetz, Paul S. Mueller, Mayo Clinic, 

Rochester, MN 

1:12* Do Advanced Practice Nurses Conform to Heart 319 

Failure Therapies at the Same Rate as Team-Based 

Physicians? 

Nancy M. Albert, Maureen O’Malley, Benjamin Nutter, 

Randall Starling, Cleveland Clinic, Cleveland, OH 

1:18* Complex Telemonitoring or a Simple Telephone 321 

Call, Which is More Effective in Post-Discharge 

Heart Failure (HF) ]Management? 

Robyn A. Clark, Sally C. Inglis, Finlay A. McAllister, 

Simon Stewart, John G.F. Cleland, Cochrane Heart Group, 

Queensland University of Technology, Brisbane, Australia 

1:24* Effect of QRS Morphology on Clinical Event 139 

Reduction with Cardiac Resynchronization Therapy: 

Meta-Analysis of Randomized Controlled Trials 

Josephine C. Chou, Iike Sipahi, Marshall Hyden, Daniel I. 

Simon, James C. Fang, University Hospitals Case Medical 

Center, Cleveland, OH 


Learning Objective: Discuss findings from recent research 

in heart failure and their implications for heart failure 

research and treatment. 

To learn more about these studies, visit their posters during 

the poster presentation session in the Exhibit Hall this 

afternoon. 

1:45 Announcement of Awards 

Jay N. Cohn New Investigator Awards 

Nursing Research Award 

2011 Nursing Clinical Excellence Award 

2011-12 HFSA Research Fellowship Awards 

Steven R. Houser, Philadelphia, PA 

Corrine Jurgens, Stony Brook, NY 

Martin LeWinter, Burington, VT 

Barbara J. Riegel, Philadelphia, PA 


2:00 2012 HFSA Strategic Plan Overview 


Hyde Park Session 

Moderators: Michael B. Fowler, Stanford, CA 

Douglas D. Schocken, Durham, NC 

2:15* It’s Time to Examine Intramural Conflicts of Interest 

Matthew A. Movsesian, Salt Lake City, Utah 

2:30* The Arrogance of Statistics 

Jay N. Cohn, Minneapolis, MN 

2:45* Get Away from the Guidelines (GAFTG) 

Ronald M. Witteles, Stanford, CA 

3:00* How a Maserati Might Solve the Health Care Problem 

Stephen S. Gottlieb, Baltimore, MD 

3:15* Move All Our Symptomatic Patients to Tibet: 

High Altitude Cures Heart Failure 

Simon Maybaum, Bronx, NY 

TuesdAY 


Learning objective: Discuss new insights into heart failure 

research, education, and clinical practice. 



102 

103

Sept. 20 

Tuesday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Room 304 

SYMPOSIUM 


2:00-3:30 PM 

Room 306 

Sept. 20 

Tuesday 

PM 

Through Thick and Thin: Issues in 

Anticoagulation 

Patients Ask About Stem Cells: 

Are We Almost There Yet? 

Moderators: Samuel Z. Goldhaber, Boston, MA 

Robinton J. Morris, Abington, PA 

Moderators: Jan Kajstura, Boston, MA 

Ronglih Liao, Boston, MA 

TuesdAY 

2:00* When is Low Ejection Fraction an Indication for 

Anticoagulation? 

Susan E. Ammon, San Fransisco, CA 

2:15* Anticoagulation for Continuous Flow Ventricular Assist 

Devices 

Mary Patricia Massicotte, Edmonton, AB, Canada 

2:30* Bleeding with Ventricular Assist Devices 

Jeffrey J. Teuteberg, Pittsburgh, PA 

2:45* What is the Incidence of Heparin-Induced 

Thrombocytopenia? 

Samuel Z. Goldhaber, Boston, MA 

3:00* Home INR Monitoring 

Melissa A. Mikelson, Marshfield, WI 

2:00 Cell-Based Therapy (Vascular Progenitor Cells) 

Douglas W. Losordo, Chicago, IL 

2:15 Bone Marrow Stem Cells to Repair the Damaged Heart 

Robert D. Simari, Rochester, MN 

2:30 The SCIPIO Trial (Cardiac Progenitor Cells) 

Roberto Bolli, Louisville, KY 

2:45 Stem Cells: Next Generation of Mesenchymal Cells 

Joshua M. Hare, Miami, FL 

3:00 Assessing the Efficacy of Stem Cell Therapy in Clinical 

Trials 

Scott D. Solomon, Boston, MA 


TuesdAY 

3:15* Early Lessons with Dabigatran 

Michael D. Ezekowitz, Wynnewood, PA 

Learning Objective: Discuss the current status of stem cell 

therapy for cardiovascular disease. 


Learning Objective: Describe circumstances in which 

anticoagulation is called for in patients with heart failure and 

the options available. 





104 

105

Sept. 20 

Tuesday 

PM 

DEBATES 


4:00-5:30 PM 

Ballrooms A-B 

SYMPOSIUM 


4:00-5:30 PM 

Room 306 

Sept. 20 

Tuesday 

PM 

Moderators: Lynne Warner Stevenson, Boston, MA 

James B. Young, Cleveland, OH 

Status with Novel Proteins and Metabolic 

Markers in Characterizing Heart Failure 

TuesdAY 

DEBATE: How Do You Vote: The Weekly Meeting 

4:00 A 71 Year-Old Man with Heart Failure 

James B. Young, Cleveland, OH 

4:09 Why He Should Have a Heart Transplant 

Sharon A. Hunt, Stanford, CA 

4:16 Why He Should Receive an LVAD 

Leslie W. Miller, Tampa, FL 

4:23 Why He Should Have Palliative Care 

Heather J. Ross, Toronto, ON, Canada 

4:30 Panel Discussion: What if? 

Sharon A. Hunt, Stanford, CA 

Leslie W. Miller, Tampa, FL 

Michael G. Petty, Minneapolis, MN 

Heather J. Ross, Toronto, ON, Canada 

Ben Sun, Minneapolis, MN 

DEBATE: Risk Stratification Is an Intervention 

4:45 Protagonist: Christopher M. O’Connor, Durham, NC 

5:00 Antagonist: Milton Packer, Dallas, TX 

5:15 Questions from moderators 

Learning Objective: Outline considerations influencing 

selection of therapies in advanced heart failure and the 

arguments for and against risk stratification. 

Moderators: Wilson S. Colucci, Boston, MA 

Pothur R. Srinivas, Bethesda, MD 

4:00* The Proteome as the Key Determinant of Phenotype in 

Cardiovascular Health and Disease 

Joseph Loscalzo, Boston, MA 

4:18* K (ATP): Channel-Dependent Metaboproteome 

Decoded: Systems Approaches to Heart Failure 

Prediction, Diagnosis, and Therapy 

Andre Terzic, Rochester, MN 

4:36* Novel Metabolomic Defects in Heart Failure 

Catherine E. Costello, Boston, MA 

4:54* New Protein Markers in Acute Myocardial Infarction 

Robert E. Gerszten, Boston, MA 

5:12* The Cardiac Organellar Proteoms Atlas 

(COPa Library): A Protein Knowledgebase for 

Cardiovascular Medicine 

Peipei Ping, Los Angeles, CA 


Learning Objective: Discuss the role of novel proteins and 

metabolic markers in heart failure and their implications for 

research and therapy. 

TuesdAY 





106 





107

Sept. 20 

Tuesday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Room 302 

SYMPOSIUM 


4:00-5:30 PM 

Room 304 

Sept. 20 

Tuesday 

PM 

Paradox on the Right 

Oxidative Stress and Uric Acid 

TuesdAY 

Moderators: Teresa De Marco, San Francisco, CA 

Michael A. Mathier, Pittsburgh, PA 

4:00* Role of the Right Ventricle in Exercise Limitation 

Gregory D. Lewis, Boston, MA 

4:15* Pulmonary Hypertension from Increased Forward vs. 

Increased Backward Flow 

Anne Marie Valente, Boston, MA 

4:30* Pulmonary Versus Arterial Vascular Loading 

Ryan J. Tedford, Baltimore, MD 

4:45* The Right Ventricle as Victim of Heart Failure 

Preserved EF 

Aaron B. Waxman, Boston, MA 

5:00* Pulmonary Hypertension in Potential Transplant 

Candidates 

Richard J. Rodeheffer, Rochester, MN 

5:15* When Does Mechanical Support Need to be 

Biventricular? 



Learning Objective: Discuss the importance of the right 

ventricle in the progression of heart failure and the selection 

of therapies. 

Moderators: Inder S. Anand, Minneapolis, MN 

Horng H. Chen, Rochester, MN 

4:00* Why Do We Worry About Oxidative Stress in Heart 

Failure? 

Joshua M. Hare, Miami, FL 

4:18* Mitochondrial ROS and Arrhythmias 

Samuel C. Dudley, Chicago, IL 

4:36* NADPH and CHF 

Junichi Sadoshima, Newark, NJ 

4:54* Treatment of Gout Exacerbations in Heart Failure 

Brian F. Mandell, Cleveland, OH 

5:12* Should Therapy Be Guided by Uric Acid Levels? 

Michael M. Givertz, Boston, MA 


Learning Objective: Describe the role of oxidative stress and 

potential interventions to reduce it for patients with heart 

failure and identify recommended clinical responses. 

TuesdAY 





108 





109

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

036 Non-Invasive Hemodynamic Assessment Using 

Photoplethysmography (PPG) for CRT Optimization 

Wenbo Hou 1 , Sturt P. Rosenberg 1 , Steve Koh 1 , John W. 

Poore 1 , Jeffery D. Snell 1 , Michael Yang 1 , Nirav Dalal 1 , Gene 

A. Bornzin 1 ; 1 Cardiac Rhythm Management Division, St Jude 

Medical, Sylmar, CA 

037 Renal Tubule Is the Critical Site in Patients with 

Idiopathic Dilated Cardiomyopathy Showing 

Microalbuminuria 

Masahiro Ito 1 , Makoto Tomita 1 , Yukako Ohno 1 , Hiroaki Obata 1 , 

Makoto Kodama 1 , Yoshifusa Aizawa 1 ; 1 First Department of 

Internal Medicine, Niigata University School of Medicine, 

Niigata, Japan 

038 M-Atrial Natriuretic Peptide and Nitroglycerin in 

a Model of Acute Hypertensive Heart Failure: A 

Comparison of Two cGMP Therapeutics 

Paul M. McKie 1 , Tomoko Ichiki 1 , S. Jeson Sangaralingham 1 , 

Alessandro Cataliotti 1 , Horng H. Chen 1 , John C. Burnett, Jr. 1 ; 

1 

Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN 

039 Ranolazine Prevents Heart Failure with Preserved 

Ejection Fraction; Diastolic Dysfunction and Left 

Ventricular Hypertrophy in a Hypertensive Murine 

Model 

R. Valadri 1 , R. Gadesam 2 , A. Onwuanyi 2 , M.T. Fan 1 , H. Bloom 1 ; 

1 

Cardio, Emory SM, ATL; 2 Cardio, Morehouse SM, ATL 

040 Early Experimental Chronic Kidney Disease Activates 

Myocardial Apoptotic Genes and Leads to Early 

Myocardial Fibrosis 

Fernando L. Martin 1 , Brenda K. Huntley 1 , Gerald E. Harders 1 , 

S. Jeson Sangaralingham 1 , Tomoko Ichiki 1 , Paul M. McKie 1 , 

Alessandro Cataliotti 1 , Josef Korinek 1 , Horng H. Chen 1 , John C. 

Burnett 1 ; 1 Cardiovascular Diseases, Mayo Clinic, Rochester, MN 

041 Role of Caveolae in Shear Stress-Induced Endothelium- 

Dependent Vasodilation in Isolated Mouse Coronary 

Arteries 

Hon-Chi Lee 1 , Qiang Chai 1 ; 1 Internal Medicine/Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

042 Calcium/ Calmodulin Dependent Kinase Type II 

(CaMKIIδ) Phosphorylation of the Cardiac Ryanodine 

Receptor Is Crucial for the Development of Heart 


Jonathan L. Respress 1 , Ralph J. van Oort 1 , Angela C. de 

Almeida 1 , Na Li 1 , Natale Rolim 2 , Ulrik Wisloff 2 , Xander H.T. 

Wehrens 1 ; 1 Molecular Physiology and Biophysics, Baylor 

College of Medicine, Houston, TX; 2 Circulation and Medical 

Imaging, Norwegian University of Science and Technology, 

Trondheim, Norway 

043 Speckle Tracking Echo Derived Measures of Left 

Ventricular Contraction Have Better Correlation with 

Functional Status Than Does Ejection Fraction 

John W. Petersen 1 ; 1 Cardiovascular Disease, University of 

Florida, Gainesville, FL 

044 Ventricular-Vascular Coupling at Rest and with Exercise 

Predicts Heart Failure in Coronary Artery Disease 

Rakesh K. Mishra 1 , Mary A. Whooley 1 , Nelson B. Schiller 1 ; 

1 

Medicine, University of California, San Francisco, CA 

045 The Difference in Radial Strain Pattern of Contractility 

of the Right Ventricular Free Wall Versus the Septum by 

Speckle Tracking 

Mujeeb A. Sheikh 1 , Steven R. Bruhl 1 , Samer Khouri 1 ; 

1 

Department of Cardiology, University of Toledo (UT), Toledo, 

OH 

046 Lean Mass as an Indicator of Muscle Strength in 

Patients with Heart Failure 

A. Zavin 1 , K. Allsup 1 , D.R. Gagnon 6,7 , R. Arena 4 , J. Joseph 1,2 , A. 

Lazzari 1,3 , P.C. Schulze 5 , S. Lecker 2 , S. Davis 1 , D.E. Forman 1,2 ; 

1 

VA Boston Healthcare System, Boston; 2 Harvard Medical 

School, Boston, MA; 3 Boston University School of Medicine, 

Boston, MA; 4 University of New Mexico, Albuquerque, 

NM; 5 Columbia University Medical Center, New York, NY; 

6 

Boston University SPH, Boston, MA; 7 VA Cooperative Studies 

Program, Boston, MA 

047 Blunted Vital Sign Changes during Exercise Can Help 

Identify or Exclude Severe Impairment 

Michael C. Tjandrawidjaja 1 , Lynne W. Stevenson 1 , Jennifer Ho 1 , 

Garrick Stewart 1 , Daniel E. Forman 1 ; 1 Cardiovascular Division, 

Brigham and Women’s Hospital, Boston, MA 

048 Which Drug Is the Best for Pulmonary Hypertension 

Reversibility Testing? 

Maya Guglin 1 , Shabnam Mehra 2 , Thomas Mason 2 ; 1 Cardiology, 

University of South Florida, Tampa, FL; 2 Statistics and 

Epidemiology, University of South Florida, Tampa, FL 

tuesdAY 

110 

111

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

049 Discordance between Aortic Augmentation Index and 

Hemodynamic Measurements in Patients with Acute 

Decompensated Heart Failure Receiving Intensive 

Medical Therapy 

Maria M. Patarroyo 1 , Yi Lu 2 , Mohammad Rafey 3 , W.H. Wilson 

Tang 2 ; 1 Internal Medicine, Cleveland Clinic Foundation, 

Cleveland, OH; 2 Cardiovascular Medicine, Cleveland Clinic 

Foundation, Cleveland, OH; 3 Nephrology and Hypertension, 


050 Electrophysiological Properties of the Infarcted Rodent 

Myocardium 

Elisabeth Steadman 1 , Joao Ferreira-Martins 1 , Sergio Signore 1 , 

Justin A. Korn 1 , Fumihiro Sanada 1 , Hanqiao Zheng 1 , Francesco 

Cappetta 1 , Toru Hosoda 1 , Claudia Fiorini 1 , Annarosa Leri 1 , Piero 

Anversa 1 , Jan Kajstura 1 , Marcello Rota 1 ; 1 Anesthesia Medicine, 

Brigham Women’s Hospital-Harvard Medical School, Boston, 

MA 

051 Right Ventricle Glucose Metabolism and Pressure 

Overload in Patients with Pulmonary Arterial 

Hypertension 

Peter R. Mitoff 1 , Ian Burwash 1 , Rob J. deKemp 1 , May Aung 1 , 

George Chandy 1 , Duncan J. Stewart 1 , Ross A. Davies 1 , Carolyn 

Pugliese 1 , Jean DaSilva 1 , Rob Beanlands 1 , Lisa M. Mielniczuk 1 ; 

1 

Cardiology, University of Ottawa Heart Institute, Ottawa, ON, 

Canada 

052 Pulmonary Hypertension as a Function of Diastolic 

Grade in Patients with Left Heart Failure Is a Predictor 

of Right Heart Function and Can Be Used To Optimize 

Timing of LVAD Therapy 

Daniel Zakhary 1 , Eyad Alhaj 1 , Robert Berkowitz 1 ; 1 Heart Failure 

and Pulmonary Hypertension Program of the Heart and Vascular 

Hospital, Hackensack University Medical Center, Hackensack, 

NJ 

053 Association between Arterial Load and Left Ventricular 

Rotation in Heart Failure with Preserved Ejection 

Fraction 

Holly S. Norman 1 , Gary F. Mitchell 2 , Nancy K. Sweitzer 1 ; 

1 

Medicine, University of Wisconsin-Madison, Madison, WI; 

2 

Cardiovascular Engineering, Inc, Norwood, MA 

054 Do Asymptomatic Chronic Kidney Disease Patients 

without Primary Cardiac Disease Have Diminished 

Cardiac Reserve? 

Shanmugakumar Chinnappa 1 , Meguid El Nahas 2 , Andrew 

Mooney 1 , Lip-Bun Tan 1 ; 1 Leeds Teaching Hospitals NHS Trust, 

Leeds, United Kingdom; 2 Sheffield Teaching Hospitals NHS 

Foundation Trust, Sheffield, United Kingdom 

055 Strength and Aerobic Capacities Both Contribute to 

Functional Decline in Heart Failure 

K. Allsup 1 , A. Zavin 1 , J. Joseph 1,2 , R. Arena 4 , P. Vokonas 1,3 , S. 

Lecker 1,2 , L. Lazzari 1,3 , P.C. Schulze 5 , D.E. Forman 1,2 ; 1 VA Boston 

Healthcare System, Boston, MA; 2 Harvard Medical School, 

Boston, MA; 3 Boston University School of Medicine, Boston, 

MA; 4 University of New Mexico, Albuquerque, NM; 5 Columbia 

University Medical Center, New York, NY 

Cardiovascular Structure 

061 Diastolic Dysfunction in Patients with End-Stage Liver 

Disease Is Associated with Development of Heart Failure 

Early after Liver Transplantation 

Taylor F. Dowsley 1 , David B. Bayne 1 , Alan N. Langnas 2 , 

Ioana Dumitru 1 , John R. Windle 1 , Thomas R. Porter 1 , Eugenia 

Raichlin 1 ; 1 Cardiology, University of Nebraska Medical Center, 

Omaha, NE; 2 Section of Transplantation, Department of Surgery, 

University of Nebraska Medical Center, Omaha, NE 

062 Risk Stratification and Serious Ventricular Arrhythmias: 

The Importance of Left Ventricular Hypertrophic 

Remodeling in Patients with Depressed Ejection Fraction 

Timothy S. Draper, Jr. 1 , Jonathan S. Silver 1 , William H. Gaasch 1 ; 

1 

Cardiovascular Medicine, Lahey Clinic, Burlington, MA 

063 Right Ventricular Diastolic Parameter Changes and 

Correlation with Pulmonary Pressure Severity 

Jayme Rock-Willoughby 1 , Steven Bruhl 1 , Mujeeb Sheikh 1 , 

Samer Khouri; 1 University of Toledo Medical Center, Toledo, 

OH 

064 Endoplasmic Reticulum Stress Is a Mechanism of Self- 

Progression in Congestive Heart Failure 

Paul J. Mather 1 , Holly Stewart 1 , John L. Farber 2 ; 1 Cardiology, 

Thomas Jefferson University Hospital, Philadelphia, PA; 

2 

Pathology, Thomas Jefferson University Hospital, Philadelphia, 

PA 

065 Prognostic Utility of Left Atrial Volume Index in Older 

Patients with Heart Failure and Moderate or Severe 

Mitral Regurgitation 

Justin S. Sadhu 1 , Majesh Makan 1 , Michael W. Rich 1 ; 

1 

Cardiovascular Division, Washington University School of 

Medicine in St. Louis, St. Louis, MO 

tuesdAY 

112 

113

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

083 Comparison of Rest and Peak Exercise Exhaled Nitric 

Oxide in Determining Underlying Pulmonary Vascular 

Dysfunction in Heart Failure 

Andres Schuster 1 , Allen G. Borowski 1 , Akanksha Thakur 2 , W.H. 

Wilson Tang 1 ; 1 Department of Cardiovascular Medicine, Heart 

and Vascular Institute, Cleveland Clinic Foundation, Cleveland, 

OH; 2 Case Western Reserve School of Medicine, Case Western 

Reserve University, Cleveland, OH 

084 Fms-Like Tyrosine Kinase 3 Protects Cardiomyocytes 

Against Oxidative Stress-Induced Apoptosis 

Otmar Pfister 1,2 , Vera Lorenz 1 , Stephanie P. Hauselmann 1 , Katrin 

Buhler 1 , Aleksandra Wodnar-Filipowicz 1 , Gabriela M. Kuster 1,2 ; 

1 

Department of Biomedicine, University Hospital, Basel, 

Switzerland; 2 Division of Cardiology, University Hospital, 

Basel, Switzerland 

085 Systemic Asymmetric Dimethylarginine Levels Identify 

Chronic Systolic Heart Failure Patients with Diminished 

Exercise Capacity and Impaired Peripheral Vascular 

Reactivity 

Andres Schuster 1 , Akanksha Thakur 2 , Allen G. Borowski 1 , W.H. 

Wilson Tang 1 ; 1 Department of Cardiovascular Medicine, Heart 

and Vascular Institute, Cleveland Clinic Foundation, Cleveland, 

OH; 2 Case Western Reserve School of Medicine, Case Western 

Reserve University, Cleveland, OH 

086 Serum Arylesterase Activity Levels Provide Stronger 

Prognostic Value Than Serum Paraoxonase Activity 

Levels in Patients with Heart Failure 

Zhili Shao 1 , Yuping Wu 2 , Yi Lu 1 , Stanley L. Hazen 1 , W.H. 

Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland 

State University, Cleveland, OH 

087 Diminished Endothelial Progenitor Cells Were 

Associated with Endothelial Dysfunction in Patients 

with Pulmonary Hypertension Secondary to Left Heart 

Disease 

Yenal Harper 1 , Kewal Asosingh 1 , Cotleur Anne 1 , Serpil C. 

Erzurum 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic Foundation, 

Cleveland, OH 

088 Protein Carbamylation in Chronic Systolic Heart 

Failure: Relation with Renal Insufficiency and Adverse 

Long-Term Clinical Outcomes 

Kevin Shrestha 1 , Zeneng Wang 1 , Allen G. Borowski 1 , Richard 

W. Troughton 2 , Allan L. Klein 1 , Stanley L. Hazen 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Christchurch School 

of Medicine and Health Sciences, Christchurch, New Zealand 

089 Elevated Urinary Neopterin Levels Are Associated with 

Cardiac and Functional Impairment in Patients with 

Chronic Systolic Heart Failure 

Zhili Shao 1 , Renliang Zhang 1 , Allen G. Borowski 1 , Akanksha 

Thakur 2 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 

2 

Case Western Reserve University, Cleveland, OH 

090 Gut-Flora-Dependent Phosphatidylcholine Metabolites 

Predict Adverse Clinical Outcomes in Chronic Systolic 


Kevin Shrestha 1 , Zeneng Wang 1 , Allen G. Borowski 1 , Richard 

W. Troughton 2 , Allan L. Klein 1 , Stanley L. Hazen 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Christchurch School 

of Medicine and Health Sciences, Christchurch, New Zealand 

091 Do Cytokines and Biomarkers Play a Role on Cognitive 

Impairment in Heart Failure? 

Ponrathi R. Athilingam 1 , Leway Chen 2 ; 1 University of South 

Florida, Tampa, FL; 2 University of Rochester, Rochester, NY 

092 High Sensitivity C-Reactive Protein Predicts Carvedilol- 

Induced Improvement of Left Ventricular Systolic 

Function in Patients with Heart Failure 

Jadwiga M. Nessler 1 , Bohdan J. Nessler 1 , Mariusz Kitlinski 2 , 

Ole Melander 2 , Artur Fedorowski 2 ; 1 Dpt of Coronary Heart 

Disease, Institute of Cardiology, Medical School of Jagiellonian 

University, Cracow, Poland; 2 Dpt of Cardiology, Skane 

University Hospital, Malmoe, Sweden 

093 Adrenergic-Mediated Suppression of Monocyte 

Proinflammatory Cytokine Production Is Reduced in 

Acute Heart Failure 

Tien M.H. Ng 1 , Brian J. Kim 1 , Jennifer I. Park 1 , Stan G. Louie 1 , 

Uri Elkayam 1 ; 1 School of Pharmacy and Keck School of 

Medicine, University of Southern California, Los Angeles, CA 

094 IL-17 RA PLAD-Ig Reduces Cardiac Fibrosis in 

Experimental Autoimmune Myocarditis Rats 

Wei Liu, Weimin Li, Ning Yang, Yunyan Song; Cardiology, The 

First Affiliated Hospital of Harbin Medical University, Harbin, 

Heilongjiang, China 

095 Plasma Galectin-3 in Patients with Heart Failure: 

Relationship to Clinical Status, Pathophysiology of Heart 

Failure, and Renal Function 

Deepa M. Gopal 1 , Maya Kommineni 1 , Nir Ayalon 1 , Christian 

Koelbl 1 , Rivka Ayalon 1 , Andreia Biolo 1 , Laura M. Dember 1 , 

Jill Downing 1 , Deborah A. Siwik 1 , Chang-seng Liang 1 , Wilson 

S. Colucci 1 ; 1 Cardiovascular Medicine Section, Department of 

Medicine, and the Myocardial Biology Unit, Boston University 

Medical Center, Boston, MA 

tuesdAY 

114 

115

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

096 Systemic and Urinary Neutrophil Gelatinase-Associated 

Lipocalin (NGAL) Levels Reflect Different Aspects 

of Renal Impairment in Acute Decompensated Heart 


Kevin Shrestha 1 , Dhssraj Singh 1 , Matthias Dupont 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH 

097 Prediction of Future Cardiovascular Risk by Detecting 

Subclinical Myocardial Necrosis in Stable Patients with 

Diabetes Mellitus 

Earl B. Britt, Jr. 1 , Yuping Wu 2 , Stanley L. Hazen 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Cleveland State 

University, Cleveland, OH 

098 Elevated Plasma Nitrate Levels Are Associated with 

Decompensated Heart Failure and with Oral Nitrate 

Therapy in Chronic Heart Failure 

Zhili Shao 1 , Allison Janocha 1 , Allen G. Borowski 1 , Serpil C. 

Erzurum 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH 


107 DNA Variants in NOS3 Are Associated with Improved 

Small Artery Elasticity and Decreased Systolic Blood 

Pressure in Asymptomatic Individuals 

Jennifer L. Hall 1 , Natalia Florez 1 , Marj Carlson 1 , Sara Saul 1 , 

Mark Lawson 2 , Aaron Mackey 2 , Joao Lima 3 , Jay Cohn 1 , 

Stephen S. Rich 2 , Wei Zhong 1 , Gregory Grandits 1 , Daniel 

A. Duprez 1 ; 1 Cardiology, Medicine, Lillehei Heart Institute, 

University of Minnesota, Minneapolis, MN; 2 Center for Public 

Health Genomics, University of Virginia, Charlottesville, VA; 

3 

Medicine, Johns Hopkins University, Baltimore, MD 

108 Oxidative Modification of the Extracellular Domain 

Decreases β1-Integrin Avidity and Interferes with 

Outside-In Signaling and Cell Survival 

Stephanie P. Hauselmann 1 , Vera Lorenz 1 , Otmar Pfister 1,2 , 

Gabriela M. Kuster 1,2 ; 1 Department of Biomedicine, University 

Hospital, Basel, Switzerland; 2 Division of Cardiology, 

University Hospital, Basel, Switzerland 

109 Right Ventricular Failure in Patients Requiring 

Mechanical Circulatory Assistance Is Associated with 

Elevated miR-15b Expression 

Alexander G. Moore 1 , Marc Simon 2 , Bonnie Lemster 2 , John 

Gorcsan 2 , Charles McTiernan 2 , Ravi Ramani 2 ; 1 University 

of Pittsburgh School of Medicine, Pittsburgh, PA; 2 UPMC 

Cardiovascular Institute, Pittsburgh, PA 

110 Right Ventricular Metabolic Imaging in Experimental 

Pulmonary Artery Hypertension 

Lisa M. Mielniczuk 1 , Stephanie Thorn 1 , Jennifer J. Renaud 1 , Ran 

Klein 1 , Jean DaSilva 1 , Robert J. deKemp 1 , Rob A. Beanlands 1 , 

Duncan J. Stewart 1 ; 1 Cardiology, University of Ottawa Heart 

Institute, Ottawa, ON, Canada 

111 Evidence of Anti-Cardiac Antibody Deposition in End- 

Stage Failing Myocardium: A Potential Contributor to 

Disease Progression 

Alejandro Trevino 1 , Jose H. Flores-Arredondo 1 , Roberto 

Barrios 1 , Keith A. Youker 1 , Andrea M. Cordero-Reyes 1 , Jerry 

D. Estep 1 , Carlos M. Orrego 1 , Guillermo Torre-Amione 1,2 ; 1 The 

Methodist DeBakey Heart Vascular Center, The Methodist 

Hospital, Houston, TX; 2 Instituto de Cardiología y Medicina 

Vascular, Hospital San José Tec de Monterrey, Monterery, 

Nuevo Leon, Mexico 

112 Cardiac Fibrosis Induced by Angiotensin II Is Dependent 

on a Radiation Sensitive or Bone Marrow Derived Cell 

Jose H. Flores-Arredondo 1 , Andrea M. Cordero-Reyes 1 , 

Alejandro Trevino 1 , Keith A. Youker 1 , Carlos M. Orrego 1 , Jerry 

D. Estep 1 , Guillermo Torre-Amione 1,2 ; 1 The Methodist DeBakey 

Heart Vascular Center, The Methodist Hospital, Houston, TX; 

2 

Instituto de Cardiología y Medicina Vascular, Hospital San José 

Tec de Monterrey, Monterrey, Nuevo Leon, Mexico 

113 Transcriptional Profiles of Ventricular Ectopy on 

β-Blocker Therapy 

Andreas Brieke 1 , David P. Kao 1 , Ronald Zolty 2 , Edward M. 

Gilbert 3 , Alastair D. Robertson 1 , Michael R. Bristow 1 , Brian 

D. Lowes 1 ; 1 Cardiology, University of Colorado School of 

Medicine, Aurora, CO; 2 Montefiore Medical Center, Bronx, NY; 

3 

University of Utah HSC, Salt Lake City, UT 

114 Novel Findings of Upregulated Neutrophil Gelatinase- 

Associated Lipocalin (NGAL) in Myocytes of Advanced 


Cara Statz 1 , Mridula Rai 1,2 , Aleksandra Ras 1 , Jacqueline Imse 1 , 

Faisal Zaeem 1 , Roja Mulamalla 1 , Jonathan Hammond 1 , Detlef 

Wencker 1 ; 1 Heart Failure and Transplant Center, Hartford 

Hospital, Hartford, CT; 2 University of Connecticut Health 

Center, Farmington, CT 

tuesdAY 

116 

117

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

138 Treatment of Functional Mitral Regurgitation by 

Percutaneous Annuloplasty Results in Durable Clinical 

Efficacy through 18 Months 

David G. Reuter 1 , Michael Haude 2 , Tomasz Siminiak 3 , Jerzy 

Sadowski 4 , Janusz Lipiecki 5 , Jean Fajadet 6 , Uta C. Hoppe 7 ; 

1 

Cardiology, Seattle Childrens Hosp and Cardiac Dimensions, 

Kirkland, WA; 2 Stadtische Kliniken Neuss Lukaskrankenhaus, 

Neuss, Germany; 3 Poznan University, Poznan, Poland; 4 John 

Paul II Hospital, Krakow, Poland; 5 Univeristy Hospital, 

Clermont Ferrand, France; 6 La Clinique Pasteur, Toulouse, 

France; 7 Cologne University, Cologne, Germany 

139 Effect of QRS Morphology on Clinical Event Reduction 

with Cardiac Resynchronization Therapy: Meta-Analysis 

of Randomized Controlled Trials 

Josephine C. Chou 1 , Ilke Sipahi 1 , Marshall Hyden 1 , Daniel I. 

Simon 1 , James C. Fang 1 ; 1 Harrington-McLaughlin Heart and 

Vascular Institute, University Hospitals Case Medical Center, 

Cleveland, OH 

140 Heart Failure Diagnostic Parameters and Symptoms: 

Observations from the ALTITUDE Study 

John P. Boehmer 1 , John D. Day 2 , Francis R. Gilliam 3 , Paul A. 

Heidenreich 4 , David L. Hayes 5 , Kristine Roy 6 , Songtao Jiang 6 , 

Leslie A. Saxon 7 ; 1 Penn State, Hershey, PA; 2 Intermountain 

Medical Ctr, Salt Lake City, UT; 3 Cardiology Assoc of NE 

Arkansas, Jonesboro, AR; 4 VA Palo Alto Health Care System, 

Palo Alto, CA; 5 Mayo Clinic, Rochester, MN; 6 Boston 

Scientific, Natick, MA; 7 USC, Los Angeles, CA 

141 Virtual Cross-Match in Orthotopic Heart Transplant: A 

Blessing or a Curse? 

Roja Mulamalla 1 , Jason Gluck 1 , Joseph Radojevic 1 , Detlef 

Wencker 1 , Todd Alberghini 1 , Michael Rewiniski 1 ; 1 Heart Failure 

Transplant, University of Connecticut-Hartford Hospital, 

Hartford, CT 

142 Continuous Flow Left Ventricular Assist Device Support 

as a Bridge to Decision in Patients with End-Stage Heart 

Failure Complicated by Pulmonary Hypertension 

Toshikazu D. Tanaka 1 , Robert L. Kormos 2 , Basar Sareyyupoglu 2 , 

Ravi Ramani 1 , Jeffrey J. Teuteberg 1 , Michael A. Mathier 1 , 

Dennis M. McNamara 1 , Marc A. Simon 1 ; 1 Cardiovascular 

Institute, University of Pittsburgh, Pittsburgh, PA; 2 Artificial 

Heart Program, University of Pittsburgh, Pittsburgh, PA 

143 Elderly Patients with Advanced Heart Failure and Atrial 

Fibrillation Benefit from Cardiac Tissue Ablation at the 

Time of Structural Heart Repair 

Mark A. Groh 1 , Ben I. Groh 1 , Oliver A. Binns 1 , Alan 

M. Johnson 1 , Stephen W. Ely 1 , Gerard L. Champsaur 2 ; 

1 

Cardiovascular Surgery, Asheville Heart, Asheville, NC; 

2 

Clinical Research, Mission Hospitals, Asheville, NC 

144 A Robust Cardiac MRI Assessment for the 

Characterization of an Ovine Ischemic Cardiomyopathy 

Model Creation Protocol Demonstrates Rapid Heart 

Failure Progression with Minimized Mortality 

Anthony S. Fargnoli 1 , Michael G. Katz 1 , Kevin Koomalsingh 1 , 

Louella Pritchette 1 , James J. Pilla 1 , Charles R. Bridges 1 ; 

1 

Cardiovascular Surgery, University of Pennsylvania, 


145 Cardiac Amyloidosis: Screening Criteria for Heart 

Transplantation and New Strategies for Post-Transplant 

Therapy 

Brandon C. Varr 1 , Michaela Liedtke 2 , Sally Arai 3 , Richard 

A. Lafayette 4 , Stanley L. Schrier 2 , Ronald M. Witteles 5 ; 

1 

Department of Internal Medicine, Stanford University School 

of Medicine, Stanford, CA; 2 Division of Hematology, Stanford 

University School of Medicine, Stanford, CA; 3 Division of 

Blood and Marrow Transplantation, Stanford University School 

of Medicine, Stanford, CA; 4 Division of Nephrology, Stanford 

University School of Medicine, Stanford, CA; 5 Division of 

Cardiovascular Medicine, Stanford University School of 

Medicine, Stanford, CA 

146 Outcomes of Patients with Acute Right Ventricular 

Failure in the Era of Mechanical Circulatory Support 

Margot K. Davis 1 , Jennifer Higgins 1 , Annemarie Kaan 2 , Andrew 

Ignaszewski 1 , Anson Cheung 1 ; 1 University of British Columbia, 

Vancouver, BC, Canada; 2 St. Paul’s Hospital, Vancouver, BC, 

Canada 

147 Can Right Ventricular Failure Associated with LVAD 

Insertion Be Avoided? 

Robert M. Adamson 1 , Sam Baradarian 1 , Joseph Chammas 1 , 

Vanja Norman 1 , Brian Jaski 2 , Peter Hoagland 2 , Suzanne 

Chilcott 3 , Marcia Stahovich 3 , Lesli Hazard 3 , Vicki McCalmont 3 , 

Kristi Ortiz 3 , Walter P. Dembitsky 1 ; 1 Cardiothoracic Surgery, 

Sharp Memorial Hospital, San Diego, CA; 2 Cardiology, Sharp 

Memorial Hospital, San Diego, CA; 3 Nursing, Sharp Memorial 

Hospital, San Diego, CA 

tuesdAY 

118 

119

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

148 Transthoracic Echocardiography of the HeartWare Left 

Ventricular Assist Device 

Nishant R. Shah 1,2 , Cihan Cevik 1,2 , Antonieta Hernandez 1 , Igor D. 

Gregoric 1 , O.H. Frazier 1,2 , Raymond F. Stainback 1,2 ; 1 Texas Heart 

Institute at St. Luke’s Episcopal Hospital, Houston, TX; 2 Baylor 

College of Medicine, Houston, TX 

149 Reduced Serum Albumin Concentration before Heart 

Transplantation Predicts Poor Post-Transplant Prognosis 

Tomoko S. Kato 1 , Faisal H. Cheema 1 , Jonathan Yang 2 , Hiroo 

Takayama 2 , Yoshifumi Naka 2 , Maryjane Farr 1 , Donna Mancini 1 , 

P. Christian Schulze 1 ; 1 Department of Medicine, Division of 

Cardiology, Columbia University Medical Center, New York, 

NY; 2 Department of Surgery, Division of Cardiothoracic 

Surgery, Columbia University Medical Center, New York, NY 

150 Psychological and Cognitive Profiles of Advanced Heart 

Failure Surgical Intervention Candidates 

Rebecca A. Stout 1 , Moises Gaviria 1 , Sunil Pauwaa 1 , Geetha 

Bhat 1 ; 1 Advocate Christ Medical Center, Oak Lawn, IL 

151 Impairment of Myocardial Endocannabinoid Signaling 

and Depletion of the Endogenous Ligands Anandamide 

and Arachidonoylglycerol in Patients with Advanced 


Ruiping Ji 1 , Aalap Chokshi 1 , Faisal Cheema 2 , Tuba Khawaja 1 , 

Raffay Khan 1 , Shuiqing Yu 1 , Hiroo Takayama 2 , Yoshifumi 

Naka 2 , Hongfeng Jiang 1 , Donna Mancini 1 , P. Christian 

Schulze 1 ; 1 Cardiology, Columbia University, New York, NY; 

2 

Cardiothoracic Surgery, Columbia University, New York, NY 

152 AV Delay Optimization in CRT Based on LV dP/dtmax 

and Fick Cardiac Output 

Stuart P. Rosenberg 1 , Steve Koh 1 , Wenbo Hou 1 , John W. Poore 1 , 

Jeffery D. Snell 1 , Nirav Dalal 1 , Gene A. Bornzin 1 ; 1 Cardiac 

Rhythm Management Division, Research, St. Jude Medical, 

Sylmar, CA 

153 Comparison of Heart Sound Index from Accelerometer 

and Microphone for Hemodynamic Optimization of CRT 

Steve Koh 1 , Wenbo Hou 1 , Stuart P. Rosenberg 1 , Jeffery D. 

Snell 1 , John W. Poore 1 , Nirav Dalal 1 , Gene A. Bornzin 1 ; 1 St. Jude 

Medical Cardiac Rhythm Management Division, Sylmar, CA 

154 Correction of Diastolic Dyssynchrony by Cardiac 

Resynchronization Therapy Improves Heart Failure Via 

Acceleration of Global Diastolic Filling 

Takeshi Yamamoto 1 , Miyuki Ando 1 , Masunori Matsuzaki 1 ; 

1 

Department of Medicine and Clinical Science, Yamaguchi 

University Graduate School of Medicine, Ube, Japan 

155 Changes in Hemoglobin Associated with Different 

Unloading Conditions in Patient Supported with 

Continuous Flow Left Ventricular Assist Devices 

Omar Wever Pinzon 1 , Abdulfattah Saidi 1 , Stavros Drakos 1 , 

Edward Gilbert 1 , Craig Selzman 1 , Rami Alharethi 2 , Deborah 

Budge 2 , Bruce Reid 2 , Abdallah Kfoury 2 , Josef Stehlik 1 , Feras 

Bader 1 ; 1 University of Utah Health Sciences Center, Salt Lake 

City, UT; 2 Intermountain Medical Center, Salt Lake City, UT 

156 Aquapheresis Can Be Safely Applied for Volume 

Overload in Patients with Left-Ventricular Assist Device 

Peter M. Eckman 1 , Douglas Horstmanshof 2 , Megan Wroblewski 1 ; 

1 

Department of Medicine, Cardiovascular Division, University 

of Minnesota, Minneapolis, MN; 2 INTEGRIS Advanced Cardiac 

Care, Oklahoma City, OK 

157 Left Ventricular Assist Device Implantation Is 

an Effective Therapy for Decreasing Pulmonary 

Hypertension and Reducing Heart Transplant Allograft 

Right Ventricular Strain 

Pavan Atluri 1 , Brant W. Ullery 1 , John W. MacArthur 1 , Ashwin 

Murthy 1 , William Hiesinger 1 , Mary Lou O’Hara 1 , Kimberly 

Breuer 1 , Mariell Jessup 2 , Michael A. Acker 1 , J. Eduardo 

Rame 2 , Kenneth B. Marguiles 2 , Y. Joseph Woo 1 ; 1 Division 

of Cardiovascular Surgery, University of Pennsylvania, 

Philadelphia, PA; 2 Division of Cardiovascular Medicine, 

University of Pennsylvania, Philadelphia, PA 

158 Effect of Alemtuzumab on Gene Expression Profile of 

Mononuclear Cells Score in Cardiac Transplant Patients 

Aarti A. Patel 1 , Renzo Y. Loyaga-Rendon 2 , Si Pham 3 , Sandra 

Chaparro 1 ; 1 Internal Medicine, University of Miami/Jackson 

Memorial Hospital, Miami, FL; 2 Cardiology, University of 

Miami, Miami, FL; 3 Cardiothoracic Surgery, University of 

Miami, Miami, FL 

159 Successful Initiation of a Mechanical Circulatory 

Support Program in a Non-Transplant Institution 

Barbara Lee-Grasso 1 , Audrey C. Kleet 1 , Nancy L. Bonnet 1 , 

James P. Slater 1 ; 1 Heart Success Program, Morristown Memorial 

Hospital, Morristown, NJ 

160 Can Optimal LVAD Speed Be Determined by Body 

Surface Area and Pulsatile Index 

Mubashir Ahmed 1 , Kulpreet Barn 1 , William Posligua 1 , Farshad 

Raissi 1 , Raymond Stainback 1 , Howard O. Frazier 1 , MacArthur A. 

Elayda 1 , Reynolds M. Delgado 1 ; 1 Heart Failure and Transplant, 

Texas Heart Institute/St Luke’s Episcopal Hospital, Houston, TX 

tuesdAY 

120 

121

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

161 Immediate Post-Transplant Hyperglycemia and the Risk 

of Heart Allograft Rejection 

James Fleming, Mohamed Ahmed, David Lanfear; Heart and 

Vascular Institute, Henry Ford Hospital, Detroit, MI 


171 Requests for ICD and Pacemaker Deactivation: 

Characteristics of Affected Patients and Outcomes 

Tracy L. Webster 1 , Lillian C. Buchhalter 1 , Abigale L. Ottenberg 1 , 

Keith M. Swetz 1 , Paul S. Mueller 1 ; 1 Mayo Clinic, Rochester, MN 

172 Impact of B-Type Natruretic Peptide and Renal 

Function on Mortality in Patients with Atrial Fibrillation 

Receiving Cardiac Resynchronization Therapy 

Clay A. Cauthen 1 , John Rickard 1 , Bruce L. Wilkoff 1 , W.H. 

Wilson Tang 1 ; 1 Department of Cardiovascular Medicine, 


173 Calcium Mobilization Via IP3 Receptors Alters 

Electrical, Calcium Cycling and Contractile Properties 

of Human and Rodent Cardiomyocytes 

Sergio Signore 1 , Joao Ferreira-Martins 1 , Elisabeth Steadman 1 , 

Justin A. Korn 1 , Polina Goihberg 1 , Yingnan A. Bai 1 , Fumihiro 

Sanada 1 , Hanqiao Zheng 1 , Claudia Fiorini 1 , Federica del Monte 2 , 

Barbara Ogorek 1 , Francesco Cappetta 1 , Domenico D’Amario 1 , 

Toru Hosoda 1 , Annarosa Leri 1 , Piero Anversa 1 , Jan Kajstura 1 , 

Marcello Rota 1 ; 1 Anesthesia Medicine, Brigham Women’s 

Hospital-Harvard Medical School, Boston, MA; 2 Beth Israel 

Deaconess Medical Ctr, Boston, MA 

174 Withdrawn 

175 The Effects of Cardiac Resynchronization Therapy on 

Chronotropic Incompetence in Patients Intolerant of 

Beta Antagonist Therapy. Data from the DECREASE 

HF Trial 

Michael A. Samara 1 , Masaomi Kimura 1 , Lillian Batizy 2 , Donald 

L. Hopper 3 , Bruce Wilkoff 1 ; 1 Department of Cardiovascular 

Medicine; Heart and Vascular Institute, Cleveland Clinic, 

Cleveland, OH; 2 Department of Quantitative Health Sciences, 

Cleveland Clinic, Cleveland, OH; 3 Boston Scientific 

Corporation, Natick, MA 

176 Protecting Tako-Tsubo Patients from Sudden Death: Are 

Wearable Defibrillators the Answer? 

Jo Ann M. Glad 1 , Nicole R. Bianco 1 , Chingping Wan 1 , Steven J. 

Szymkiewicz 1 ; 1 Medical Affairs, Zoll, Pittsburgh, PA 

177 Mortality Benefit of Statins in Patients with Atrial 

Fibrillation 

Jason N. Salamon 1 , Jeremy Mazurek 1 , Muhammad R. Sardar 1 , 

Ronald Zolty 1 ; 1 Cardiology, Montefiore Medical Center, Bronx, 

NY 

178 Electro-Mechanical Remodeling and Survival after 

Cardiac Resynchronization Therapy 

Jawad Kiani 1 , Sunil Kumar Agarwal 1 , Swapna Kamireddy 1 , Evan 

Adelstein 1 , Samir Saba 1 ; 1 University of Pittsburgh, Pittsburgh, 

PA 


188 The Prognosis Investigation in Patients with Chronic 

Heart Failure and Pericardial Effusion 

Shengbo Yu 1 , Qingyan Zhao 1 , He Huang 1 , Hongying Cui 1 , Mu 

Qin 1 , Congxin Huang 1 ; 1 Cardiovascular Research Institute of 

Wuhan University, Renmin Hospital of Wuhan University, 

Wuhan, China 

189 Role of Lung Impedance Monitoring in the Outpatient 

Clinic for Predicting and Preventing of Hospitalizations 

Patients with Chronic Heart Failure 

Michael Shochat 1 , Avraham Shotan 1 , Aya Asif 1 , Yaniv Levy 1 , 

Ilia Shochat 1 , Iris Dahan 1 , David Blonheim 1 , Simcha Meisel 1 ; 

1 

Cardiology, Hillel Yaffe, Hadera, Israel 

190 Design of the Investigations in Pregnancy Associated 

Cardiomyopathy (IPAC) Trial: A Multicenter 

Investigation of Immune Pathogenesis and Myocardial 

Recovery in Peripartum Cardiomyopathy 

Dennis M. McNamara 1 , Uri Elkayam 2 , Leslie T. Cooper 3 , Jessica 

Pisarcik 1 , John Gorcsan 1 , Erik B. Schelbert 1 , Charles McTiernan 1 , 

James D. Fett 4 , For the IPAC Investigators; 1 Cardiovascular 

Institute, University of Pittsburgh Medical Center, Pittsburgh, 

PA; 2 University of Southern California, Los Angeles, CA; 

3 

Mayo Clinic Foundation, Rochester, MN; 4 Peripartum 

Cardiomyopathy Consultant, Seattle, WA 

191 The Relationship between Red Cell Distribution Width 

with Clinical Characteristics: Analysis Based on 16681 

Chronic Systolic Heart Failure Patients with Different 

Causation 


Qin 1 , Congxin Huang 1 ; 1 Renmin Hospital of Wuhan University, 

Wuhan, China 

tuesdAY 

122 

123

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

192 Intervention Research for Heart Failure Patients and 

Caregivers in Hospice – Is It Even Feasible? 

Cheryl H. Zambroski 1 , Chris Garrison 1 , Harleah G. Buck 2 , Susan 

C. McMillan 1 ; 1 Nursing, University of South Florida, Tampa, 

FL; 2 Nursing, Pennsylvannia State University, University Park, 

PA 

193 International Differences in Acute Heart Failure (AHF) 

Patients: Insight from the PROTECT Trial 

M. Fiuzat 1 , B. Massie 2 , K. Chiswell 1 , M. Givertz 3 , B. Davison 4 , 

G. Cotter 4 , J. Cleland 5 , H. Dittrich 6 , G. Mansoor 6 , P. Ponikowski 7 , 

A. Voors 8 , J.R. Teerlink 2 , R. Mentz 1 , M. Metra 9 , C. O’Connor 1 ; 

1 

Duke Univ, Durham, NC; 2 SFVAMC; 3 Brigham Womens; 

4 

Momentum; 5 Univ of Hull, United Kingdom; 6 Merck; 

7 

Med. Univ, Wroclaw, Poland; 8 Univ Med. Ctr, Groningen, 

Netherlands; 9 Univ of Brescia, Brescia, Italy 

194 The Prognostic Value of Right Ventricular End-Diastolic 

Diameter in Patients with Chronic Systolic Heart Failure 


Qin 1 , Congxin Huang 1 ; 1 Renmin Hospital of Wuhan University, 

Wuhan, China 

195 Impairment of Muscle Fiber Recruitment and Decreased 

Total Muscle Work Capacity during Isokinetic Exercise 

in Patients with Advanced Heart Failure 

Meaghan L. Jones 1 , Aalap Chokshi 1 , J. Elias Collado 1 , Aimee 

Layton 1 , Hilary F. Armstrong 1 , Daniel E. Forman 2 , Matthew 

Bartels 1 , Donna Mancini 1 , P. Christian Schulze 1 ; 1 Cardiology, 

Columbia University, New York, NY; 2 Cardiology, VA Boston 

Health Care System, Boston, MA 

196 Is Radial Strain by 2D Speckle Tracking Ready for 

Prime Time in Multicenter Echocardiographic Study of 

Heart Failure Patients? 

Salima Qamruddin 1 , Reza Rafie 1 , Kyungmoo Ryu 2 , Allen J. 

Keel 2 , Tasneem Z. Naqvi 1 ; 1 Non Invasive Lab, Division of 

Cardiology, Department of Medicine, University of Southern 

California, Los Angeles, CA; 2 Research Division, St. Jude 

Medical, Inc., Sylmar, CA 

197 The Clinical Efficacy of CRT-D in Japanese Heart 

Failure Patients. Comparison of MOMIJI (MIRACLE- 

ICD Outcome Measured in Japanese Indication) Study 

and MIRACLE ICD 

Shin-ichi Momomura 1 , Kaoru Sugi 2 , Tomoyuki Tejima 3 , 

Hiroyuki Tsutsui 4 , For the MOMIJI Study Investigators; 

1 

Cardiovascular Medicine, Jichi Medical University Saitama 

Meducal Center, Saitama, Japan; 2 Toho University Ohashi 

Medical Center, Tokyo, Japan; 3 Medtronic Japan, Tokyo, Japan; 

4 

Hokkaido University Graduate School of Medicine, Sapporo, 

Japan 

206 Clenbuterol + C-CSF Administration Improves Left 

Ventricular Function through Stem/Progenitor Cell 

Mobilization in Rats with Heart Failure 

Toshikazu D. Tanaka 1 , Jordan J. Lancaster 1 , Elizabeth Juneman 1 , 

Sarah Arnce 1 , Nicholle M. Johnson 1 , Maribeth Stansifer 1 , 

Howard Byrne 1 , Grace Gorman 1 , Joseph J. Bahl 1 , Steven 

Goldman 1 ; 1 Cardiology, Southern Arizona VA Health Care 

System, Tucson, AZ 

207 Optimal Heart Failure Management in the Outpatient 

Setting: Assessing Treatment by Provider Type 

Megan E. Cevasco 1 , Katherine M. Sullivan 1 , Mark E. Dunlap 1 ; 

1 

MetroHealth Campus of Case Western Reserve University, 

Cleveland, OH 

208 Pro-Fibrotic Role of the A2B Adenosine Receptor in 

Human Cardiac Fibroblasts 

Hongyan Zhong 1 , Luiz Belardinelli 1 , Dewan Zeng 1 ; 1 Gilead 

Sciences, Inc., Palo Alto, CA 

209 Antiviral Activity of Water Soluble Coxsackievirus B3 

3C Protease Inhibitor 

Eun-Seok Jeon 1 , Soo-Hyeon Yun 1 , Jin-Oh Choi 1 , Eun-Seon 

Ju 1 , Yong-Chul Kim 2 ; 1 Cardiology, Sungkyunkwan University 

School of Medicine, Seoul, Republic of Korea; 2 School of 

Life Science, Gwangju Institute of Science and Technology, 

Gwangju, Republic of Korea 

210 Use of Fish Oil in Systolic Heart Failure (SHF): A 

Retrospective Mortality Analysis 

Zia Rab 1 , Wajeeha Saeed 2 , Jason Salamon 2 , Muhammad 

R. Sardar 2 , Ronald Zolty 2 ; 1 Internal Medicine, Montefiore 

Medical Center, Bronx, NY; 2 Cardiology/CHF and Transplant, 

Montefiore Medical Center, Bronx, NY 

211 Use of Carpeptide in Patients Admitted with Acutely 

Decompensated Heart Failure in Japan 

Yoshihisa Morita 1 , Shun Kohsaka 2 , Yutaka Endo 2 , Kazuki 

Oshima 2 , Tsutomu Yoshikawa 2 , Keiichi Fukuda 2 ; 1 Department of 

Anesthesiology and Critical Care, Teikyo University, School of 

Medicine, Itabashi, Tokyo, Japan; 2 Department of Cardiology, 

Keio University, School of Medicine, Shinjuku, Tokyo, Japan 

212 Clinical Experience with Low-Dose Continuous Infusion 

Furosemide in Acute Heart Failure: Assessment of 

Efficacy and Safety 

Tien M.H. Ng 1 , Shenche Hshieh 1 , Cynthia Y. Chan 1 , Uri 

Elkayam 1 ; 1 School of Pharmacy and Keck School of Medicine, 

University of Southern California, Los Angeles, CA 

tuesdAY 

124 

125

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

213 Affect of Warfarin on Pulmonary Arterial Hypertension 

(PAH) Mortality: Facts Have Changed? 

Wajeeha Saeed 1 , Nidhish Tiwari 2 , Jason Salamon 1 , Muhammad 

R. Sardar 1 , Zia Rab 1 , Ronald Zolty 1 ; 1 Cardiology/CHF and 

Transplant, Montefiore Medical Center, Bronx, NY; 2 Internal 

Medicine, Jacobi Medical Center, Bronx, NY 


221 Genotype and Phenotypic Characteristics of Persons 

with Cardiac Amyloidosis from the Multinational 

Transthyretin Amyloidosis Outcomes Survey (THAOS) 

Registry 

Kumar Dharmarajan 1 , Say Salomon 1 , Stephen Helmke 1 , Sergio 

Tereyua 1 , Claudio Rapezzi 2 , Rodney Falk 3 , Mathew S. Maurer 1 ; 

1 

Clinical Cardiovascular Research Lab for the Elderly, Columbia 

University, New York, NY; 2 Harvard Vanguard Medical 

Associates, Boston, MA; 3 University of Bologna, Bologna, Italy 

222 Heart Failure Patients with Lower Socioeconomic Status 

Generate Lower Charges 

Billy G. Chacko 1 , Tej K. Atluri 1 , Hamza Rana 1 , Syed U. 

Naqvi 1 , Pavel Levy 1 , Kimberley J. Hansen 2 ; 1 Vascular and 

Endovascular Surgery, Section on Vascular Medicine, Wake 

Forest Baptist Medical Center, Winston-Salem, NC; 2 Vascular 

and Endovascular Surgery, Wake Forest Baptist Medical Center, 

Winston-Salem, NC 

223 Ethnicity and Heart Failure and Their Epidemiological 

Profile and Outcomes in a Multi-Ethnic Asian Cohort in 

Singapore 

Kui Toh Gerard Leong 1 , Yan Cao 2 , Michelle Tan 2 , Ping Ping 

Goh 1 ; 1 Cardiology, Changi General Hospital, Singapore, 

Singapore; 2 Case Management, Changi General Hospital, 

Singapore, Singapore 

224 Systolic Dysfunction Predicts 30 Day Heart Failure 

Specific Readmission in US Academic Medical Centers 

and All-Cause Readmission in Academic Safety Net 

Hospitals 

Edward F. Gibbons 1 , Ellen Robinson 1 , Paula Minton-Foltz 1 , 

J. Richard Goss 1 ; 1 Departments of Cardiology, Quality 

Improvement, Patient Care Services, and Medicine, University 

of Washington School of Medicine, Harborview Medical Center, 

Seattle, WA 

226 The Actual Utilization and the Reasons for Donor Heart 

Unacceptability in Korean Heart Transplantation 

Myung-jin Cha 1 , Hae-Young Lee 1 , Hyun-Jai Cho 1 , Kee-Bong 

Kim 1 , Byung-Hee Oh 1 ; 1 Seoul National University Hospital, 

Seoul, Korea 

227 Navigating the Cultural Geography of an Indigenous 

Community’s Attitude toward Genetic Research Is 

Dependant upon a History of Fostered Trust 

May Vawer 1 , Ann E. Leonard 1 , Patsy Kaina 2 , Beth Blackburn 1 , 

Malia Young 1 , Todd B. Seto 1 ; 1 The Queen’s Medical Center, 

Honolulu, HI; 2 Rural Community, Kahului, HI 

Outcomes 

255 Early Enalapril Therapy on Long-Term Mortality in 

Patients with Asymptomatic Left Ventricular Systolic 

Dysfunction: A 22-Year Follow-Up of SOLVD in Belgium 

Philip Jong 2 , Sylvie A. Ahn 1 , Michel F. Rousseau 1 ; 1 Division of 

Cardiology, University of Louvain, Brussels, Belgium; 2 Division 

of Cardiology, University of Toronto, Toronto, ON, Canada 

256 Is B-Type Natriuretic Peptide Predictive of Outcomes in 

Non-Heart Failure Patients with Differing Body Mass? 

K. Rasmusson 1 , R. Alharethi, B. Horne, T. Bair, K. Brunisholz, 

D. Budge, J. Nixon, J. Connolly, A. Kfoury; 1 Heart Failure 

Prevention and Treatment Program, Intermountain Medical 

Center, Heart and Lung Institute, Salt Lake City, UT 

257 Canadian Heart Failure Patient and Caregiver Emotions 

Karen I. Harkness 1,2,3 , Estrellita Estrella-Holder 3,4 , Annemarie 

Kaaan 3,5 , Heather M. Arthur 1,2 , Robert S. McKelvie 1,2 ; 1 Faculty of 

Health Sciences, McMaster University, Hamilton, ON, Canada; 

2 

Hamilton Health Sciences, Hamilton, ON, Canada; 3 Canadian 

Heart Failure Network, London, ON, Canada; 4 Cardiac Sciences 

Program Heart Failure Clinic, Y3 Bergen Cardiac Centre, 

Winnipeg, MB, Canada; 5 Vancouver Coastal Heart Failure 

Strategy, St Paul’s Hospital, Vancouver, BC, Canada 

258 ICD Implantation May Increase Heart Failure 

Admissions in Patients with Left Ventricular Systolic 

Dysfunction Who Demonstrate Reverse Remodeling 

Pradeep K. Bhat 1 , Ottorino Costantini 1 ; 1 Heart and Vascular 

Center, MetroHealth Campus, Case Western Reserve University, 

Cleveland, OH 

tuesdAY 

225 Broken Heart, That’s Right 

Deepakraj Gajanana, Prasanna Sugathan, Jeffrey Veluz; 

Department of Cardiology, St Luke’s Hospital and Health 

Network, Bethlehem, PA 

126 

127

Sept. 20 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 20 

Tuesday 

Posters 

tuesdAY 

259 Seattle Heart Failure Model Scores Significantly Predict 

Medical Resource Use and Costs in HF-ACTION 

Shelby D. Reed 1 , Yanhong Li 1 , Stephen J. Ellis 1 , David J. 

Whellan 2 , Kevin A. Schulman 1 , Christopher M. O’Connor 1 , 

Wayne C. Levy 3 ; 1 Duke Clinical Research Institute, Durham, 

NC; 2 Jefferson Medical College, Philadelphia, PA; 3 University 

of Washington, Seattle, WA 

260 Longitudinal Investigation of Patient Centric Outcomes: 

Comparisons between CRT-D vs. ICD Patients 

Brian Ramza 1 , Samuel F. Sears 2 , Christina Murray 3 , John House 1 , 

Paul Kennedy 1 , Rose Thompson 1 , Michelle M. Fedewa 4 ; 1 St. 

Luke’s Hospital, Kansas City, KS; 2 East Carolina, Greenville, 

NC; 3 Oklahoma University Health Sciences Ctr, Oklahoma City, 

OK; 4 Medtronic, Inc., Fridley, MN 

261 One-Year Survival Post-ICD Implantation: Another 

Indicator of Appropriate Candidate Selection 

Kismet Rasmusson 1 , Roberta James 1 , Rami Alharethi 1 , Deborah 

Budge 1 , Kim Brunisholz 1 , Jenny Connolly 1 , Joe Tuinei 1 , Dylan 

Nelson 1 , Colleen Roberts 1 , Abdallah Kfoury 1 ; 1 Heart Failure 


Center, Salt Lake City, UT 

262 Quality of Life and Family Function Are Poorest When 

Both Patients with Heart Failure and Their Caregivers 

Depressed 

Misook L. Chung 1 , Debra K. Moser 1 , Susan K. Frazier 1 , Terry A. 

Lennie 1 ; 1 Nursing, University of Kentucky, Lexington, KY 

263 Clinical Characteristics and Outcomes of Patients with 

Ischemic Cardiomyopathy (ICM) and Angina: Findings 

from the Duke Cardiovascular Database 

R.J. Mentz 1 , M. Fiuzat 1 , L. Shaw 1 , S. Borges-Neto 1 , H.R. 

Phillips 1 , M. Gheorghiade 2 , C.M. O’Connor 1 ; 1 DCRI, Duke Univ, 

Durham, NC; 2 Northwestern Univ, Chicago, IL 

264 Effect of Spironolactone on 30 Day Readmission Rates 

in Patients with Heart Failure Following Ultrafiltration 

Therapy 

Mahesh Aradhya 1 , Deepakraj Gajanana 1 , Santh V.S. 

Silpershetty 1 , Hyma Vani Polimera 1 , Ellen Amedeo 2 , Prasanna 

Sugathan 2 ; 1 Internal Medicine, St Luke’s Hospital, Bethlehem, 

PA; 2 Cardiology, St Luke’s Hospital, Bethlehem, PA 

265 Do Comorbidity Scores Compare with or Improve the 

Performance of the Seattle Heart Failure Model in 

Predicting Outcomes? 

Omar F. Abouezzeddine 1 , Sultan A. Mirzoyev 1 , Wayne C. 

Levy 2 , Margaret M. Redfield 1 ; 1 Mayo Clinic, Rochester, MN; 

2 


266 Hypoalbuminemia Is an Independent Predictor of Long 

Term Mortality in Patients with Heart Failure with 

Preserved Ejection Fraction (HFpEF) 

Muhammad R. Sardar 1 , Zia Rab 1 , Jason N. Salamon 1 , Wajeeha 

Saeed 1 , Ronald Zolty 1 ; 1 Cardiology/CHF and Transplant, 

Montefiore Medical Center, Bronx, NY 

267 Prognostic Value of Serial Clinical, Laboratory and 

Ecocardiographic Tests in Ambulatory Patients with 

Chronic Heart Failure 

Carlo Lombardi 1 , Alessandra Manerba 1 , Enrico Vizzardi 1 , 

Giovanni Cuminetti 1 , Silvia Bugatti 1 , Valentina Carubelli 1 , 

Valentina Lazzarini 1 , Savina Nodari 1 , Marco Metra 1 , Livio Dei 

Cas 1 ; 1 Cardiology, University of Brescia, Brescia, Italy 

268 Optimal Low-Density Lipoprotein Levels in Patients 

with Acutely Decompensated Heart Failure 

Mark R. Kahn 1 , Arzhang Fallahi 1 , Greg Serrao 1 , Gabriel 

Wagman 1 , Timothy J. Vittorio 1 ; 1 Zena and Michael A. Wiener 

Cardiovascular Institute, Mount Sinai Medical Center, New 

York, NY 

269 Prognostic Scoring in Patients Requiring BIVAD as a 

Bridge to Cardiac Transplantation 

Richard K. Cheng 1 , Chi-Hong Tseng 2 , Richard Shemin 3 , 

W. Robb MacLellan 1 ; 1 Cardiology, UCLA, Los Angeles, 

CA; 2 General Internal Medicine, UCLA, Los Angeles, CA; 

3 

Cardiothoracic Surgery, UCLA, Los Angeles, CA 

270 Successful Facilitation of the Save 5 Million Lives 

Campaign at VA VISNs (Regions): CHF QUERI 

Anju Sahay 1 , Paul A. Heidenreich 1 ; 1 CHF QUERI, Dept of 

Veterans Affairs, Palo Alto, CA 

271 Performance of Generic Health Related Quality of Life 

Instruments in Heart Failure Clinics 

Andrew J. Henn 1 , Steven Tally 2 , Robert M. Kaplan 3 , Dennis 

Fryback 1 , Theodore G. Ganiats 2 , Nancy K. Sweitzer 1 ; 1 University 

of Wisconsin School of Medicine and Public Health, Madison, 

WI; 2 University of California - San Diego, San Diego, CA; 

3 

Department of Health Services, UCLA School of Public Health, 


272 Changing Clinical Profiles and Timing of Enrollment in 

Acute Heart Failure Syndromes Clinical Trials 

Sean Collins 1 , Alan Storrow 2 , Karen Miller 2 , Sue Roll 1 , Greg 

Fermann 1 , Peter Pang 3 , Mihai Gheorghiade 3 , Chris Lindsell 1 , 

Douglas Sawyer 2 , Neal Weintraub 1 ; 1 Emergency Medicine, 

University of Cincinnati, Cincinnati, OH; 2 Emergency Medicine, 

Vanderbilt, Nashville, TN; 3 Emergency Medicine, Northwestern 


tuesdAY 

128 

129

Sept. 20 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 20 

Tuesday 

Posters 

tuesdAY 

273 Variation in Right Heart Catheterization Use for Patients 

Hospitalized with Heart Failure 

Richard K. Cheng 1 , Haiyong Xu 2 , Carol Mangione 2 , Jose 

Escarce 2 , Michael Ong 2 ; 1 Cardiology, UCLA Medical Center, 

Los Angeles, CA; 2 General Internal Medicine, UCLA Medical 

Center, Los Angeles, CA 

274 Association of Soluble ST2, an Emerging Biomarker of 

Heart Failure, with Peripartum Cardiomyopathy 

Kismet Rasmusson 1 , Benjamin Horne 1 , Kim Brunisholz 1 , James 

Januzzi 2 , Rami Alharethi 1 , Deborah Budge 1 , Oxana Galenko 1 , 

Josef Stehlik 3 , John Carlquist 1 , Jenny Connollly 1 , Stacey 

Frampton 1 , Stephanie Moore 2 , Abdallah Kfoury 1 ; 1 Heart Failure 


Center, Salt Lake City, UT; 2 Heart Failure and Transplant, 

Massachusetts General Hospital, Boston, MA; 3 Heart Failure 

and Transplant, University of Utah, Salt Lake City, UT 

275 Type II Diabetes Is Associated with Sleep Continuity, 

Variability in Wake Time, and Excess Daytime Sleepiness 

in Patients with Stable Heart Failure 

Nancy S. Redeker 1 , Sangchoon Jeon 1 ; 1 School of Nursing, Yale 

University, New Haven, CT 

276 Symptom Recognition and Decision To Seek Care by 

Both Chronic Heart Failure Patients and Their Family 

Caregivers/Significant Others Prior to Hospitalization 

Jill R. Quinn 1 , Leway Chen 2 , Judy Brasch 1 , Joyce A. Smith 1 , 

Rebecca Tucker 1 , Ding-Geng Chen 1 ; 1 School of Nursing, 

University of Rochester, Rochester, NY; 2 School of Medicine 

and Dentistry, University of Rochester, Rochester, NY 

277 Sex Differences in the Obesity Paradox of Systolic Heart 

Failure? 

Adrienne L. Clark 1 , Tamara B. Horwich 2 ; 1 David Geffen 

School of Medicine, University of California, Los Angeles, 

Los Angeles, CA; 2 Ahmanson-UCLA Cardiomyopathy Center, 

University of California, Los Angeles, Los Angeles, CA 

278 Prognostic Importance of Serial Evaluation of Blood 

Urea Nitrogen in Ambulatory Patients with Chronic 

Systolic Heart Failure and Preserved Renal Function 

Clay A. Cauthen 1 , Matthew Tong 2 , Yuping Wu 3 , Anil Jain 4 , 

W.H. Wilson Tang 1 ; 1 Department of Cardiovascular Medicine, 

Cleveland Clinic Foundation, Cleveland, OH; 2 Department 

of Internal Medicine, Kettering Medical Center, Kettering, 

OH; 3 Department of Mathematics, Cleveland State University, 

Cleveland, OH; 4 Division of Information Technology, Cleveland 

Clinic Foundation, Cleveland, OH 

279 Predictors of 30-Day Hospital Readmissions in Patients 

with Heart Failure (HF) 

Manreet Kanwar 1 , Daniel Spinuzzi 2 , Diane Vido 1 , Raymond 

Benza 1 , Srinivas Murali 1 , George Sokos 1 ; 1 Cardiology, Allegheny 

General Hospital, Pittsburgh, PA; 2 Internal Medicine, Allegheny 

General Hospital, Pittsburgh, PA 

280 Clinical Characteristics and Outcomes for Hospitalized 

Heart Failure (HF) Patients with Chronic Obstructive 

Pulmonary Disease (COPD): Findings from OPTIMIZE- 

HF 

R.J. Mentz 1 , M. Fiuzat 1 , D. Wojdyla 1 , K. Chiswell 1 , K. Pieper 1 , 

M. Gheorghiade 2 , G.C. Fonarow 3 , C.M. O’Connor 1 ; 1 Duke 

Univ, Durham, NC; 2 Northwestern Univ, Chicago, IL; 3 UCLA 

Medical Center, Los Angeles, CA 

281 Long-Term Follow-Up of Stem Cell Therapy after Acute 

Myocardial Infarction 

Suzana A. Alves 1 , Sabrina B. Pereira 1 , Rose Frajtag 1 , Rodrigo 

C. Moreira 1 , Andre L.S. Souza 1 , Andrea Haddad 1 , Fabio Tuche 1 , 

Karla Menezes 1 , Radovan Borojevic 2 , Hans F. Dohmann 1 ; 

1 

Procardíaco Hospital, Rio de Janeiro, Brazil; 2 Federal 

University of Rio de Janeiro, Rio de Janeiro, Brazil 


319 Do Advanced Practice Nurses Conform to Heart Failure 

Therapies at the Same Rate as Team-Based Physicians? 

Nancy M. Albert 1 , Maureen O’Malley 1 , Benjamin Nutter 1 , 

Randall Starling 1 ; 1 Cleveland Clinic Foundation, Cleveland, OH 

320 Exercise Induced Pulmonary Hypertension: 

Comparison of Stress Echocardiography to Right Heart 

Catheterization 

Karthik Gujja 1 , Deepika Misra 1 , Christine Roncari 1 , Roxana 

Sulica 1 ; 1 Cardiology, Beth Israel Medical Center, New York, NY 

321 Complex Telemonitoring or a Simple Telephone Call, 

Which Is More Effective in Post-Discharge Heart Failure 

(HF) Management? 

Robyn A. Clark 1 , Sally C. Inglis 2 , Finlay A. McAllister 3 , 

Simon Stewart 4 , John G.F. Cleland 5 , Cochrane Heart Group 5 ; 

1 

Queensland University of Technology, Brisbane, Australia; 

2 

University of Technology, Sydney, Australia; 3 University 

of Alberta, Alberta, Canada; 4 Baker IDI Heart and Diabetes 

Institute, Melbourne, Australia; 5 Castle Hill Hospital, Hull, 

United Kingdom 

tuesdAY 

130 

131

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

322 Hyponatremia in Hospitalized Heart Failure Patients: 

Interim Data from an Observational, Prospective, Multi- 

Center, Global Hyponatremia Registry 

Jun Chiong 1 , Paul Hauptman 2 , Sonnie Kim 3 ; 1 Loma Linda 

University Medical Center, Loma Linda, CA; 2 Saint Louis 

University School of Medicine, Saint Louis, MO; 3 Otsuka 

America Pharmaceutical, Inc., Princeton, NJ 

323 Pilot Study of a Hospital-to-Home Program To Reduce 

Heart Failure Readmissions Led by Heart Failure Nurse 

Practitioners 

Aileen Sauris 1 , Carol Flavell 1 , Joanne Weintraub 1 , Michelle 

Young 1 , Parakash Pratibhu 1 , Michael Givertz 1 , Neal Lakdawala 1 , 

Eldrin Lewis 1 , Gilbert Mudge 1 , Anju Nohria 1 , Lynne Stevenson 1 , 

Akshay Desai 1 ; 1 Cardiovascular Division, Brigham and Women’s 


324 NT proBNP Can Predict the Cardiovascular Events in 

Patients with Dilated Cardiomyopathy Which Is the 

First Manifestation of Heart Failure 

Eun-Young Kim 1 , Jin-Oh Choi 1 , Soo-Hyeon Yun 1 , Eun-Seon Ju 

Ju 1 , Eun-Seok Jeon 1 ; 1 Cardiology, Sungkyunkwan University 

School of Medicine, Seoul, Republic of Korea 

325 The Association of Sodium Intake and Objective and 

Subjective Indicators of Heart Failure Severity 

Kristie M. Harris 1 , Andrew J. Wawrzyniak 1 , Jennifer M. 

Marshall 2 , Sarah M. Godoy 1 , Joanne P. Marshall 2 , Shawn W. 

Robinson 2 , David S. Krantz 1 , Stephen S. Gottlieb 2 ; 1 Medical 

Clinical Psychology, Uniformed Services University, Bethesda, 

MD; 2 Medicine, University of Maryland, Baltimore, MD 

326 Early Detection of Left Ventricular Dysfunction in 

Asymptomatic Type 2 Diabetic Patients 

Angelina Stevanovic 1 , Mirjana Krotin 2 , Milica Dekleva 3 , Nevena 

Paunovic 1 , Snezana Trajic 4 ; 1 Cardiology Department, Railway 

Health Care Institute, Belgrade, Serbia; 2 Cardiology Department, 

University Clinical Center “Bezanijska Kosa”, Belgrade, Serbia; 

3 

Cardiology Department, University Clinical Center Zvezdara, 

Belgrade, Serbia; 4 Cardiology Department, Institute for 

Cardiovascular Dedinje, Belgrade, Serbia 

327 Technetium Pyrophosphate SPECT Imaging for 

Non-Invasive Identification of Transthyretin Cardiac 

Amyloidosis 

Mathew S. Maurer 1 , Farhana Latif 1 , Sabahat Bokhari 1 ; 

1 

Cardiology, Columbia University Medical Center, New York, 

NY 

328 What Type of Social Support Do Heart Failure Patients 

Need? 

Seongkum Heo 1 , Debra K. Moser 2 , Terry A. Lennie 2 ; 1 College 

of Nursing, University of Arkansas for Medical Science, 

Little Rock, AR; 2 College of Nursing, University of Kentucky, 

Lexington, KY 

329 Factors Related to Self-Care Behavior among 

Outpatients with Heart Failure in Korea 

Jong Sun Ok 1 , Heejung Choi 2 , Kyu Hyung Ryu 1 , Sung Hea 

Kim 1 , Min-Seok Kim 3 , Jin-Oh Choi 4 ; 1 Cardiovascular Center, 

KonKuk University Medical Center, Seoul, Republic of Korea; 

2 

Nursing, Konkuk Univeristy, Chungju, Republic of Korea; 

3 

Cardiovascular Center, Asan Medical Center, Seoul, Republic 

of Korea; 4 Division of Cardiology, Samsung Medical Center, 

Seoul, Republic of Korea 

330 Frequency of Improvement in Ventricular Function 

Allows Many Patients To Defer Defibrillator 

Implantation 

Bethany A. Austin 1 , Nicole R. Bianco 2 , Steven J. Szymkiewicz 2 , 

Sanjeev Aggarwal 1 , Andrew C. Kao 1 ; 1 Saint Luke’s Mid-America 

Heart and Vascular Institute, Saint Luke’s Hospital, Kansas City, 

MO; 2 Zoll Corporation, Pittsburgh, PA 

331 Teach-Back Is an Effective Strategy for Educating Older 


Jill Howie-Esquivel 1 , Matthew White 1 , Maureen Carroll 2 , Eileen 

Brinker 2 ; 1 Physiological Nursing, University of California, San 

Francisco, CA; 2 Cardiovascular Service Line, University of 

California, San Francisco, CA 

332 Clinic-Based Systematic Optimization Algorithm To 

Improve Rate of Response to Cardiac Resynchronization 

Therapy 

Keith Miller 1 , Andrew D. Merliss 1 , Rhonda Olmsted 1 , Vinay 

Thohan 2 , William Sauer 3 , Duy Nguyen 3 , Keith Bruce 4 , Gregg 

Yamada 5 , Michelle M. Fedewa 6 , Jason Brown 6 , Jeff Torrey 6 ; 

1 

Bryan LGH Hospital, Lincoln, NE; 2 Wake Forest University 

Health Sciences, Winston-Salem, NC; 3 University of Colorado, 

Denver, CO; 4 Chattanooga Heart Institute, Chattanooga, TN; 

5 

Pacific Cardiology, Honolulu, HI; 6 Medtronic, Inc., Fridley, 

MN 

333 Improving Heart Failure Symptom Assessment 

Congruence through a Perspective-Taking Intervention: 

A Pilot Study 

Christina Quinn 1 , Sandra B. Dunbar 2 , Melinda Higgins 2 ; 

1 

Division of Nursing, Gordon College, Barnesville, GA; 2 Nell 

Hodgson Woodruff School of Nursing, Emory University, 

Atlanta, GA 

tuesdAY 

132 

133

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

334 Prevalence and Clinical Features of Heart Failure 

with Preserved Ejection Fraction in a Veterans 

Administration Medical Center 

Edlira Maska 1 , Tamarah Jungklaus 2 , Samantha Malloy 2 , 

Shawn Anderson 2 , Timothy Cleeton 2 , Juan Aranda 1,2 , Richard 

Schofield 1,2 ; 1 University of Florida College of Medicine, 

Gainesville, FL; 2 Department of Veterans Affairs Medical 

Center, Gainesville, FL 

335 Suffering and Spiritual Transformation in Heart Failure 

Melissa Dyo 1 , Cheryl Westlake 1 ; 1 Nursing, Azusa Pacific 

University, Azusa, CA 

336 Utilizing Cardiac Magnetic Resonance Imaging to 

Prognosticate for Peripartum Cardiomyopathy 

Jacob A. Misenheimer 1 , Andrew Lenneman 2 , William S. 

Bradham 2 , Julie B. Damp 2 ; 1 Internal Medicine, Vanderbilt 

University Medical Center, Nashville, TN; 2 Cardiology, 

Vanderbilt Heart and Vascular Institute, Nashville, TN 

337 Left Ventricular Non-Compaction Often Masquerades as 

a Dilated Cardiomyopathy: Implications for Prognosis 

and Treatment 

Elizabeth A. Langlois 1 , Frank W. Smart 1 ; 1 Cardiovascular 

Medicine, Morristown Memorial Hospital, Morristown, NJ 

338 The Lack of a Standardized Heart Failure Assessment 

Leads to Under Dosing Diuretics in the Emergency 

Department 

Frank W. Smart 1 , Elizabeth A. Langlois 1 , Frank Manole 1 , 

Jacqueline Fearon-Clarke 1 , Steve Sheris 2 ; 1 Cardiovascular 

Medicine, Morristown Memorial Hospital, Morristown, NJ; 

2 

Medicine, Overlook Hospital, Summit, NJ 

339 Validating the Physical Exam: Using Orthopnea To 

Assess Inpatient Diuresis and Time to Readmission 

Shaline D. Rao 1 , Stacey Rotman 1 , Stuart D. Russell 1 ; 

1 

Department of Cardiology, Johns Hopkins Hospital, Baltimore, 

MD 

340 Physiologic Sensor Response to Activity Level in the 

MultiSENSE Study 

John P. Boehmer 1 , Yi Zhang 2 , Kenneth C. Beck 2 , Robert J. 

Sweeny 2 ; 1 Heart Vascular Institute, The Penn State College of 

Medicine, Hershey, PA; 2 Boston Scientific CRV, Minneapolis, 

MN 

341 Cardiac Resynchronization Therapy, Pre Implantation 

Cardiac Magnetic Resonance Imaging and Long Term 

Mortality 

Maria E. Tettamanti 1 , Ana Revilla Orodea 1 , Roman Arnold 1 , 

Javier Lopez Diaz 1 , Luis de la Fuente Galan 1 , Itziar Gomez 

Salvador 1 , Jose A. San Roman Calvar 1 ; 1 Cardiology, Heart 

Failure and Cardiac Transplantation Section, Hospital Clinico 

Universitario de Valladolid, Valladolid, Spain 

342 Survival Benefit of Beta-Blockers in Patients with Heart 

Failure and Hyperbilirubinemia 

Christopher Labos 1 , Viviane Nguyen 1 , Nadia Giannetti 1 , Thao 

Huynh 1 ; 1 Department of Cardiology, McGill University Health 

Centre, Montreal, QC, Canada 

343 The Metabolic Profile and Global Cardiovascular Risk 

in a Cohort of Chronic Heart Failure Outpatients 

Wolney A. Martins 2 , Lucia B. Oliveira 1 , Luciana N. Barros 1 , 

Rosiane S.F. Abreu 1 , Gelsomina A.M. Pereira 1 , Maria A.R. 

Manhaes 1 , Paulo J.P. Camandaroba 1 , Sergio F. Sgaraglia 1 , Marli 

G. Oliveira 1 , Eugenio P. Campos 1 , Monica M.P. Quintao 1 , 

Ana C.D. Cavalcanti 2 , Evandro T. Mesquita 2 ; 1 Heart Failure 

Clinic (CLIC), HCTCO, Serra dos Órgãos University Center, 

Teresópolis, RJ, Brazil; 2 Fluminense Federal University, Niterói, 

RJ, Brazil 

344 Heart Failure Patients with Diabetes Have Higher 

Incidence of Heart Failure Hospitalization and 

Rehospitalization 

Vinod Sharma 1 , Jodi Koehler 1 , David J. Whellan 2 ; 1 New 

Therapies and Diagnostics, Medtronic Inc., Minneapolis, MN; 

2 

Jefferson University Hospitals, Philadelphia, PA 

345 Sodium Polystyrene Sulfonate for Secondary Prevention 

of Hyperkalemia in Patients with Chronic Kidney and 

Heart Diseases on Renin-Angiotensin-Aldosterone 

System Blockade Therapy 

Gil Chernin 1 , Amir Gal-Oz 1 , Idit F. Schwartz 1 , Doron Schwartz 1 , 

Donald S. Silverberg 1 ; 1 Nephrology Department, Tel Aviv 

Medical Center, Tel Aviv, Israel 

346 Changes of Left Ventricular Function Assessed by 2D 

and Doppler Echocardiography in Patients Receiving 

Tratsuzumab Therapy 

Sun Hwa Lee 1 , Won Ho Kim 1 , Jae Ki Ko 1 , Yun Ji Park 1 , Lae 

Young Jung 1 , Min Ju Song 1 , Hae Eun Yun 1 ; 1 Cardiology, 

Chonbuk National University Medical School, Jeonju, Korea 

tuesdAY 

134 

135

Sept. 20 

Tuesday 

Posters 

Posters 


Posters 


Sept. 20 

Tuesday 

Posters 

tuesdAY 

347 Evaluation of an Educational Intervention, Utilizing 

Simulation and a Teach Back (TB) Method, To Increase 

Nurses’ Knowledge and Retention of Heart Failure (HF) 

Self-Management (SM) Principles 

Sarah Frewin 1 , Tara Mahramus 1 , Lyne Chamberlain 2 , Debra 

Wilson 3 , Daleen Penoyer 4 , Mary Lou Sole 4 ; 1 Cardiology, Orlando 

Health: ORMC, Orlando, FL; 2 Cardiology, Orlando Health: Dr. 

P. Phillips, Orlando, FL; 3 Home Health, Orlando Health: Visiting 

Nurses Association, Orlando, FL; 4 Nursing Research, Orlando 

Health, Orlando, FL 

348 Diabetes and Heart Failure: Does the Type of Anti- 

Diabetic Therapy Matter? 

Lazaros A. Nikolaidis 1 , Swetang Shah 1 , Laurie Russell 1 , Alfred 

A. Bove 1 ; 1 Cardiology, Temple University School of Medicine, 


349 Improved Survival with HeartMate II Left Ventricular 

Assist Device for Acute Cardiogenic Shock 

Susan Lien 1 , Ryan C. Nelson 1 , Scott McNitt 1 , H. Todd Massey 1 , 

Jeffrey D. Alexis 1 , Leway Chen 1 , Eugene Storozynsky 1 , Michael 

W. Fong 2 ; 1 Cardiology Division, Cardiac Surgery Division, 

University of Rochester Medical Center, Rochester, NY; 

2 

Cardiology Division, University of Southern California, Los 

Angeles, CA 

350 Electronic Identifiers Accurately Identify Inpatient 

Heart Failure Admissions 

Carrie Geisberg 1 , Connie Lewis 1 , Starmer Jack 1 , Zachary 

Cox 1 , DiSalvo Thomas 1 , Douglas Sawyer 1 , Daniel Lenihan 1 ; 

1 

Cardiovascular Medicine, Vanderbilt University, Nashville, TN 

353 Specialized Heart Failure Outpatient Clinics: What 

Staff Are Required, What Is Their Workload, and Can 

These Data Facilitate the Planning of New Heart Failure 

Clinics? 

Malcolm Arnold, Anne Marie Kaan, Jonathan Howlett, Andrew 

Ignaszewski, Marie-Helene LeBlanc, Liu Peter, Haddad 

Hassam, Miroslav Rajda, Shelley Zieroth, Michael Chan; 

London Health Sciences Center, London, Canada; St Paul’s 

Hospital, Vancouver, Canada; Foothills Hospital, Calgary, 

Canada; St Paul’s Hospital, Vancouver, Canada; Institute de 

Cardiologie de Quebec, Quebec City, Canada; University Health 

Network, Toronto, Canada; Ottawa Heart Institute, Ottawa, 

Canada; Halifax Infirmary, Halifax, Canada; St Boniface 

Hospital, Winnipeg, Canada; Royal Alexandra Hospital, 

Edmonton, Canada 

354 Early Ultrafiltration May Reduce Length of Hospital 

Stay for Decompensated Heart Failure 

Santh V.S. Silparshetty 1 , Hyma V. Polimera 1 , Mahesh Aradhya 1 , 

Deepakraj Gajanana 1 , Ellen Amedeo 2 , Prasanna Sugathan 2 ; 

1 

Internal Medicine, Saint Luke’s Hospital and Health Network, 

Bethlehem, PA; 2 Cardiology, Saint Luke’s Hospital and Health 

Network, Bethlehem, PA 

355 Prevalence and Clinical Correlates of 

Hemoconcentration during Hospitalization for Acute 


Carlos Davila 1 , Alex Reyentovich 1 , Stuart D. Katz 1 ; 1 Leon H. 

Charney Division of Cardiology, New York University Langone 

Medical Center, New York, NY 

tuesdAY 

351 Pilot Program To Improve Self Management of Patients 

with Heart Failure by Redesigning Care Coordination 

Jessica Shaw 1 , Dan O’Neal 2 , Frances Zarella 3 , Kris Siddharthan 2 , 

Britta Neugaard 1 ; 1 Quality Management, James A Haley VA, 

Tampa, FL; 2 Research Service, James A Haley VA, Tampa, FL; 

3 

Nursing Service, James A Haley VA, Tampa, FL 

352 An Evaluation of Pharmacist-Led Heart Failure Clinic in 

Tan Tock Seng Hospital 

Kai Xin Ong 1 , Hwei Khien Lee 1 , Daniel Yeo 2 ; 1 Outpatient 

Pharmacy, Tan Tock Seng Hospital, Singapore, Singapore; 

2 

Cardiology, Tan Tock Seng Hospital, Singapore, Singapore 

136 

137

Sept. 21 

Wednesday 

AM 

CLINICAL FUNDAMENTALS 


7:00-8:15 AM 

Room 306 

GUIDELINE SESSION 


8:30-10:00 AM 

Ballroom A 

Sept. 21 

Wednesday 

AM 

WEDNESDAY 

Clinical Fundamentals: Atrial and Ventricular 

Arrhythmias/Troubleshooting CRT/ICD/ 

Mechanical Circulatory Support 

Moderators: Denise D. Barnard, San Diego, CA 

Ravi V. Shah, Boston, MA 

7:00 Indications and Profiles for Implantable Circulatory 

Support Devices 

Garrick C. Stewart, Boston, MA 

7:10 Outcomes and Adverse Events with Continuous Flow 

Devices 


7:25 Atrial Fibrillation with all EF: Prevalence and Approach 


7:35 After the First Shock, and After Many 

Roy M. John, Boston, MA 

7:45 Rhythm Device Programming 101 



Faculty 

Learning Objective: Describe the use of implantable devices 

in the treatment of patients with heart failure. 

Guideline Updates 2011: What’s Current, 

Controversial, and Coming Next 

Moderators: Michael M. Givertz, Boston, MA 

Randall C. Starling, Cleveland, OH 

8:30 Use of Aldosterone Antagonists in Heart Failure 

Justin A. Ezekowitz, Edmonton, AB, Canada 


Kirkwood F. Adams, Jr., Chapel Hill, NC 


Wendy Gattis Stough, Cary, NC 

8:52 Use of CRT in Mild, Moderate, and Severe Heart Failure 

Adrian F. Hernandez, Durham, NC 





9:14 Use of LVADs in Heart Failure 

Joseph G. Rogers, Durham, NC 





9:36 Acute Decompensated Heart Failure Therapy 

John R. Teerlink, San Francisco, CA 





Learning Objective: Describe updates to guideline 

recommendations for the treatment of patients with heart 

failure. 

WEDNESDAY 

8:15 HFSA Annual Business Meeting 

Room 311 


Room 311 


Refreshments served in 3rd floor foyer area 



138 

139

Sept. 21 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 302 

SYMPOSIUM 


8:30-10:00 AM 

Room 304 

Sept. 21 

Wednesday 

AM 

WEDNESDAY 

What to Evaluate After the Office Visit: To 

Diagnose, Predict or Guide? 

Moderators: Stefan D. Anker, Berlin, Germany 

Marc A. Silver, Oak Lawn, IL 

8:30* Biomarkers for Diagnostic and Risk Stratification 


8:45* Indications for Magnetic Resonance Imaging for 

Diagnosis and Follow-Up 

Raymond Y. Kwong, Boston, MA 

9:00* Are Biomarkers Useful as Targets to Titrate Therapy? 

Inder S. Anand, Minneapolis, MN 

9:15* Quality of Life Assessments: Routine or Investigational? 

Debra K. Moser, Lexington, KY 

9:30* Exercise Testing: Who and When? 

Donna M. Mancini, New York, NY 

9:45* When Should You Look For Reverse Remodeling and 

What if You Find It? 



Learning Objective: Outline evaluation and prognostic 

options for patients diagnosed with heart failure and the 

circumstances in which they are recommended. 

The Supported Circulation 

Moderators: Mariell L. Jessup, Philadelphia, PA 

Ben Sun, Minneapolis, MN 

8:30 Supporting the Less Sick: Approved or Investigational? 

Joseph G. Rogers, Durham, NC 


8:45 Needs for RVAD: None, Temporary or Permanent? 

Mark S. Slaughter, Louisville, KY 


9:00 Organ Function Before and After VAD 

Katherine Lietz, Maywood, IL 


9:15 Prevalence and Impact of Aortic Regurgitation 

Jennifer Cowger, Ann Arbor, MI 


9:30 Function and Quality of Life with Current Devices 

Kathleen L. Grady, Chicago, IL 


9:45 What Are Optimal Continuous Pressures and Flows? 



Learning Objective: Describe the use of mechanical 

circulatory support in patients with heart failure. 

WEDNESDAY 


Room 311 


Room 311 





140 

141

Sept. 21 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Room 311 

SYMPOSIUM 


10:30 AM-NOON 

Room 302 

Sept. 21 

Wednesday 

AM 

Cancer Chemotherapy and Cardiotoxicity 

How Will Therapy Change This Year? 

Moderators: Daniel J. Lenihan, Nashville, TN 

Douglas B. Sawyer, Nashville, TN 

Moderators: Eugene Braunwald, Boston, MA 

Barry M. Massie, San Francisco, CA 

8:30 Long-Term Cancer Care and Cardiomyopathies 

Thomas Force, Philadelphia, PA 

10:30 Major Drug Trials That Could Change Practice 

John R. Teerlink, San Francisco, CA 

WEDNESDAY 

8:50 Detecting and Reporting Cardiotoxicity: 

Does the End Justify the Means? 

Ronald M. Witteles, Stanford, CA 

9:00 Studies in Cancer Therapy Cardiotoxicity: 

What Can We Learn from Chronic Heart Failure? 

Bonnie Ky, Philadelphia, PA 

9:10 The Cardio-Oncology Population 

Anju Nohria, Boston, MA 

9:20 Cardiotoxicity and Cardiac Repair: Role of Neureregulin 

Carrie A. Geisberg, Nashville, TN 

9:30 Is Chemotherapy Creating a Stage B Population that 

Needs Treatment? 

Jean-Bernard Durand, Houston, TX 


10:42 Major Device Studies 


10:54 Real World Data on Heart Failure Management 

Barbara J. Riegel, Philadelphia, PA 

11:06 Any Subpopulations That Merit Change in Therapy? 

Clyde W. Yancy, Chicago, IL 

11:18 New Quality-of-Life Data 

Eldrin F. Lewis, Boston, MA 

11:30 Panel Discussion: How Do You Treat Patients Differently 

Than Last Year? 

Faculty 

Learning Objective: Discuss recent research and its potential 

impact on the treatment of heart failure. 

WEDNESDAY 

Learning Objective: Describe the impact of 

chemotherapeutic agents on heart failure and recommended 

management options. 


Room 311 



142 

143

Sept. 21 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Room 304 

SYMPOSIUM 


10:30 AM-NOON 

Room 306 

Sept. 21 

Wednesday 

AM 

WEDNESDAY 

Making Decisions with Level of Evidence C 

Moderators: J. Thomas Heywood, La Jolla, CA 

Corrine Y. Jurgens, Stony Brook, NY 

10:30* How Do You Initiate Aldosterone Antagonists 

in Someone on ACEI/ARB, Diuretics, and K+ 

Replacement? 


10:45* Fluid Restriction - Essential or Water Torture? 

Nancy M. Albert, Cleveland, OH 

11:00* When Do You Decrease Beta Blockers in a Patient Who 

Still Feels Tired After Six Months? 

W.H. Wilson Tang, Cleveland, OH 

11:15* When Is It Time to Introduce Palliative Care? 

Harleah G. Buck, University Park, PA 

11:30* End-of-Life Symptoms and Therapies 

Carol Flavell, Boston, MA 

11:45* Whom Do You Send Home on Intravenous Inotropic 

Therapy? 

Randall C. Starling, Cleveland, OH 


Learning Objective: Describe clinical recommendations 

in difficult clinical circumstances in the treatment of heart 

failure. 

Hope for Heart Failure with Preserved Ejection 

Fraction 

Moderators: James C. Fang, Cleveland, OH 


10:30* Why Are Heart Failure Patients with Preserved Ejection 

Fraction Short of Breath? 

Barry A. Borlaug, Rochester, MN 

10:45* A Disease of Diastole? 


11:00* Co-Morbidities in Heart Failure with Preserved Ejection 

Fraction as Alternate Targets for “Therapy” 

Flora Sam, Boston, MA 

11:15* Clinical Trials in Heart Failure with Preserved Ejection 

Fraction: Can We Learn From Failure? 

Nancy K. Sweitzer, Madison, WI 

11:30* Is It All About Fluid? 

Stuart D. Katz, New York, NY 

11:45* Is It Time to Relax? 

Gregory D. Lewis, Boston, MA 


Learning Objective: Describe current knowledge about 

heart failure with preserved ejection fraction and identify 

treatment strategies. 

WEDNESDAY 

144 

145

Thank you for coming – 

see you next year! 

16th Annual Scientific Meeting 

September 9 – 12, 2012 

Washington State Convention and Trade Center 

Seattle, WA 

147 

www.hfsa.org


10:00 AM-4:00 PM 


Hands-on Workshop 

Mechanical Circulatory Support (MCS) 

Hands-on Workshop 

10:00-11:00 AM Case Study Presentations 

11:15-11:45 AM HeartMate II Patient Exam 

NOON-1:30 PM 

Case Study Presentations 

1:45-2:15 PM HeartMate II Patient Exam 

2:30-4:00 PM Case Study Presentations 

This non-CME workshop is designed to provide practical information 

and hands-on experience for participants who may care for patients 

being supported by the HeartMate II® (Left Ventricular Assist System) 

LVAS and optional CentriMag® RVAS. The topics for presentation 

and discussion are related to routine care and problem resolution in 

VAD-supported patients. Specific topics include: 


12:30-1:45 PM 


Product Theater 

Understanding Hyponatremia: Treating Beyond the 

Primary Diagnosis 

John B. O’Connell, MD 

Executive Director 

Heart Failure Program 

Heart and Vascular Institute 

St. Joseph’s Hospital 

Atlanta, Georgia 

Program Description: This non-CME actaivity is an overview of 

hyponatremia and the management of patients presenting with 

hyponatremia in the hospital setting. 

Sponsored by Otsuka America Pharmaceutials, Inc. 

1. Selection of patients for VAD support 

2. Common early postoperative problems (patient and device) 

3. Routine outpatient exam; patient review and device 

interrogation 

4. Echocardiography for diagnosing specific problems and 

assessing recovery 

5. Making changes to the VAD systems (operating parameters 

and equipment) 

6. Troubleshooting problems with device and patient (case 

presentations) 

Expert cardiologists, nurses and Thoratec clinical support staff will 

be available throughout the workshop to give presentations and for 

discussion. Case studies will be used for presenting problem-solving 

information. Patients currently supported by the HeartMate II LVAS 

will be available for discussion with participants. 

The main focus of presentations and discussions will be the use of the 

HeartMate II LVAS. GoGear® System Components for the HeartMate 

II will be available for hands-on learning and discussion. Working 

HeartMate II and CentriMag pumps attached to mock loops will be 

available to simulate operation. A simulated outpatient clinic visit with 

a HeartMate II patient will also be conducted. 

The schedule of events will be posted onsite. No preregistration is 

necessary. However, participants must be registered for the HFSA 

Annual Scientific Meeting. 

Sponsored by Thoratec Corporation 

148 149

EXHIBIT FLOOR PLAN 

HFSA Exhibitor Booth # 

ABIOMED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2724 

Alere . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2721 

American Association of Heart Failure Nurses . . . . . . . . . . .Booth #2920 

American Express OPEN . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2926 

American Heart Association . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2918 

Aton Pharma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2726 

COFFEE STATION 

2926 

2924 

2922 

2920 

2918 

2916 

2914 

2912 

2910 

2906 

BG Medicine, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2511 

PRODUCT 

THEATER 

2530 

LAPTOP 

LOUNGE 

2830 

2925 

2826 

COFFEE 

STATION 

2825 

2726 

EMAIL 

STATION 

2923 

2824 

2823 

2724 

2721 

2622 

2426 

2821 

2722 

2719 

2620 

2522 

COFFEE 

STATION 

2818 2917 

2617 

2518 

2815 

2716 

COFFEE 

STATION 

2813 

2714 

2613 

2514 

2812 2911 

2511 

2412 

2626 

2705 

2506 

2406 

ENTRANCE TO 

EXHIBIT HALL 

REGISTRATION 

REGISTRATION 

CME 

Boston Scientific Corporation . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2821 

BTG International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2823 

CardiacAssist, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2925 

Cytokinetics, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2705 

Daxor Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2620 

Elsevier Publishing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2910 

Gambro UF Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2917 

GeneDX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2617 

Gilead Sciences, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2514 

Gilead Sciences, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2613 

Heart Failure Society of America . . . . . . . . . . . . . . . . . . . . . .Booth #2906 

Heart Institute Diagnostic Laboratory . . . . . . . . . . . . . . . . . .Booth #2922 

CLINICAL TRIAL ROW 

HFSA Laptop Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Booth # 2830 

HFSA E-mail Retrieval Stations . . . . . . . . . . . . . . . . . . . . . . .Booth #2522 

HeartWare, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2716 

Home Solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2924 

Infinite Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2825 

Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2506 

WORKSHOP 

LabCorp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2824 

Lippincott Williams & Wilkins - WRH . . . . . . . . . . . . . . . . .Booth #2714 

Medtronic, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2626 

Millar Instruments, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2813 

POSTER SESSIONS 

COFFEE STATION 

Miller Pharmacal Group, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2622 

NeuMeDx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2518 

NitroMed, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2923 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . .Booth #2406 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . .Booth #2426 

Oxford University Press . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2719 

St. Jude Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2818 

Shape Medical Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2911 

SynCardia Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2826 

The Joint Commission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2912 

The Methodist JC Walter Jr Transplant Center . . . . . . . . . . . .Booth #2914 

Thoratec Corporation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2815 

Vasomedical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2722 

Wiley-Blackwell . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2916 

XDx, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2412 

ZOLL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Booth #2812 

150 

151

Clinical Trial Row 

EXHIBITORS 

Amgen Inc. 

B1 

ATOMIC-HF 

Acute Treatment with Omecamtiv Mecarbil to 

Increase Contractility in Acute Heart Failure 

ABIOMED.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2724 

22 Cherry Hill Drive 

Danvers, MA 01923 

Website: www.abiomed.com 

BioControl Medical LTD 

B2 

INOVATE-HF 

INcrease Of VAgal Tone in Heart Failure 

Gambro UF Solutions, Inc. 

B3 

AVOID-HF 

Aquapheresis Versus Intravenous Diuretics and 

Hospitalizations for Heart Failure 

Medtronic CRDM 

B4 

aCRT 

Adaptive Cardiac Resynchronization Therapy Study 

B5 

BLOCK HF 

Biventricular Versus Right Ventricular Pacing in 

Heart Failure Patients with Atrioventricular Block 

B6 

PainFree SST 

Study to Evaluate System Safety and Clinical 

Performances of the Protecta ICD Plus CRT- 

Defibrillator 

Medtronic CRDM (University of Calgary) 

B7 

REFINE-ICD 

Efficacy of Implantable Defibrillator Therapy After 

a Myocardial Infarction 

Medtronic CRDM 

B8 

Medtronic Product Performance Platform 

B9 

Medtronic Feasibility Research Program 

Pfizer 

B10 

THAOS 

Transthyretin-Associated Amyloidosis Outcomes 

Survey 

Abiomed, Inc. is a leading provider of breakthrough heart support 

technologies enabling safer revascularization, heart muscle recovery 

and cost-effective patient care. 

Alere.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2721 

2 Research Way 

Princeton, NJ 08540 

Website: www.alere.com 

Alere enables individuals to take charge of improving their health and 

quality of life by developing new capabilities in near-patient diagnosis 

and monitoring. Alere offers a suite of leading CLIA waived and 

moderately complex near-patient tests, including the Triage® MeterPro, 

which test quantitative BNP, CK-MB, D-Dimer, Myoglobin, Troponin I. 

American Association of Heart Failure Nurses.. . . . . . . . . . . . . 2920 

15000 Commerce Parkway 

Suite C 

Mount Laurel, NJ 08054 

Website: www.aahfn.org 

The American Association of Heart Failure Nurses (AAHFN) is a 

specialty organization dedicated to advancing nursing education, 

clinical practice and research to improve heart failure patient 

outcomes. We serve as the interface for sharing ideas, translating 

research findings into practice and setting priorities for the future. 

American Express OPEN .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2926 

200 Vessey St 

New York, NY 10281 

Website: www.AmericanExpress.com/OPEN 

American Express OPEN consists of small business cash flow 

management tools along with products focusing on small business 

purchasing needs which assist business owners with managing their 

bottom line. Our award winning line of charge cards provide travel 

benefits, purchasing power, management tools, warranties, insurances, 

assurances, and protections. 

152 

153

EXHIBITORS 

EXHIBITORS 

American Heart Association.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2918 

7272 Greenville Avenue 

Dallas, TX 75231 

Website: www.heart.org/quality 

The American Heart Association/American Stroke Association offers 

a complete portfolio of quality improvement programs dedicated to 

bettering patient care through guideline adherence. The programs 

address improving quality of patient care for patients of heart disease 

and stroke from primary prevention all the way through outpatient care. 

BTG International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2823 

300 Barr Harbor Drive, Suite 800 

West Consho Hocken, PA 19428 

Website: www.btgplc.com 

BTG is an international specialist healthcare company, developing 

and commercializing products targeting critical care, cancer and other 

disorders. BTG’s products, CroFab® Crotalidae Polyvalent Immune 

Fab (Ovine) and DigiFab® Digoxin Immune Fab (Ovine) are FDAapproved 

and marketed in the United States. 

Aton Pharma.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2726 

7545 Irvine Center Drive 

Suite 100 

Irvine, CA 92618 

Website: www.valeant.com 

Aton Pharma, Inc., a division of Valeant Pharmaceuticals North 

America, is a specialty pharmaceutical company that is committed to 

improving medical outcomes and enhancing quality of life for patients 

worldwide by facilitating and expanding the availability of medically 

essential products and therapies, and ensuring accessibility to these 

vital treatments. 

BG Medicine, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2511 

610 N. Lincoln Street 

Waltham, MA 02451 

Website: www.bg-medicine.com 

BG Medicine (NASDAQ:BGMD) is a life sciences company focused 

on the discovery, development, and commercialization of novel 

diagnostics to improve patient outcomes and contain healthcare 

costs. BG Medicine’s galectin-3 blood test identifies patients with 

an inherently progressive form of heart failure resulting from 

fibrogenesis. 

Boston Scientific Corporation. . . . . . . . . . . . . . . . . . . . . . . . . . . 2821 

4100 Hamline Avenue North 


Website: www.bostonscientific.com 

Boston Scientific is a worldwide developer, manufacturer, and 

marketer of medical devices whose products are used in a broad 

range of interventional medical specialties. With approximately 

25,000 employees and annual revenue of more than $8 billion, Boston 

Scientific is the world’s largest medical device company dedicated to 

less-invasive therapies. 

CardiacAssist, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2925 

240 Alpha Drive 

Pittsburgh, PA 15238 

Website: www.cardiacassist.com 

CardiacAssist’s Tandem Heart® System delivers extracorporeal 

circulatory support. System can provide up to 5.0 L/min of circulatory 

support when deployed percutaneously and up to 8.0 L/min of support 

with direct surgical cannulation. 

Cytokinetics, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2705 

280 E Grand Ave 

South San Francisco, CA 94080 

Website: www.cytokinetics.com 

Cytokinetics, Inc. is a biopharmaceutical company focused on 

the discovery, development and commercialization of novel small 

molecule drugs that specifically target the cytoskeleton. Cytokinetics’ 

heart failure program is focused towards small molecule activators 

of cardiac myosin, the cytoskeletal motor protein in cardiac muscle 

responsible for cardiac contraction. 

Daxor Corporation .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2620 

350 Fifth Avenue 

Suite 7120 

New York, NY 10118 

Website: www.daxor.com 

Daxor Corporation’s BVA-100® Blood Volume Analyzer is a 

semi-automated instrument patented for direct measurement of 

blood volume, red cell and plasma volume. The system utilizes 

the Volumex® injection kit for a multi-sample blood volume. 

Measurement of blood volume is applicable for hypertension, CHF, 

transfusion, ICU/CCU, anemia, orthostatic hypotension and syncope. 

154 

155

Elsevier Publishing .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2910 

1600 JFK Blvd., Suite 1800 

Philadelphia, PA 19103 

Website: www.elsevier.com 

EXHIBITORS 

ELSEVIER, proud publisher of the Journal of Cardiac Failure, 

official journal of the HFSA. Come view the latest issue of the Journal 

and browse our books such as the NEW Braunwald’s Textbook of 

Heart Disease, Mann’s Heart Failure Textbook, Heart Failure Clinics, 

and many other new and exciting periodicals and online solutions in 

the field of cardiology. 

Gilead Sciences, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2613 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

EXHIBITORS 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes innovative therapeutics in areas of 

unmet medical need. The company’s mission is to advance the 

care of patients suffering from life-threatening diseases worldwide. 

Headquartered in Foster City, California, Gilead has operations in 

North America, Europe and Australia. 

Gambro UF Solutions .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2917 

7601 Northland Drive 

Suite 170 

Brooklyn Park, MN 55428 

Website: www.gambro.com 

Gambro UF Solutions offers a proven way to manage patients 

suffering from fluid overload. Aquapheresis therapy with the Aquadex 

FlexFlow is evidence-based, guideline recommended, and guaranteed. 

Visit www.Gambro.com for more information. 

Heart Failure Society of America.. . . . . . . . . . . . . . . . . . . . . . . . 2906 

Court International, Suite 240 South 



Website: www.hfsa.org 

The Society welcomes you to our 15th Annual Scientific Meeting. We 

hope you enjoy your stay in Boston and look forward to seeing you 

at the 16th Annual Scientific Meeting, September 9-12, 2012, Seattle, 

WA. Please visit our booth for more information about the Society. 

GeneDx.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2617 

207 Perry Parkway 

Gaithersburg, MD 20877 

Website: www.GeneDx.com 

GeneDx offers testing for more than 350 rare Mendelian disorders, 

using DNA sequencing and deletion/duplication analysis of the 

associated gene(s). GeneDx also offers genetic testing services for 

inherited cardiac disorders such as Hypertrophic cardiomyopathy, 

Dilated cardiomyopathy and Arrhythmias. Our services include 

mutation analysis, carrier testing, prenatal diagnosis, and mutation 

confirmations. 

Heart Institute Diagnostic Laboratory. . . . . . . . . . . . . . . . . . . . 2922 

Cincinnati Children’s Hospital Medical Center 

3333 Burnet Avenue 

Cincinnati, OH 45227 

Website: www.cincinnatichildrens.org 

The Heart Institute Diagnostic Lab at Cincinnati Children’s Hospital 

Medical Center specializes in sequencing of genes associated with 

cardiovascular disease and molecular analysis of viruses known 

to cause myocarditis. The lab draws upon the expert analysis and 

consultation services of the Heart Institute’s cardiologists, cardiacfocused 

geneticists and dedicated genetic counselors. 

Gilead Sciences, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2514 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes innovative therapeutics in areas of 

unmet medical need. The company’s mission is to advance the 

care of patients suffering from life-threatening diseases worldwide. 

Headquartered in Foster City, California, Gilead has operations in 

North America, Europe and Australia. 

HFSA Laptop Lounge.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2830 

HFSA E-mail Retrieval Stations.. . . . . . . . . . . . . . . . . . . . . . . . . 2522 

During exhibit hours, this booth will have computers available for 

attendees to retrieve their e-mail. 

156 

157

HeartWare, Inc .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2716 

205 Newbury Street 

Framingham, MA 01701 

Website: www.heartware.com 

HeartWare, Inc. is developing a family of implantable mechanical 

circulatory support systems for the treatment of advanced heart 

failure. HeartWare’s lead device, the HeartWare® Ventricular Assist 

System, incorporates state-of-the-art peripherals and features the 

only full-output pump designed to be implanted less invasively in the 

pericardial space. The HeartWare® System is commercially available 

in Europe and is the subject of a 150-patient US IDE trial. 

Home Solutions .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2924 

1601 New Road, #100 

Northfield, NJ 08225 

Website: www.infusioncare.com 

EXHIBITORS 

Home Solutions is one of the largest independent home infusion 

providers in the country that specializes in cardiac therapies. With full 

service locations in the Northeast and Mid-Atlantic regions, Home 

Solutions recently launched InfuLink®, a patient driven/clinician 

focused web-monitoring tool dedicated to sharing vital information 

about a patient’s care while receiving service. 

Infinite Therapeutics.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2825 

68 Route 125 

Kingston, NH 03848 

Website: www.infinitetherapeutics.com 

The cardiovascular benefits of Massage Therapy & Inversion Massage 

Therapy have been well documented in the medical community 

of years. The ADA / American Diabetes Association are a strong 

proponent of massage therapy for the significant cardiovascular 

circulation benefits it yields. Many practitioners today are prescribing 

massage therapy strictly for the cardiovascular benefits. 

Janssen Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . 2506 

1000 Route 202 

Raritan, NJ 08869 

Website: www.janssenpharmaceuticalsinc.com 

Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & 

Johnson, provides medicines for an array of health concerns in several 

therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), 

general medicine (acid reflux disease, infectious diseases), mental health 

(bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, 

migraine prevention and treatment), pain management, and women’s health. 

158 

LabCorp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2824 

531 S. Spring Street, 3rd Floor 

Burlington, NC 27523 

LabCorp provides leading-edge tests and services through a national 

network of primary clinical and specialized laboratories to support 

cardiovascular disease prevention, diagnosis and management. 

Services include traditional lipids; lipoproteins; markers of 

inflammation, acute ischemia and heart failure; genetic tests for 

inherited diseases and conditions; genetic counseling and ambulatory 

electrocardiography. 

Lippincott Williams & Wilkins – WRH.. . . . . . . . . . . . . . . . . . . 2714 

Two Commerce Square 

2001 Market Street 

Philadelphia, PA 19103 

Website: www.wolterskluwer.com 

Lippincott Williams & Wilkins, a Wolters Kluwer Health company 

is a leading international publisher of medical books, journals, and 

electronic media. We proudly offer specialized publications and 

software for physicians, nurses, students and clinicians. Please visit 

our booth to browse our comprehensive product line. 

Medtronic, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2626 

710 Medtronic Parkway 

Minneapolis, MN 55432 

Website: www.medtronic.com 

At Medtronic (www.medtronic.com), we’re committed to Innovating 

for life by pushing the boundaries of medical technology and actually 

changing the way the world treats and manages heart failure. Visit 

booth #2626 to see how our newest products and therapies are solving 

unmet needs by diagnosing, monitoring, and treating patients. 

Millar Instruments, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2813 

6001-A Gulf Freeway 

Houston, TX 77023 

Website: www.millar.com 

EXHIBITORS 

Millar manufactures a complete line of Mikro-Tip pressure and 

pressure-volume catheters for evaluation of cardiac function. Our 

catheters range from 8F down to 1F, with single to multiple sensors. 

Additionally, Millar offers the Mikro-Cath disposable pressure 

catheter. This single-use, sterile catheter delivers a high-fidelity signal 

for everyday cath lab use. 

159

Miller Pharmacal Group, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . 2622 

350 Randy Road, Suite 2 

Carol Stream, IL 60188 

Website: www.millerpharmacal.com 

“MG PLUS PROTEIN” (TM) supplies 133 mg of elemental 

magnesium in an easy to swallow tablet. It is well-tolerated and does 

not cause the GI disturbances common with magnesium oxide, even in 

high doses commonly required for patients on tacrolimus or diuretics. 

“MG PLUS PROTEIN”, inexpensive and well-tolerated. 

NeuMeDx.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2518 

2014 Ford Road, Unit G 

Bristol, PA 19007 

Website: www.neumedx.com 

NeuMeDx presents the PhysioFlow NICO monitor; beneficial in 

assisting clinicians in optimizing stroke volume, usage for EGDT and 

fluid management. It is noninvasive, user independent and can receive 

data in less than five minutes. Used everywhere from the ER to the 

ICU for the critically ill or in your office! 

NitroMed, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2923 

6000 Fairview Road 

Suite 610 

Charlotte, NC 28210 

Website: www.nitromed.com 

BiDil is a fixed dose combination of hydralazine and isosorbide 

dinitrate that’s approved for use in self proclaimed black patients 

with heart failure. It’s been shown to reduce mortality by 43% and 

risk of first hospitalization by 39% when added onto standard of care 

including ACE inhibitors and beta blockers. 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . 2406 

1 University Square Drive 

Suite 500 


Website: www.otsuka-us.com 

EXHIBITORS 

Otsuka is hard at work investigating potential new treatments, with 

numerous compounds in various stages of development to treat 

disorders of the cardiovascular, gastrointestinal, respiratory, renal, and 

central nervous systems, and to treat cancer and ophthalmic disorders. 

Our goal is to create new products for better health worldwide. For 

information, please visit www.otsuka-us.com. 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . 2426 

1 University Square Drive 

Suite 500 


Website: www.otsuka-us.com 

Otsuka is hard at work investigating potential new treatments, with 

numerous compounds in various stages of development to treat 

disorders of the cardiovascular, gastrointestinal, respiratory, renal, and 

central nervous systems, and to treat cancer and ophthalmic disorders. 

Our goal is to create new products for better health worldwide. For 

information, please visit www.otsuka-us.com. 

Oxford University Press .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2719 

2001 Evans Road 

Cary, NC 27513 

Website: www.oup.com 

Oxford University Press publishes some of the most respected medical 

and scientific books and journals in the world, including The ESC 

Textbook of Cardiovascular Medicine, and European Journal of Heart 

Failure, the official international journal of the European Society of 

Cardiology. Visit www.oup.com for more information. 

St. Jude Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2818 

6400 Bee Cave Road 

Bldg 2, Suite 100 

Austin, TX 78746 

Website: www.sjm.com 

EXHIBITORS 

St. Jude Medical develops medical technology designed to put more 

control into the hands of those who treat cardiac, neurological and 

chronic pain patients worldwide. The company is dedicated to advancing 

the practice of medicine by reducing risk wherever possible and 

contributing to successful patient outcomes. Learn more at sjm.com. 

Shape Medical Systems, Inc. .. . . . . . . . . . . . . . . . . . . . . . . . . . . 2911 

5000 Township Parkway 


Website: www.shapemedsystems.com 

Shape Medical Systems provides predictive modeling to improve 

the detection and therapeutic outcome assessment of heart and lung 

disease. Technology assesses cardiopulmonary function, defines the 

probable source of heart or lung limitations, quantifies prognosis, 

predicts future risk, provides recommendations regarding future 

treatment and monitors the ongoing clinical response to therapy. 

160 

161

SynCardia Systems, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2826 

1992 E. Silverlake Rd. 

Tucson, AZ 85713 

Website: www.syncardia.com 

EXHIBITORS 

The SynCardia temporary Total Artificial Heart (TAH-t) is the world’s 

only FDA, Health Canada and CE approved Total Artificial Heart. It 

is approved as a bridge to transplant for patients dying from end-stage 

biventricular failure. Visit our booth for updates on the Freedom 

portable driver and more. 

The Joint Commission.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2912 

One Renaissance Blvd 

Oakbrook Terrace, IL 60181 

Website: www.jointcommission.org 

The Joint Commission’s advanced certification for heart failure uses 

Get With The Guidelines heart failure measures as the clinical practice 

requirement. Advanced certification for heart failure provides a 

comprehensive evaluation of this patient population. Certification of 

your heart failure program demonstrates excellence in fostering better 

outcomes. 

Vasomedical.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2722 

180 Linden Avenue 

Westbury, NY 11590 

Website: www.vasomedical.com 

Vasomedical EECP® therapy systems are the only non-invasive 

external counterpulsation therapy devices proven safe and effective 

in angina and heart failure clinical trials published in peer reviewed 

medical journals. EECP® therapy is FDA cleared and Medicare 

approved. Vasomedical also features Holter monitors (including the 

unique combined 3-channel ECG Holter and ABP recorder) and EZ 

patient management products. 

Wiley-Blackwell.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2916 

350 Main Street 

Malden, MA 02148 

Website: www.wiley.com 

EXHIBITORS 

Wiley-Blackwell is the international scientific, technical, medical and 

scholarly publishing business of John Wiley & Sons, with strengths 

in every major academic and professional field and partnerships with 

many of the world’s leading societies. 

The Methodist JC Walter Jr Transplant Center.. . . . . . . . . . . . 2914 

6550 Fannin, Suite 1200 

Houston, TX 77030 

Website: www.tmhs.org 

Since 1963 Methodist has been a pioneer in thoracic transplantation 

and assist devices. In 2010, we completed 362 total transplants, 

making Methodist the largest transplant center in Texas and the 

region. Methodist is number one in the nation for combined heart/lung 

transplants and became the first center in Texas to offer total artificial 

heart procedures. 

Thoratec Corporation.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2815 

6035 Stoneridge Drive 

Pleasanton, CA 94588 

Website: www.thoratec.com 

Thoratec Corporation is a world leader in therapies to address 

advanced-stage heart failure. The company’s products include the 

HeartMate® LVAS and Thoratec® VAD (Ventricular Assist Device) 

with more than 18,000 devices implanted in patients suffering from 

heart failure. For more information, visit the company’s web site at 

http://www.thoratec.com. 

XDx, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2412 

3260 Bayshore Blvd. 

Brisbane, CA 94005 

Website: www.xdx.com 

XDx is a molecular diagnostics company focused on the discovery, 

development and commercialization of gene expression testing in the 

areas of transplant medicine and autoimmunity. XDx has one marketed 

product, AlloMap® Molecular Expression Testing, a non-invasive gene 

expression test that aids in the management of heart transplant patients. 

ZOLL .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2812 

121 Gamma Road 

Pittsburgh, PA 15238 

Website: www.zoll.com 

The ZOLL® LifeVest® wearable defibrillator protects patients at 

risk of sudden cardiac arrest, during a patient’s changing condition 

and when permanent SCA risk has not been established. The LifeVest 

provides patients constant monitoring, immediate protection, and 

peace of mind. 

162 163

AUTHOR INDEX 

15th Annual Scientific Meeting 


“P” preceding number indicates a poster 

Aaronson, Keith D. 33 

Aban, Inmaculada 

P205 

Abdellatif, Maha 42 

Abouezzeddine, Omar F. 

P236, P265 

Abraham, William T. 

36, 97, P126, P132, P299 

Abreu, Rosiane S.F. 

P343 

Acker, Michael A. 

P157 

Adams, Jr., Kirkwood F. 96, 139 

Adams, Volker 

P020 

Adamson, Philip B. 

P299 

Adamson, Robert M. 

P119, P147 

Adelstein, Evan 

P178 

Adourian, Aram S. 

45, P294, P297 

Agarwal, Sunil Kumar 

P178 

Aggarwal, Sanjeev 

P330 

Aguilar, David 

P293 

Ahmed, Ali 

P205 

Ahmed, Mohamed 

P161, P310 

Ahmed, Mubashir 

P160 

Ahmet, Ismayil 

P202 

Ahn, Sylvie A. 

101, P078, P079, P255 

Aizawa, Yoshifusa 

P037 

Akashi, Hirokazu 

55, P130 

Al-Khatib, Sana M. 49 

Alberghini, Todd 

P141 

Albert, Nancy M. 

102, 144, P319 

Aleong, Ryan G. 

P168 

Alexis, Jeffrey D. 

P349 

Alhaj, Eyad 

P052 

Alharethi, R. 

P256 

Alharethi, Rami 44, P060, P155, P235, P249, 

P261, P274 

Ali, Shah R. 

P099 

Allen, Larry A. 30, 48 

Allman, Richard 

P205 

Allsup, K. 

P024, P046, P055 

Almond, Christopher S. 

44, P229 

Alves, Suzana A. 

P281 

Amedeo, Ellen 

P264, P354 

Ameenuddin, Syed 

45, P068 

Amin, Alpesh 

P228, P243 

Ammon, Susan E. 104 

Anand, Inder S. 109, 140 

Anderson, Jeffrey L. 

P106 

164 

AUTHOR INDEX 

Anderson, Mark E. 51 

Anderson, Shawn 

P334 

Ando, Miyuki 

P154 

Andrade, Wolney 

P102 

Andriulli, John 

P162, P301 

Andriulli, John A. 

P163 

Anjan, Venkatesh 

P298 

Anker, Stefan D. 

49, 91, 140, P020, P029 

Anna, Kiran 

P215 

Anne, Cotleur 

P087 

Anstrom, Kevin J. 52 

Anversa, Piero 

56, 92, P050, P173 

Anyanwu, Anelechi C. 

44, P122, P127 

Aoyagi, Toshinori 56 

Arabia, Francisco A. 

P128 

Aradhya, Mahesh 

P264, P354 

Arai, Sally 

P145 

Aranda, Juan 

P334 

Ardehali, Reza 

P099 

Arena, R. 

P024, P046, P055 

Arenja, N. 

P069 

Armstrong, Hilary F. 

P195 

Armstrong, Paul W. 52 

Arnce, Sarah 

P206 

Arnold, J. Malcolm O. 48 

Arnold, Malcolm 

P353 

Arnold, Roman 

P341 

Arora, Tarun 

P205 

Arthur, Heather M. 

P257 

Ashley, Kimberly 

44, P122, P127 

Asif, Aya 

P181, P189, P317 

Asirvatham, Samuel J. 

P248 

Asosingh, Kewal 

P087 

Ather, Sameer 

P101, P293 

Atherton, John J. 

P230 

Athilingam, Ponrathi R. 

P034, P091 

Atluri, Pavan 

P157 

Atluri, Tej K. 

P222 

Attig, Stacie M. 

P128 

Aukrust, Pal 

45, P294 

Aung, May 

P051 

Austin, Bethany A. 

P330 

Awad, Adiveh 

P077 

Ayalon, Nir 

P095 

Ayalon, Rivka 

P095 

Azad, Nahid 

P291 

Bachtel, Carol S. 

P128 

Bader, Feras 

P060, P155 

Bahl, Joseph J. 

P120, P206 

165

AUTHOR INDEX 

Bai, Yingnan A. 

P173 

Bair, T. 

P256 

Balla, Cristina 56 

Balling, Kyle D. 

44, P235 

Balshaw, Robert 

P137 

Bang, Claudia 

P020 

Bank, Alan J. 

P170 

Baradarian, Sam 

P119, P147 

Barajas, Justine 

P303 

Barajas, Linda 

P303 

Barker, Diane 

P023 

Barn, Kulpreet 

P160 

Barnard, Denise 

45, P289 

Barnard, Denise D. 138 

Barrett-Connor, Elizabeth 

P074 

Barrios, Roberto 

P111 

Barros, Luciana N. 

P343 

Bart, Bradley A. 47 

Bartels, Matthew 

P195 

Basraon, Jagroop 

P121 

Batizy, Lillian 

P175 

Battiprolua, Pavan K. 56 

Baumann, Matthew 

P292 

Baumer, Dorothy 

P228, P243 

Baumgarten, Anna 

P020 

Bayne, David B. 

P061 

Beanlands, Rob 

P051 

Beanlands, Rob A. 

P110 

Beck, Kenneth C. 

P340 

Belardinelli, Luiz 

P208 

Belk, Kathy 

P228, P243 

Bellavia, Diego 

45, P067 

Bennett, Alexandra A. 

P300 

Bennett-Gittens, Raquel L. 

P187 

Benton, Casey R. 

P127 

Benza, Raymond 

P279 

Berkowitz, Robert 

P052 

Bers, Donald M. 98 

Bhardwaj, Anju 

P303 

Bhat, Geetha 

P150 

Bhat, Pradeep K. 

P258 

Bhatia, Vivek 

P125 

Bianco, Nicole R. 

P166, P176, P330 

Binns, Oliver A. 

P143 

Biolo, Andreia 

P095 

Birks, Emma J. 40 

Blackburn, Beth 

P214, P227 

Blackwell, Minnie P. 

P308 

Blaxall, Burns C. 56 

166 

AUTHOR INDEX 

Blecker, Saul 

P217 

Blomdhaim, David 

P317 

Blomqvist, Andreas 

P179 

Blondheim, David 

P181 

Blonheim, David 

P189 

Bloom, H. 

P039 

Boehmer, John P. 

35, P140, P247, P340 

Boerrigter, Guido 

P027, P070, P200, P204 

Boilson, Barry A. 

P116 

Bokhari, Sabahat 

P327 

Bolli, Roberto 105 

Bolwell, Gregory J. 

P292 

Bonde, Pramod 

P136 

Bonnet, Nancy L. 

P159 

Bonow, Robert O. 

P298 

Borges-Neto, S. 

P263 

Borges-Neto, Salvador 

P251 

Borlaug, Barry A. 

145, P184 

Bornzin, Gene A. 

P036, P152, P153 

Borojevic, Radovan 

P281 

Borowski, Allen G. 101, P019, P076, P083, P085, 

P088, P089, P090, P098 

Bourgoun, Mikhail 

P183 

Bove, Alfred A. 

P348 

Bozkurt, Biykem 

P101, P293 

Bradham, William S. 

P336 

Branch, Ashley C. 

P167 

Brasch, Judy 

P276 

Braunwald, Eugene 

52, 143, P081 

Breidthardt, T. 

P069 

Brennan, Simarta 

P295 

Breuer, Kimberly 

P157 

Bridges, Charles R. 

P144 

Brieke, Andreas 

P113 

Briggs, Patricia E. 

P253 

Brinker, Eileen 

P331 

Brinkley, Douglas M. 

P239 

Bristow, Michael R. 

51, P113 

Britt, Jr., Earl B. 

P072, P097 

Britton, Nancy 

P030 

Brook, Robert D. 55 

Brooke, Kelly L. 

P169, P248 

Brown, Jason 

P332 

Brown, Patricia 

P103 

Brozovich, Frank C. 55 

Bruce, Keith 

P332 

Bruck, S. 

P129 

Bruckner, Brian 

P186 

Bruhl, Steven 

P063 

167

AUTHOR INDEX 

Bruhl, Steven R. 

P045 

Brunisholz, K. 

P256 

Brunisholz, Kim 

P249, P261, P274 

Brunisholz, Kimberly D. 

44, P106, P235 

Buchhalter, Lillian C. 

102, P171 

Buck, Harleah G. 

144, P192 

Budge, D. 

P256 

Budge, Deborah 44, P060, P155, P235, P249, 

P261, P274 

Bufe, Alexander 

P070 

Bugatti, Silvia 

P267 

Buhler, Katrin 

101, P084 

Bull, David A. 

P186 

Burgess, Pamela R. 

P017 

Burke, Michael A. 

P298 

Burnett, John C. 

P040, P067 

Burnett, Jr., John C. 45, 47, 52, 55, P027, P038, 

P057, P068, P070, P104, P116, 

P200, P204 

Burns, Kevin V. 

P170 

Burwash, Ian 

P051 

Bustami, Rami 

P295 

Butler, Javed 

30, P187 

Buxton, Alfred E. 41 

Byrne, Howard 

P206 

Califf, Robert M. 52 

Calvin, Andrew D. 

P059 

Camandaroba, Paulo J.P. 

P343 

Campbell, Patricia 

P115, P183 

Campos, Eugenio P. 

P343 

Cannone, Valentina 

P027 

Canter, Charles E. 

44, P229 

Cao, Dian J. 56 

Cao, Yan 

P223 

Cappetta, Francesco 

56, P050, P173 

Cappola, Thomas P. 

44, P066, P314 

Carlquist, John 

P106, P274 

Carlson, Marj 

P107 

Carroll, Maureen 

P331 

Carson, Peter E. 48 

Carubelli, Valentina 

P267 

Castriani, Anna Isotta 

P315 

Cataliotti, Alessandro 45, P027, P038, P040, P067, 

P200 

Cauthen, Clay A. 

P165, P172, P278 

Cavalcanti, Ana C.D. 

P343 

Cevasco, Megan E. 

P207 

Cevik, Cihan 

P148 

Cha, Myung-jin 

P226 

168 

AUTHOR INDEX 

Cha, Yong-Mei 

P169, P248 

Chacko, Billy G. 

P222 

Chai, Qiang 

P041 

Chamberlain, Lyne 

P347 

Chambers, Susan V. 

P031 

Chammas, Joseph 

P119, P147 

Champsaur, Gerard L. 

P143 

Chan, Cynthia Y. 

P212 

Chan, Michael 

P353 

Chan, Wandy 

P179 

Chan, Wenyaw 

P293 

Chandra, Ramesh 

P237 

Chandy, George 

P051 

Chang, Patricia 

P217 

Channah, Soheni 

P028 

Chaparro, Sandra 

P158 

Chareonthaitawee, Panithaya 

P169 

Charles, Chris 

P318 

Charonko, John J. 

P017 

Cheema, Faisal 

55, P151 

Cheema, Faisal H. 

P130, P149 

Chen, Ding-Geng 

P276 

Chen, Horng H. 45, 109, P038, P040, P057, 

P058, P068, P116 

Chen, Jennifer 

P314 

Chen, Leway 

P091, P276, P349 

Chen, Virginia 

P137 

Cheng, Che Ping 

P199 

Cheng, Heng-Jie 

P199 

Cheng, Richard K. 

P254, P269, P273 

Chermont, Sergio 

P102 

Chernin, Gil 

P345 

Cheung, Anson 

P146 

Cheung, Rebecca 

P252 

Chew, Michael 55 

Chia, Shaw Yang 

P218 

Chilcott, Suzanne 

P147 

Chin, John 87 

Chinnappa, Shanmugakumar 

P023, P054 

Chiong, Jun 

P252, P322 

Chiswell, K. 

P193, P245, P280 

Cho, Hyun-Jai 

P226 

Choi, Heejung 

P329 

Choi, Jin-Oh 

P071, P209, P324, P329 

Chokshi, Aalap 

55, P117, P130, P151, P195 

Chopra, Deepak 37 

Chou, Josephine C. 

102, P139 

Chruscinski, Andrzej 

P123 

Chung, Misook L. 

P262 

169

AUTHOR INDEX 

Clark, Adrienne L. 

P277 

Clark, Robyn A. 

102, P288, P321 

Clark, William 

P134 

Cleeland, Charles 

P316 

Cleeton, Timothy 

P334 

Cleland, J. 

P193, P245 

Cleland, John G.F. 

102, P288, P321 

Clopton, Paul 

55, P074, P185, P219, P302 

Coca, Steven G. 

P314 

Cochrane Heart Group 

P321 

Cohen Freue, Gabriela 

P137 

Cohn, Jay 

P107 

Cohn, Jay N. 52, 103 

Colecraft, Henry M. 98 

Collado, J. Elias 

P195 

Collins, Sean 

P272 

Colombo, Paolo C. 

P124 

Colucci, Wilson S. 

89, 107, P095 

Condorelli, Gianluigi 42 

Connollly, Jenny 

P274 

Connolly, J. 

P256 

Connolly, Jenny 

P249, P261 

Contarato, Luiza 

P102 

Cooper, Christopher 

P216 

Cooper, Leslie T. 

P190 

Corcoran, Kevin M. 

P299 

Cordero-Reyes, Andrea 56 

Cordero-Reyes, Andrea M. 

P111, P112 

Costantini, Ottorino 

P258 

Costanza, Maria Rosa 

P132 

Costanzo, Maria Rosa 

33, 86, P299 

Costello, Catherine E. 107 

Costello, Elizabeth C. 

P070, P200 

Cotter, G. 

P193, P245 

Cowart, Pam A. 

P299 

Cowger, Jennifer 141 

Cowger, Jennifer A. 

44, P118 

Cox, Scott 

P030 

Cox, Zachary 

P306, P350 

Cox, Zachary L. 

P296 

Coyle, Laura A. 33 

Cristian, Maiandi 

P315 

Crook, Martin 

P103 

Crozier, Ian 

P179 

Cui, Hongying 

P188, P191, P194 

Cuminetti, Giovanni 

P267, P315 

Cunningham, Brittany L. 

P296 

Curl, Kevin 

P313 

Dahan, Iris 

P181, P189, P317 

170 

AUTHOR INDEX 

Dalal, Nirav 

P036, P152, P153 

Dallesandro, David 

P125 

Daly, Richard 

P116 

D’Amario, Domenico 

P173 

Damp, Julie B. 

P336 

Dandamudi, Sanjay 

P058 

Daniels, Lori 55 

Daniels, Lori B. 

P074 

DaSilva, Jean 

P051, P110 

Daubert, James P. 41, 97 

Davidson, Patricia M. 

P300 

Davies, Ross A. 

P051 

Davila, Carlos 

P355 

Davis, Margot K. 

P146 

Davis, S. 

P024, P046 

Davison, B. 

P193, P245 

Day, John D. 

P140, P247 

de Almeida, Angela C. 

P042 

de Boer, Rudolf A. 

45, P294, P297 

de Couto, Geoffrey 

P016 

de la Fuente Galan, Luis 

P341 

De Marco, Teresa 108 

Deedwania, Prakash C. 48 

deFilippi, Christopher 

P297 

Dei Cas, Livio 

P267 

Deitelzweig, Steven 

P228, P243 

deKemp, Rob J. 

P051 

deKemp, Robert J. 

P110 

Dekleva, Milica 

P326 

del Monte, Federica 

56, 98, P173 

del Rio, Carlos L. 

P126 

Delgado, Reynolds M. 

P160 

Dember, Laura M. 

P095 

Dembitsky, Walter P. 

P119, P147 

Demmer, Ryan T. 

P124 

DeNofrio, David 48 

Desai, Akshay 

P323 

Desai, Akshay M. 30, 94, 144 

Desvigne-Nickens, Patrice 52 

Deswal, Anita 

P293 

Dev, Sandesh 

P308 

DeValeria, Patrick A. 

P128 

Dhaliwal, Amandeep 

P293 

Dharmarajan, Kumar 

101, P221 

Di Carli, Marcelo F. 

P115 

Dickey, Amy 

P080 

Dickson, Victoria V. 39, 54 

Dickstein, Kenneth 52 

DiSalvo, Thomas 

P296, P306 

171

AUTHOR INDEX 

DiSomma, Salvatore 

P082 

Dispenzieri, Angela 

P304 

Dittrich, H. 

P193 

Dittrich, H.C. 

P245 

Doering, Lynn V. 39 

Dohmann, Hans F. 

P281 

Domanski, Michael J. 

44, P122, P127 

Dorn, II, Gerald W. 32 

Douglas, Sawyer 

P080 

Dowling, R. 

P129 

Downing, Jill 

P095 

Dowsley, Taylor F. 

P061 

Dracup, Kathleen 54 

Drakos, Stavros 

P155 

Drakos, Stavros G. 

P060 

Draper, Jr., Timothy S. 

P062 

Drazner, Mark H. 30 

Drew, Laura A. 52 

Drexler, B. 

P069 

Drukker, Micha 

P099 

Dudley, Samuel C. 109 

Dumitru, Ioana 

P061, P135 

Dunbar, Sandra B. 

54, P333 

Dunlap, Mark 

P282 

Dunlap, Mark E. 

P207, P215, P250 

Dupont, Matthias 

P072, P077, P096 

Dupree, Carla 

P217 

Duprez, Daniel A. 

P107 

Durand, Jean-Bernard 142 

Dweik, Raed A. 55 

Dyo, Melissa 

P335 

East, Cara 

P186 

Eckman, Peter 

P121 

Eckman, Peter M. 

P156 

Edwards, Brooks S. 

P116 

Edwards, Pauline 

P125 

Eigler, Neal 

P318 

El Nahas, Meguid 

P054 

El Shahawy, Mahfouz 

P220 

Elayda, MacArthur A. 

P160 

Elkayam, Uri 

P093, P190, P212 

Ellenbogen, Kenneth A. 30 

Elliot, Tonya 100 

Ellis, Stephen J. 

P259 

Ely, Stephen W. 

P143 

Endo, Yutaka 

P211 

Entcheva, Miglena 

P220 

Epstein, Andrew E. 97 

Epstein, Jonathan A. 32 

172 

AUTHOR INDEX 

Erdmann, Erland 52 

Erzurum, Serpil C. 

P087, P098 

Escarce, Jose 

P273 

Estep, Jerry D. 

56, P111, P112 

Estrella-Holder, Estrellita 

P257 

Ezekowitz, Justin A. 55, 139 

Ezekowitz, Michael D. 104 

Fadol, Anecita P. 

P316 

Fajadet, Jean 

101, P138 

Fakorede, Foluso 

P313 

Falk, Rodney 

101, P180, P221 

Fallahi, Arzhang 

P268 

Fan, M.T. 

P039 

Fang, James C. 

44, 94, 102, 145, P066, P139 

Farber, John L. 

P064 

Fard, Arrash 

P219 

Fargnoli, Anthony S. 

P144 

Farr, MaryJane 

P130, P149 

Fearon-Clarke, Jacqueline 

P295, P338 

Fedewa, Michelle M. 

P260, P332 

Fedorowski, Artur 

P092 

Fedson, Savitri 

P180 

Feldman, Arthur M. 101 

Felker, G. Michael 

46, P308, P081 

Felker, G.M. 

P022 

Felker, Mike 

P187 

Fermann, Greg 

P272 

Fermin, David R. 

P116 

Ferrari, Roberto 52 

Ferreira-Martins, Joao 

56, P050, P173 

Fett, James D. 

P190 

Fields, Anjali V. 

P031 

Fiessinger, Lori 

P311 

Filippatos, Gerasimos 52 

Fiorini, Claudia 

56, P050, P173 

Firek, Anthony 54 

Firek, Chistopher J. 54 

Fiuzat, M. 

P193, P245, P263, P280 

Fiuzat, Mona 

P251 

Flannery, Margaret 

P124 

Flattery, Maureen 

P134 

Flavell, Carol 

144, P323 

Fleming, James 

P161 

Floras, John S. 96 

Flores-Arredondo, Jose 56 

Flores-Arredondo, Jose H. 

P111, P112 

Florez, Natalia 

P107 

Flynn, Rachel 

44, P122, P127 

Fonarow, G.C. 

P280 

173

AUTHOR INDEX 

Fonarow, Gregg 

P205 

Fonarow, Gregg C. 34, 46 

Fong, Michael W. 

P349 

Force, Thomas 

142, P029 

Forfia, Paul R. 

31, P031 

Forman, D.E. 

P024, P046, P055 

Forman, Daniel 55 

Forman, Daniel E. 

P047, P117, P195 

Forrest, Michael 

P103 

Fotuhi, Majid 37 

Fowler, Michael B. 100, 103 

Frajtag, Rose 

P281 

Frampton, Stacey 

P274 

Francis, Gary S. 43 

Frank, Dana L. 

P292 

Frantz, Robert P. 31 

Frazier, Howard O. 

P160 

Frazier, O.H. 

P148 

Frazier, Susan K. 

P262 

Freehardt, Darla 

P080 

French, Benjamin 

44, P066 

Frewin, Sarah 

P347 

Frivold, Geir 

45, P289 

Fryback, Dennis 

P271 

Fukuda, Keiichi 

P211 

Gaasch, William H. 

P062 

Gadesam, R. 

P039 

Gage, Ryan M. 

P170 

Gagnon, D.R. 

P024, P046 

Gajanana, Deepakraj 

P225, P264, P354 

Galenko, Oxana 

P106, P274 

Gal-Oz, Amir 

P345 

Ganiats, Theodore G. 

P271 

Gao, Erhe 

P018 

Gao, Sheng 

P103 

Garan, Hasan 41, 97 

Garcia, Mario J. 

P032 

Garrison, Chris 

P192 

Gaspard, Dany 

P313 

Gauvreau, Kimberlee 

P229 

Gaviria, Moises 

P150 

Geisberg, Carrie 

P080, P350 

Geisberg, Carrie A. 142 

Geltman, Edward M. 

P239 

Gennivois, Daniel 52 

Gerszten, Robert E. 107 

Ghali, Jalal K. 46 

Gheorghiade, M. 

52, 88, P263, P280, P315 

Gheorghiade, Mihai 

P272, P298 

174 

AUTHOR INDEX 

Gholami, Parisa 

P240 

Giannetti, Nadia 

P342 

Gianni, Davide 56 

Gibbons, Edward F. 

P224 

Gibson, Douglas N. 

P028 

Gilbert, Cameron 

P033 

Gilbert, Edward 

P060, P155 

Gilbert, Edward M. 

P113 

Gilbert, Michele N. 91 

Gillette, Thomas G. 56 

Gilliam, F.R. 

P247 

Gilliam, Francis R. 

P140 

Ginn, Greg L. 

P299 

Ginwalla, Mahazarin 

P282 

Giridharan, G. 

P129 

Givertz, M. 

P193 

Givertz, M.M. 

P245 

Givertz, Michael 

P323 

Givertz, Michael M. 

109, 139, P115 

Glad, Jo Ann M. 

P176 

Glockner, James F. 

P058 

Gluck, Jason 

P141 

Gluck, Jason A. 

44, P287 

Godoy, Sarah M. 

P325 

Goh, Ping Ping 

P223 

Goihberg, Eduward 56 

Goihberg, Polina 

P173 

Goldberg, Lee R. 

39, 44, P066 

Goldberg, Ythan 

P032 

Goldenberg, Ilan 

P183 

Goldhaber, Joshua I. 89, 98 

Goldhaber, Samuel Z. 104 

Goldman, Steven 

42, P120, P203, P206 

Goldsmith, Steven R. 46 

Goldspink, David 

P023 

Goldstein, Daniel 

P125 

Goldstein, Nathan E. 43 

Gomez Salvador, Itziar 

P341 

Gong, Y.T. 

P201 

Gong, Z.H. 

P286 

Gonzalez, Jaime 54 

Gopal, Deepa M. 

P095 

Gopalan, Radha S. 

P128 

Gorcsan, John 

35, P109, P190 

Gorman, Grace 

P206 

Goss, J. Richard 

P224 

Gottlieb, Stephen S. 

89, 103, P325 

Grady, Kathleen L. 141 

Grandits, Gregory 

P107 

175

AUTHOR INDEX 

Gratz, E. 

P129 

Green, Jennifer 

P242 

Greenberg, Barry 

P289 

Greenberg, Barry H. 34, 45, 140 

Greenwald, Jeffrey L. 88 

Gregoric, Igor D. 

P148 

Griffin, Leslie 

P115 

Grill, Diane E. 

P073 

Grogan, Donna 

P180 

Groh, Ben I. 

P143 

Groh, Mark A. 

P143 

Gruson, Damien 

P078, P079 

Grzesiak, Aleksandra 

P029 

Guavreau, Kimberlee 

44, P229 

Guglin, Maya 

P026, P048, P234, P290 

Guglin, Maya E. 

44, P118 

Guidetti, Federica 

P315 

Gujja, Karthik 

101, P320 

Gullestad, Lars 

45, P294 

Gunter, Staci 

P106 

Guo, Yu 

P294, P297 

Gupta, Deepak 

P298 

Gutfinger, Dan 

P318 

Haddad, Andrea 

P281 

Haghika, Arash 

P029 

Haglund, Nicholas 

P135 

Hajjar, Roger J. 40 

Hall, Jennifer L. 

P107 

Hamilton, Michele A. 100 

Hamlin, Robert L. 

P126 

Hamman, Baron L. 

52, P186 

Hammond, Elizabeth 

P060 

Hammond, Jonathan 

P105, P114 

Hansen, Kimberley J. 

P222 

Harders, Gerald E. 

P040 

Harding, Tina M. 52 

Hare, Joshua M. 105, 109 

Haring, Bernhard 56 

Harkness, Karen I. 

P257 

Harper, Yenal 

P087 

Harris, Collette R. 

P117 

Harris, Kristie M. 

P325 

Harton, Suzanne 

P134 

Hasin, Tal 

P116 

Hassam, Haddad 

P353 

Hasselblad, Vic 52 

Hatakeyama, Akiko 

P307 

Hatano, Masaru 

P307 

Haude, Michael 

101, P138 

176 

AUTHOR INDEX 

Haunschild, Carolyn 

P302 

Hauptman, Paul 

P322 

Hauptman, Paul J. 97 

Hauselmann, Stephanie P. 

101, P084, P108 

Hawkins, Lee Ann 54 

Hayashi, Yacki 

P124 

Hayes, David L. 

P140, P247, P248 

Haywood, Christopher S. 

P230 

Hazard, Lesli 

P147 

Hazen, Stanley L. P072, P075, P086, P088, P090, 

P097, P100 

Heath, Russell R. 

P168 

Heidenreich, Paul A. 52, P140, P168, P240, P246, 

P247, P270 

Heimann, Mark 

P030 

Heinisch, C. 

P069 

Heizer, Gretchen M. 52 

Helmke, Stephen 

101, P221 

Henn, Andrew J. 

P271 

Heo, Seongkum 

54, P328 

Hernandez, A.F. 

P022 

Hernandez, Adrian F. 

48, 52, 139, P187, P230 

Hernandez, Antonieta 

P148 

Herre, John M. 

P167 

Hershberger, Ray E. 99 

Hess, Michael L. 

P134 

Hesselson, Aaron 

P025 

Hettrick, Douglas 

P163 

Hettrick, Douglas A. 

P162 

Hetzer, Roland 

P020 

Heublein, Denise M. 

P027, P070 

Heximer, Scott 

P016 

Heywood, J. Thomas 

54, 96, 144, P163, P301 

Heywood, James T. 

P028 

Hiesinger, William 

P157 

Higgins, Jennifer 

P146 

Higgins, Melinda 

P333 

Hilfiker-Kleiner, Denise 

P029 

Hill, Joseph A. 42, 56 

Ho, Carolyn Yung 99 

Ho, Jennifer 

P047 

Hoagland, Peter 

P119, P147 

Hodge, David O. 

P058 

Hoek, Maarten 

P103 

Hollander, Zsuzsanna 

P137 

Hong, Namki 

P238, P244 

Hong, Sung Jin 

P238 

Hoppe, Uta C. 

101, P138 

Hopper, Donald L. 

P175 

177

AUTHOR INDEX 

Horne, B. 

P256 

Horne, Benjamin 

P249, P274 

Horne, Benjamin D. 

44, P106, P235 

Horstmanshof, Douglas 

P156 

Horwich, Tamara B. 

P277 

Hosoda, Toru 

56, P050, P173 

Hou, Wenbo 

P036, P152, P153 

House, John 

P260 

Houser, Steven R. 32, 103 

Howe, Alexandra 54 

Howie-Esquivel, Jill 

P331 

Howlett, Jonathan 

P353 

Howlett, Jonathan G. 30, 52 

Hshieh, Shenche 

P212 

Huang, Congxin 

P188, P191, P194 

Huang, He 

P188, P191, P194 

Huang, Tsuey-Yuan 54 

Huiskes, Bonita L. 54 

Hummel, Scott L. 

45, 55, P233 

Hunt, Sharon A. 106 

Hunter, Claire 39 

Huntley, Brenda K. 

55, P027, P040, P104 

Hurwitz, Shelley 

P285 

Huynh, Thao 

P342 

Hwang, Shiow-Li 54 

Hyden, Marshall 

102, P139 

Ichiki, Tomoko 55, P038, P040, P057, P104, 

P116 

Ide-Iwata, Noriko 56 

Ignaszewski, Andrew 

P137, P146, P353 

Ikeda, Yasuhiro 

45, P067 

Iliadis, Elias 

P313 

Imse, Jacqueline 

P114 

Inglis, Sally C. 

102, P288, P321 

Inouye, Brendan T. 56 

IPAC Investigators 

P190 

Iqbal, Navaid 

55, P219 

Irwin, Dennis 86 

Isaac, Debra L. 

P305 

Ito, Masahiro 

P037 

Ivanhoe, Russell J. 

P132 

Jack, Brian 91 

Jack, Starmer 

P350 

Jacoby, Meni 

P126 

Jaffe, Allan S. 

P073 

Jain, Anil 

P278 

James, Jeanne 

P021 

James, Roberta 

44, P235, P261 

Jang, Yangsoo 

P238, P244 

178 

AUTHOR INDEX 

Janocha, Allison 

P098 

Januzzi, James 

P274 

Januzzi, James L. 

P297, P303 

Januzzi, Jr., James L. 47 

Jaroszewski, Dawn E. 

P128 

Jaski, Brian 

45, P119, P147, P289 

Javaheri, Shahrokh 36 

Jensen, Kurt 

P249 

Jeon, Eun-Seok 

P071, P209, P324 

Jeon, Sangchoon 

P275 

Jessup, Mariell 

44, P066, P157 

Jessup, Mariell L. 35, 90, 141 

Ji, Ruiping 

P131, P151 

Jiang, Hongfeng 

P131, P151 

Jiang, Songtao 

P140 

John, Ranjit 

P121 

John, Roy M. 94, 138 

Johnson, Alan M. 

P143 

Johnson, Allen D. 

P028 

Johnson, Frances L. 

44, P118 

Johnson, James 

P162 

Johnson, Jeremy 

P282 

Johnson, Nicholle M. 

P120, P206 

Jones, Meaghan 55 

Jones, Meaghan L. 

P195 

Jong, Philip 

101, P255 

Jorde, Ulrich 55 

Jorde, Ulrich P. 

P124 

Joseph, J. 

P024, P046, P055 

Joseph, Jacob 30 

Joyce, Lyle 

P116 

Joynt, Karen E. 48 

Ju, Eun-Seon 

P209 

Ju, Eun-Seon Ju 

P324 

Judge, Daniel 

P180 

Juneman, Elizabeth 

P120, P203, P206 

Jung, Lae Young 

P284, P346 

Jungklaus, Tamarah 

P334 

Jurgens, Corrine Y. 103, 144 

Kaaan, Annemarie 

P257 

Kaan, Anne Marie 

P353 

Kaan, Annemarie 

P146 

Kadakia, Hemal H. 

P028 

Kahn, Mark R. 

P268 

Kaina, Patsy 

P227 

Kajstura, Jan 

56, 105, P050, P173 

Kalya, Anantharam V. 

P128 

Kamdar, Forum 

P121 

Kamireddy, Swapna 

P178 

179

AUTHOR INDEX 

Kang, Seok-Min 

P238, P244 

Kanwar, Manreet 

P279 

Kao, Andrew C. 

P330 

Kao, David P. 

P113 

Kaplan, Robert M. 

P271 

Karadolian, Sevan S. 

P310 

Karl, Justin A. 

P032 

Karpawich, Peter P. 

P164 

Kaschina, Elena 

P029 

Kashner, T. Michael 54 

Kasirajan, Vigneshwar 

P134 

Kasper, Diane L. 

P128 

Katlaps, Gundars J. 

P134 

Kato, Naoko 

P307 

Kato, Tomoko 55 

Kato, Tomoko S. 

P130, P149 

Katz, David F. 

P168 

Katz, Michael G. 

P144 

Katz, Stuart 54, 145 

Katz, Stuart D. 

P355 

Kazatsker, Mark 

P181 

Keel, Allen J. 

P196 

Kennedy, Paul 

P260 

Keown, Paul 

P137 

Keren, Gad 

P126 

Ketelslegers, Jean-Marie 

P078, P079 

Kfoury, A. 

P256 

Kfoury, Abdallah 

P155, P249, P261, P274 

Kfoury, Abdallah G. 

44, P060, P235 

Khan, Farman 

P060 

Khan, Imran 

P215 

Khan, Raffay 

55, P131, P151 

Khan, Raffay S. 

P117 

Khan, Tariq 

P028 

Khawaja, Tuba 

55, P130, P131, P151 

Khorshid, Lamees 

P292 

Khouri, Samer 

P045, P063, P216 

Kiani, Jawad 

P178 

Kiffer, Jerome 

P292 

Kilgore, Meredith 

P205 

Kilian, Shirley 54 

Kim, Antony Y. 

P242 

Kim, Brian J. 

P093 

Kim, Eun-Young 

P324 

Kim, Han-na 

P303 

Kim, Henry E. 

P310 

Kim, Jae-Joong 

P071 

Kim, Jieun 

P311 

Kim, Kee-Bong 

P226 

180 

AUTHOR INDEX 

Kim, Min-Seok 

P329 

Kim, Sonnie 

P322 

Kim, Soo-Young 

P244 

Kim, Sung Hea 

P329 

Kim, Won Ho 

P284, P346 

Kim, Yong-Chul 

P209 

Kimmel, Stephen E. 

P314 

Kimura, Masaomi 

P175 

Kinugawa, Koichiro 

P307 

Kirkpatrick, James N. 33, 87 

Kishore, Raj 92 

Kitlinski, Mariusz 

P092 

Kittleson, Michelle M. 

44, 90, P118 

Kleet, Audrey C. 

P159 

Klein, Allan L. 

P019, P088, P090 

Klein, Ran 

P110 

Klevan, Linette R. 

P167 

Knight, J. David 52 

Ko, Jae Ki 

P284, P346 

Kobashigawa, Jon A. 90 

Koch, Walter J. 

51, P018 

Kocovic, Dusan Z. 

P030 

Kodama, Makoto 

P037 

Koehler, Jodi 

P344 

Koelbl, Christian 

P095 

Koelling, Todd M. 

30, 45, P233 

Koenig, S. 

P129 

Koh, Steve 

P036, P152, P153 

Kohsaka, Shun 

P211 

Komajda, Michel 52 

Kommineni, Maya 

P095 

Kommuri, Naga V.A. 

45, P233 

Kono, Alan T. 94 

Konstam, Marvin A. 34, 140 

Koomalsingh, Kevin 

P144 

Koplan, Bruce A. 43 

Korinek, Josef 

P040 

Kormos, Robert 

P136 

Kormos, Robert L. 

86, 108, 138, P142 

Korn, Justin A. 

56, P050, P173 

Koulisis, Nicole 56 

Kovach, Cynthia 

P077 

Kowey, Peter R. 98 

Kranias, Evangalia G. 

51, P021 

Krantz, David S. 

P325 

Kraus, William E. 

P250 

Krotin, Mirjana 

P326 

Kubo, Spencer H. 

P170 

Kucharska-Newton, Anna 

P217 

181

AUTHOR INDEX 

Kumagai, Yumiko 

P307 

Kusakari, Yuichiro 56 

Kushwaha, Sudhir S. 

P116 

Kuster, Gabriela M. 

101, P084, P108 

Kwok, Bernard 

P218 

Kwong, Raymond Y. 100, 140 

Ky, Bonnie 

44, 142, P066 

Labos, Christopher 

P342 

Lafayette, Richard A. 

P145 

Lakatta, Edward G. 

89, P202 

Lakdawala, Neal 

43, 99, P323 

Lal, Hind 

P029 

Lam, Carolyn 

P218 

Lancaster, Jordan J. 

P120, P203, P206 

Landzberg, Michael J. 31 

Lanfear, David 

89, P161 

Lanfear, David E. 

45, P198 

Langlois, Elizabeth A. 

P337, P338 

Langnas, Alan N. 

P061 

Lanier, Gregg 

P124 

Lankford, Brenda 

P187 

Lanza, Louis A. 

P128 

Lapp, Harald 

P070 

Lark, Michael W. 

P204 

Larson, Douglas F. 

P056 

Larue, Catherine 

P070 

Latif, Farhana 

P327 

Lattouf, Omar M. 

P186 

Law, Catherine 

P234 

Lawson, Mark 

P107 

Layton, Aimee 

P195 

Lazzari, A. 

P024, P046 

Lazzari, L. 

P055 

Lazzarini, Valentina 

P267 

LeBlanc, Marie-Helene 

P353 

Lecker, S. 

P024, P046, P055 

Lederer, C. 

P129 

Lederer, Melissa 

P135 

Lee, Christopher S. 

P242 

Lee, Hae-Young 

P226 

Lee, Hon-Chi 

P041 

Lee, Hwei Khien 

P352 

Lee, Kerry L. 

P187 

Lee, Kyoung Suk 54 

Lee, Sang Hoon 

P071 

Lee, Sun Hwa 

P284, P346 

Lee-Grasso, Barbara 

P159 

Leier, Carl V. 44 

Lemay, Genevieve 

P291 

182 

AUTHOR INDEX 

Lemster, Bonnie 

P109 

Lenihan, Daniel 

P350 

Lenihan, Daniel J. 142 

Lenneman, Andrew 

P336 

Lennie, Terry A. 

47, 54, P262, P328 

Leonard, Ann E. 

P214, P227 

Leong, Kui Toh Gerard 

P223 

Leri, Annarosa 

56, 92, P050, P173 

Lerman, Amir 

P070 

Lerman, Bruce B. 88 

Leszczynski, Karen 

45, P198 

Levy, Gary 

P123 

Levy, Pavel 

P222 

Levy, Philip D. 52 

Levy, Wayne 

P121 

Levy, Wayne C. 

44, P066, P236, P259, P265 

Levy, Yaniv 

P181, P189 

LeWinter, Martin M. 

103, P081 

Lewis, Connie 

P350 

Lewis, Eldrin 

P323 

Lewis, Eldrin F. 143 

Lewis, Gregory D. 108, 145 

Lewis, Nigel 

P023 

Li, Dean Y. 

P060 

Li, Jun 

P103 

Li, Na 

P042, P101 

Li, W.M. 

P201, P286 

Li, Weimin 

P094 

Li, Y. 

P201, P286 

Li, Yanhong 

P250, P259 

Liang, Chang-seng 

P095 

Liang, Li 

P230 

Liao, Ronglih 92, 105 

Libby, Peter 90 

Liebenstein, Michael 

P292 

Liedtke, Michaela 

P145 

Lien, Susan 

P349 

Lietz, Katherine 141 

Lima, Joao 

P107 

Lim-Shon, Jongsung 

P123 

Lin, David 

P137 

Lin, Jay 

P228, P243 

Lindenfeld, JoAnn 39, 139 

Lindsell, Chris 

P272 

Link, Mark S. 97 

Lipiecki, Janusz 

101, P138 

Little, William C. 

52, 145, P017 

Liu, Peter 

P016 

Liu, Peter P. 44 

183

AUTHOR INDEX 

Liu, Wei 

P094 

Livio, Dei Cas 

P315 

Lombardi, Carlo 

P267, P315 

London, Barry 41, 98 

Lopes, Renato D. 

P230 

Lopez Diaz, Javier 

P341 

Lorenz, Vera 

101, P084, P108 

Loscalzo, Joseph 107 

Losordo, Douglas W. 105 

Louie, Stan G. 

P093 

Love, Thomas 

P205 

Lowe, Timothy 

P228, P243 

Lowes, Brian D. 

P113 

Loyaga-Rendon, Renzo Y. 

P158 

Lu, Yi 

P049, P075, P086 

Lundbye, Justin 

P287 

Lymperopoulos, Anastasios 

P018 

Macabasco-O’Connell, Aurelia P283 

MacArthur, John W. 

P157 

Machado, Christian 

P182 

Macheret, Fima 

P070 

Mack, Joan 

P135 

Mackey, Aaron 

P107 

MacLellan, W. Robb 

P254, P269 

Magrini, Laura 

P082 

Mahramus, Tara 

P347 

Maisel, Alan 

55, P185, P219 

Maisel, Alan S. 

45, P074, P082, P289, P302 

Maggioni, Aldo 52 

Makan, Majesh 

P065 

Malinowski, Marcin 52 

Malloy, Samantha 

P334 

Mancini, Donna 55, P117, P130, P131, P149, 

P151, P195 

Mancini, Donna M. 

140, P124 

Mandell, Brian F. 109 

Manerba, Alessandra 

P267 

Mangiafico, Sarah 

45, P067, P200 

Mangion, Judy R. 

P285 

Mangione, Carol 

P273 

Manhaes, Maria A.R. 

P343 

Mankad, Anit K. 

P134 

Mann, Douglas L. 40 

Manole, Frank 

P338 

Mansoor, G. 

P193, P245 

Marais, John 

45, P289 

Marco, Metra 

P315 

Marguiles, Kenneth B. 

92, P157 

Marian, Ali J. 32 

184 

AUTHOR INDEX 

Mark, Daniel 52 

Markham, Bruce 

P203 

Markowitz, Steven M. 

P162 

Maroo, Anjli P. 

P077 

Marshall, Jennifer M. 

P325 

Marshall, Joanne P. 

P325 

Martin, Fernando 

P070 

Martin, Fernando L. 

45, P040, P057, P067 

Martin, Tony 33 

Martins, Wolney A. 

P343 

Maska, Edlira 

P334 

Mason, Thomas 

P048 

Masoudi, Frederick A. 46, 88 

Massey, H. Todd 

P349 

Massicotte, Mary Patricia 104 

Massie, B. 

P193 

Massie, B.M. 

P245 

Massie, Barry M. 

37, 49, 52, 143, P168 

Mather, Paul J. 

90, P064 

Mathier, Michael A. 

108, P142 

Matsui, Takashi 56 

Matsuzaki, Masunori 

P154 

Mau, Marjorie K. 

P214 

Maurer, Mathew S. 

101, P221, P327 

Maurer, Matthew 

P180 

Maybaum, Simon 

103, P125 

Mazurek, Jeremy 

P177, P232, P309 

McAlister, Finlay A. 

P288 

McAllister, Finlay A. 

102, P321 

McCalmont, Vicki 

P147 

McCarthy, Margaret M. 54 

McCauley, Brian D. 

P314 

McCauley, Kathleen M. 91 

McCauley, Mark D. 

P101, P293 

McConnell, Patrick I. 

P126 

McKee, Michael G. 

P292 

McKelvie, Robert S. 

P257 

McKie, Paul M. 

55, P038, P040, P057 

McLachlan, Andrew M. 

P300 

McManus, Bruce M. 

P137 

McMaster, Robert W. 

P137 

McMillan, Susan C. 

P192 

McMurray, John JV 52 

McNally, Elizabeth M. 99 

McNamara, Dennis M. 

43, P142, P190 

McNitt, Scott 

P183, P349 

McNulty, Steven E. 

P081, P187 

McTiernan, Charles 

P109, P190 

Mebazaa, Alexandre 52 

185

AUTHOR INDEX 

Medin, Jeffrey 

P016 

Mehra, Mandeep R. 30, 141, 143 

Mehra, Shabnam 

P048 

Meisel, Simcha 

P181, P189, P317 

Melander, Ole 

P092 

Melton, Iain 

P179, P318 

Mendez, Adriana 

P283 

Mendoza, Tito 

P316 

Menezes, Karla 

P281 

Mentz, R. 

P193 

Mentz, R.J. 

P022, P245, P263, P280 

Merliss, Andrew D. 

P332 

Merveil-Ceneus, Betty 

P295 

Mesquita, Evandro T. 

P102, P343 

Metra, M. 

P193, P245 

Metra, Marco 

P267 

Meyer, Rudolf 

P020 

Michaud, Gregory F. 41, 138 

Mielniczuk, Lisa M. 

P051, P110 

Mikelson, Melissa A. 104 

Miller, Clayton 

P301 

Miller, Clayton T. 

P163 

Miller, Dylan 

P060 

Miller, Karen 

P272 

Miller, Keith 

P332 

Miller, Leslie W. 106 

Miller, Wayne L. 

P073 

Minton-Foltz, Paula 

P224 

Mirzoyev, Sultan A. 

P236, P265 

Misenheimer, Jacob A. 

P336 

Mishra, Rakesh K. 

P044 

Misra, Deepika 

101, P320 

Misselwitz, Frank 88 

Mitchell, Gary F. 

P053 

Mitoff, Peter R. 

P051 

Miura, Chikako 

P307 

Mochly-Rosen, Daria 51 

Mohammed, Asim A. 

P303 

Moldovan, Nicanor Ilie 40 

Molkentin, Jeffery D. 42, 51 

MOMIJI Study Investigators 

P197 

Momomura, Shin-ichi 

P197 

Montesino, Rosmery 

P295 

Mooney, Andrew 

P054 

Moore, Alexander G. 

P109 

Moore, Hans J. 

P162 

Moore, Stephanie 

P274 

Moore, Stephanie A. 

87, P303 

Moravec, Christine S. 

P292 

186 

AUTHOR INDEX 

Moreira, Rodrigo C. 

P281 

Morgan, Eric E. 

P216 

Morita, Yoshihisa 

P211 

Morris, Rohinton J. 94, 105 

Moser, Debra K. 

43, 54, 140, P262, P328 

Mosley, Thomas 

P217 

Moss, Arthur J. 

P183 

Moss, Noah 

P231 

Mountis, Maria M. 

44, P118 

Movsesian, Matthew A. 103 

Mudge, Gilbert 

P323 

Mueller, C. 

P069 

Mueller, Paul S. 

101, P171 

Muir, Melody 

P025 

Mujib, Marjan 

P205 

Mulamalla, Roja 

44, P105, P114, P141, P287 

Munger, Mark A. 39 

Muntendam, Pieter 

45, P294, P297 

Murali, Srinivas 

P279 

Murphy, Jennifer 

P124 

Murray, Christina 

P260 

Murthy, Ashwin 

P157 

Nadella, Neelima 

P310 

Nagai, Ryozo 

P307 

Nagaraju, Lakshmi 

P164 

Nagayama, Masayoshi 

P307 

Naik, Ajay 52 

Nair, Ajith P. 

44, P122, P127 

Naka, Yoshifumi 55, P117, P124, P130, P149, 

P151 

Nakayama, Etsuko 

P307 

Naqvi, Syed U. 

P222 

Naqvi, Tasneem Z. 

P196, P312 

Nelson, Dylan 

P261 

Nelson, Dylan P. 

44, P235 

Nelson, Ryan C. 

P349 

Nessler, Bohdan J. 

P092 

Nessler, Jadwiga M. 

P092 

Neugaard, Britta 

P351 

Ng, Raymond T. 

P137 

Ng, Tien M.H. 

P093, P212 

Nguyen, Duy 

P332 

Nguyen, Duy T. 

P168 

Nguyen, Hugh 55 

Nguyen, Viviane 

P342 

Niazi, Tariq 

P203 

Niebel, Cassie L. 

P017 

Nieminen, Markku 52 

Nikolaidis, Lazaros A. 

P348 

187

AUTHOR INDEX 

Nitzan, Yaacov 

P126 

Nixon, J. 

P256 

Nobrega, Antonio Claudio L. 

P102 

Nodari, Savina 

P267 

Nohria, Anju 

142, P323 

Noonan, Thomas E. 100 

Noren, Kjell 

P179 

Norman, Holly S. 

P053 

Norman, Vanja 

P147 

Norman, Vanjah 

P119 

Noveanu, M. 

P069 

Nowack, Christina 52 

Nucci, Cecelia 

P125 

Nutter, Benjamin 

101, P319 

O’Bara, Lynn 

P105 

Obata, Hiroaki 

P037 

O’Brien, Erin 

P025 

Ocampo, Norela 

P252 

O’Connell, John B. 

86, P298 

O’Connor, C. 

P193 

O’Connor, C.M. 

P022, P245, P263, P280 

O’Connor, Christopher M. 

52, 106, P251, P259, P308 

Oduwole, Adefisayo 

P187 

Oehler, Elise A. 

45, P068 

Ofili, Elizabeth O. 

P187 

Ogorek, Barbara 

56, P173 

Oh, Byung-Hee 

P226 

Oh, Jaewon 

P238, P244 

O’Hara, Mary Lou 

P157 

Ohara, Takahiro 

P017 

Ohno, Yukako 

P037 

Ohtani, Tomohito 

P081 

Ok, Jong Sun 

P329 

Oliva, Nancy L. 

P240 

Oliveira, Lucia B. 

P343 

Oliveira, Marli G. 

P343 

Olmsted, Rhonda 

P332 

Olson, Lyle J. 

P059 

O’Malley, Maureen 

101, P319 

O’Neal, Dan 

P351 

Ong, Kai Xin 

P352 

Ong, Michael 

P273 

Onwuanyi, A. 

P039 

Onwuanyi, Anekwe 

P187 

Orlanes, Khristine 

P124 

Orrego, Carlos M. 

56, P111, P112 

Ortiz, Kristi 

P147 

Oshima, Kazuki 

P211 

Ottenberg, Abigale L. 

101, P171 

188 

AUTHOR INDEX 

Packer, Milton 31, 106 

Packman, Jeff 

P180 

Page, II, Robert Lee 39 

Pagnanelli, Robert 

P251 

Pajaro, Octavio E. 

P128 

Panahi, Samin 

P106 

Pang, Peter 

P272 

Pang, Peter S. 88 

Pano, Arian 

P180 

Park, Jennifer I. 

P093 

Park, Myung H. 96 

Park, Soon J. 

55, P116 

Park, Sungha 

P238, P244 

Park, Sung-Ji 

P071 

Park, Yun Ji 

P284, P346 

Parker, John D. 

P033 

Partington, Sara L. 

P285 

Pasala, Tilak 

P282 

Paschke, Kelly M. 55 

Patarroyo, Maria M. 

P049, P241 

Patel, Aarti A. 

P158 

Patel, Amit N. 

P186 

Patel, Ankitkumar K. 

P313 

Patel, Ayan R. 100 

Patel, C. 

P022 

Patel, Chetan B. 

44, P118 

Patel, Parag 

44, P118 

Patel, Snehal R. 

P125 

Patterson, J. Herbert 94 

Paul, Sara C. 39 

Paulson, James F. 

P167 

Paunovic, Nevena 

P326 

Pauwaa, Sunil 

P150 

Pawar, Pushkar P. 

P205 

Peacock, W. Frank 

P311 

Pedraza, Adriana 

P126 

PEERLESS HF Investigators 

P132 

Pelligrini, Cara N. 

P168 

Pellikka, Patricia A. 

P304 

Penoyer, Daleen 

P347 

Pereira, Gelsomina A.M. 

P343 

Pereira, Naveen L. 

P304 

Pereira, Sabrina B. 

P102, P281 

Perez, Elena V. 54 

Peter, Liu 

P353 

Petersen, John W. 

P043 

Peterson, Brett J. 

P182 

Petty, Michael G. 33, 106 

Pfeffer, Marc A. 

55, P115, P183 

189

AUTHOR INDEX 

Pfister, Otmar 

101, P084, P108 

Pham, Si 

P158 

Phelps, Mary A. 

P073 

Phillips, H.R. 

P263 

Piano, Mariann R. 54 

Piccini, Jonathan P. 

P230 

Pieper, K. 

P280 

Piercey, Gary E. 

44, P229 

Pignone, Michael 

P283 

Pilla, James J. 

P144 

Piña, Ileana L. 50, 57 

Ping, Peipei 107 

Pinney, Sean P. 

44, P122, P127 

Pisarcik, Jessica 

P190 

Pointer, Lauren 

P168 

Polimera, Hyma V. 

P354 

Polimera, Hyma Vani 

P264 

Ponikowski, P. 

P193, P245 

Ponikowski, Piotr 49 

Poore, John W. 

P036, P152, P153 

Popat, Jesal 

P026, P290 

Popovtzer, Baruch 

P232, P309 

Porter, Thomas R. 

P061 

Posligua, William 

P160 

Potocki, M. 

P069 

Pratibhu, Parakash 

P323 

Pregla, Reinhard 

P020 

Pressler, Susan J. 54 

Pritchett, Allison M. 

P293 

Pritchette, Louella 

P144 

Pu, Min 

P017 

Pugliese, Carolyn 

P051 

Puig, Oscar 

P103 

Purevjav, Enkhsaikhan 

P021 

Qamruddin, Salima 

P196, P312 

Qin, Mu 

P188, P191, P194 

Qu, Fujian 

P318 

Quinn, Christina 

P333 

Quinn, Jill R. 

P276 

Quintao, Monica 

P102 

Quintao, Monica M.P. 

P343 

Quinzani, Filippo 

P315 

Quyyumi, Arshed 

P180 

Rab, Zia 

P210, P213, P266 

Rademaker, Miriam 

P318 

Rader, Florian 

P282 

Radford, Martha J. 46 

Radojevic, Joseph 

44, P141, P287 

Rafey, Mohammad 

P049 

190 

AUTHOR INDEX 

Rafferty, Kathryn M. 

P021 

Rafie, Reza 

P196, P312 

Rahn, Jennifer 

P105 

Rai, Mridula 

P105, P114 

Raichlin, Eugenia 

P061, P135 

Raina, Amresh 

P031 

Raissi, Farshad 

P160 

Rajda, Miroslav 

52, P353 

Ramani, Ravi 

P109, P142 

Ramasubbu, Kumudha 

P293 

Rame, J. Eduardo 

44, P118, P157 

Ramza, Brian 

P260 

Rana, Hamza 

P222 

Rankin, Gena 52 

Rao, Shaline D. 

P339 

Rao, Vivek 

P123 

Rapezzi, Claudio 

101, P221 

Ras, Aleksandra 

P105, P114 

Rasmusson, K. 

P256 

Rasmusson, Kismet 

P249, P261, P274 

Rasmusson, Kismet D. 

44, 87, 94, P235 

Rathman, Lisa D. 

91, P235 

Rayburn, Barry K. 

P132 

Redeker, Nancy S. 

P275 

Redfield, Margaret M. 

46, P081, P236, P265 

Redwine, Laura 

P219 

Reed, Shelby D. 

P250, P259 

Rehman, Shafiq U. 

P303 

Reid, Bruce 

P155 

Reigle, Juanita 43 

Renaud, Jennifer J. 

P110 

Rengo, Giuseppe 

P018 

Respress, Jonathan L. 

P042 

Reuter, David G. 

101, P138 

Revelo, Monica P. 

P060 

Revilla Orodea, Ana 

P341 

Rewiniski, Michael 

P141 

Reyentovich, Alex 

P355 

Reyes-Soffer, Gissette 

P117 

Ribeiro, Georgina S. 

P102 

Rich, Michael W. 

46, P065 

Rich, Stephen S. 

P107 

Rickard, John 

P165, P172 

Riegel, Barbara J. 37, 39, 103, 143 

Rivero, Abel 

P026 

Roberts, Colleen 

P261 

Robertson, Alastair D. 

P113 

Robinson, Ellen 

P224 

Robinson, Shawn W. 

P325 

191

AUTHOR INDEX 

Rock-Willoughby, Jayme 

P063 

Rodeheffer, Richard J. 108 

Rogers, J.G. 

P022 

Rogers, Joseph G. 

139, 141, P308 

Rolim, Natale 

P042 

Roll, Sue 

P272 

Roncari, Christine 

101, P320 

Rosa, Maria Luiza G. 

P102 

Rosenbaum, Andrew 

P121 

Rosenberg, Stuart P. 

P036, P152, P153 

Rosenblum, Hannah R. 55 

Rosenfeld, Anne 

P242 

Rosenzweig, Anthony 56 

Ross, Heather 

P123 

Ross, Heather J. 106 

Rota, Marcello 

56, P050, P173 

Rotman, Stacey 

P339 

Rousseau, Michel F. 

101, P078, P079, P255 

Roy, Kristine 

P140 

Roy, Sophie 

P103 

Russell, Laurie 

P348 

Russell, Stuart D. 

30, 86, 96, P339 

Ryu, Kyu Hyung 

P329 

Ryu, Kyungmoo 

P025, P196 

Saad, Walid 

P313 

Saba, Samir 

P178 

Sabbah, Hani N. 

40, 45, P198 

Sabir, Sajjad 

P313 

Sadhu, Justin S. 

P065 

Sadoshima, Junichi 109 

Sadowski, Jerzy 

101, P138 

Saeed, Wajeeha 

P210, P213, P266 

Saffitz, Jeffrey E. 99 

Sahay, Anju 

P240, P246, P270 

Sahni, Sheila 

44, P122 

Saidi, Abdulfattah 

P155 

Sakaguchi, Scott 

P182 

Salamon, Jason 

P210, P213 

Salamon, Jason N. 

P177, P232, P266, P309 

Saleh, Laith 

P203 

Salomon, Say 

101, P221 

Sam, Flora 145 

Samara, Michael A. 

55, P100, P175 

Sample, Alanson 

P136 

Samsa, Gregory 

P250 

Samuels, Martin A. 37 

San Roman Calvar, Jose A. 

P341 

Sanada, Fumihiro 

56, P050, P173 

Sandoval, M. 

P129 

192 

AUTHOR INDEX 

Sangaralingham, S. Jeson 

55, P038, P040, P057 

Sanil, Yamuna 

P164 

Sardar, Muhammad 

P232, P309 

Sardar, Muhammad R. 

P177, P210, P213, P266 

Sareyyupoglu, Basar 

P142 

Sauer, William 

P332 

Sauer, William H. 

P168 

Saul, Sara 

P107 

Sauris, Aileen 

P323 

Savina, Nodari 

P315 

Sawyer, Douglas 

P272, P350 

Sawyer, Douglas B. 142 

Saxon, Leslie A. 

P140, P247 

Sayer, Gabriel 

P127 

Sayer, Gabriel T. 

44, P122 

Scarcipino, Mario 

P077 

Schaefer, Kristen G. 43 

Schelbert, Erik B. 

P190 

Schiller, Nelson B. 

P044 

Schipper, Judith 54 

Schirger, John A. 

P116 

Schocken, Douglas D. 39, 103 

Schofield, Richard 

P334 

Schott, Gerilynn M. 43 

Schrier, Stanley L. 

P145 

Schuller, Joseph 

P168 

Schulman, Kevin A. 

P250, P259 

Schulze, P. Christian 55, P117, P130, P131, P149, 

P151, P195 

Schulze, P.C. 

P024, P046, P055 

Schuster, Andres 

101, P076, P083, P085 

Schwartz, Doron 

P345 

Schwartz, Idit F. 

P345 

Scott, Robert L. 

P128 

Sears, Samuel F. 

P260 

Seidman, Christine E. 32 

Selzman, Craig 

P060, P155 

Semigran, Marc J. 50, 57 

Semler, Herbert J. 

P184 

Serrao, Greg 

P268 

Seth, Milan 

P247 

Seto, Todd B. 

P214, P227 

Seymour, E. Mitchell 55 

Sgaraglia, Sergio F. 

P343 

Shah, Kevin S. 

P082 

Shah, Keyur B. 

P134 

Shah, Monica R. 88 

Shah, Nishant R. 

P148 

Shah, Pankil 

P316 

193

AUTHOR INDEX 

Shah, Ravi V. 138 

Shah, Riddhi 

P318 

Shah, Sanjiv J. 

P298 

Shah, Swetang 

P348 

Shao, Zhili P019, P075, P076, P086, P089, 

P098 

Sharma, Vinod 

P162, P344 

Shaw, Jessica 

P351 

Shaw, L. 

P263 

Shaw, Linda K. 

P251 

Shea, Julie B. 43 

Sheikh, Mujeeb 

P063, P216 

Sheikh, Mujeeb A. 

P045 

Shemin, Richard 

P254, P269 

Sheris, Steve 

P338 

Sheris, Steven 

P295 

Sherwood, L. 

P129 

Sheth, Samar S. 55 

Shi, J. 

P201, P286 

Shiga, Taro 

P307 

Shinn, Julie A. 90 

Shirger, John A. 55 

Shirolkar, Shailesh C. 

P308 

Shochat, Ilia 

P181, P189, P317 

Shochat, Michael 

P181, P189, P317 

Shotan, Avraham 

P181, P189, P317 

Shrestha, Kevin 

P019, P088, P090, P096 

Siddharthan, Kris 

P351 

Signore, Sergio 

56, P050, P173 

Silparshetty, Santh V.S. 

P354 

Silpershetty, Santh V.S. 

P264 

Silver, Jonathan S. 

P062 

Silver, Marc A. 140 

Silverberg, Donald S. 

P345 

Silvet, Helme 54 

Sim, Ling Ling 

P218 

Simari, Robert D. 105 

Simbaqueba, Cesar A. 

P241 

Siminiak, Tomasz 

101, P138 

Simon, Daniel I. 

102, P139 

Simon, Marc 

P109 

Simon, Marc A. 

P142 

Simons, Grant 

P182 

Singh, Dhssraj 

P096 

Singh, Harinder R. 

P164 

Singh, Jagmeet P. 35, 138 

Singh, T.P. 

44, P229 

Siou, Jeff 

P318 

Sipahi, Ilke 

102, P139 

194 

AUTHOR INDEX 

Siwik, Deborah A. 

P095 

Skali, Hicham 

P115 

Slater, James P. 

P159 

Slaughter, M. 

P129 

Slaughter, Mark S. 141 

Slawsky, Mara T. 30 

Slusser, Joshua P. 

P058 

Small, Roy 

P163 

Small, Roy S. 

P301 

Smart, Frank W. 

P337, P338 

Smedira, Nicholas G. 

P186 

Smith, Andrew L. 97 

Smith, Colleen 

P115 

Smith, Holly M. 

P080 

Smith, Joshua 

P136 

Smith, Joyce A. 

P276 

Smith, Michael R. 

P028 

Smith, Peter K. 52 

Snell, Jeffery D. 

P036, P152, P153 

Snider, J. 

P069 

Sobotka, Paul A. 47 

Socrates, T. 

P069 

Soergel, David G. 

P204 

Sokos, George 

P279 

Sole, Mary Lou 

P347 

Solomon, Scott D. 

40, 105, P115, P183 

Somers, Virend K. 

36, P059 

Song, Min Ju 

P284, P346 

Song, Yunyan 

P094 

Souza, Andre L.S. 

P281 

Spanier, G. 

P129 

Spence, P. 

P129 

Spevack, Daniel 

P032, P237 

Spinuzzi, Daniel 

P279 

Springer, Jochen 

P020, P029 

Srinivas, Pothur R. 107 

Stahovich, Marcia 

P147 

Stainback, Raymond 

P160 

Stainback, Raymond F. 

P148 

Stanford, William 

P016 

Stansifer, Maribeth 

P206 

Stanton, Marshall S. 88 

Starling, Randall 

P241, P319 

Starling, Randall C. 

52, 102, 139, 144, P292 

Statz, Cara 

P105, P114 

Steadman, Elisabeth 

56, P050, P173 

Stearns, Sally 

P217 

Stehlik, Josef 

90, P060, P155, P249, P274 

Steidley, D. Eric 

P128 

195

AUTHOR INDEX 

Stein, Kenneth M. 88 

Stein, Murray 

P219 

Stevanovic, Angelina 

P326 

Stevens, Susanna R. 

P308 

Stevenson, Lynne 

P323 

Stevenson, Lynne W. 

44, P047, P118 

Stevenson, Lynne Warner 37, 101, 106 

Stevenson, William G. 41, 97 

Stewart, Duncan J. 

P051, P110 

Stewart, Garrick 

P047 

Stewart, Garrick C. 

45, 138, P118 

Stewart, Holly 

P064 

Stewart, Kelley C. 

P017 

Stewart, Simon 

102, P288, P321 

Stoll, Scott T. 

P128 

Storozynsky, Eugene 

P349 

Storrow, Alan 

P272 

Stough, Wendy Gattis 139 

Stout, Rebecca A. 

P150 

Struck, Joachim 

P073 

Struthers, Christine 

P291 

Suarez, J. 

P022 

Suarez, Jorge 

P230 

Subramanian, Khaushik 56 

Sugathan, Prasanna 

P225, P264, P354 

Sugi, Kaoru 

P197 

Sulica, Roxana 

101, P320 

Sullivan, Dorothy 

P303 

Sullivan, Katherine M. 

P207 

Sumiyoshi, Tetsuya 

P307 

Sun, Benjamin 106, 141 

Suresh, Rahul 

P304 

Sussman, Mark A. 40, 101 

Swedberg, Karl 49, 52, 89 

Sweeney, Michael O. 

P182 

Sweeny, Robert J. 

P340 

Sweitzer, Nancy K. 

44, 145, P053, P066, P271 

Swetz, Keith M. 

101, P171 

Szymkiewicz, Steven J. 

P166, P176, P330 

Takayama, Hiroo 

55, P124, P130, P149, P151 

Takeuchi, Madoka 

P183 

Talan, Mark I. 

P202 

Talati, Asha 

P311 

Tally, Steven 

P271 

Tan, Lip-Bun 

P023, P054 

Tan, Michelle 

P223 

Tanaka, Toshikazu D. 

P142, P206 

Tang, Daniel G. 

P134 

196 

AUTHOR INDEX 

Tang, W.H. Wilson 47, 55, 101, 144, , P019, P049, 

P075, P076, P083, P085, P086, 

P087, P088, P089, P090, P096, 

P097, P098, P100, P165, P172, 

P241, P278, P292, P301 

Tang, Wilson 

P163 

Tang, Wilson W.H. 

P072, P077 

Taub, Pam 

55, P219 

Taylor, David O. 

49, 87, 90, P241 

Tedford, Ryan J. 108 

Teerlink , John R. 139, 143 

Teerlink, J.R. 

P245, P193 

Te-Frey, Rosie 

P124 

Tejima, Tomoyuki 

P197 

Tereyua, Sergio 

101, P221 

Terzic, Andre 92, 107 

Testani, Jeffrey M. 

47, P314 

Tettamanti, Maria E. 

P341 

Teuteberg, Jeffrey J. 

44, 104, P118, P142 

Thai, Hoang 

P203 

Thakur, Akanksha 

101, P076, P083, P085, P089 

Thohan, Vinay 

P332 

Thomas, DiSalvo 

P350 

Thompson, Rose 

P260 

Thompson, Shelley L. 

P308 

Thorn, Stephanie 

P110 

Thum, Thomas 

P020 

Tiwari, Nidhish 

P213 

Tjandrawidjaja, Michael C. 

P047 

Tomassoni, Gery F. 

P025 

Tomita, Makoto 

P037 

Tompkins, L. 

P129 

Tong, Deborah 

P300 

Tong, Matthew 

P278 

Tonne, Jason M. 

45, P067 

Topilsky, Yan 

P116 

Torre-Amione, Guillermo 

56, P111, P112 

Torrey, Jeff 

P332 

Towbin, Jeffrey A. 

99, P021 

Trajic, Snezana 

P326 

Trevino, Alejandro 

56, P111, P112 

Troughton, Richard 

P179, P318 

Troughton, Richard W. 

P019, P088, P090 

Tsai, Ming-Feng 54 

Tschirner, Anika 

P020, P029 

Tseng, Chi-hong 

P254 

Tseng, Chi-Hong 

P269 

Tsutsui, Hiroyuki 

P197 

Tuche, Fabio 

P281 

197

AUTHOR INDEX 

Tucker, Rebecca 

P276 

Tuinei, Joe 

P261 

Tuinei, Joseph M. 

44, P235 

Tuy, Tertius 

P311 

Uber, Patricia A. 96 

Udelson, James E. 34, 43, 47, 100 

Udlis, Kimberly A. 

P133 

Ueland, Thor 

45, P294 

Ueyama, Yukie 

P126 

Ullery, Brant W. 

P157 

Uriel, Nir 

P124 

Valadri, R. 

P039 

Valdez, Riccardo 

P128 

Valente, Anne Marie 108 

van der Walt, Christelle 

P059 

van Oort, Ralph J. 

P042 

van Rooij, Eva 42 

van Veldhuisen, Dirk J. 

45, 49, P294, P297 

Vargas, Bernardo 

P295 

Vargas, Pedro 

P126 

Varosy, Paul D. 

P168 

Varr, Brandon C. 

P145 

Vatterott, Daniel B. 

P170 

Vawer, May 

P214, P227 

Velazquez, Eric J. 52 

Veloso, Monica W. 

P102 

Veluz, Jeffrey 

P225 

Ventura, Hector O. 96 

Verbalis, Joseph G. 34 

Verheye, Stefan 

P126 

Verma, Divya Ratan 

P060 

Vido, Diane 

P279 

Villacorta, Humberto 

P102 

Vishneski, Susan R. 

P167 

Vittorio, Timothy J. 

P268 

Vizzardi, Enrico 

P267 

Vlachos, Pavlos P. 

P017 

Vokonas, P. 

P055 

Volpe, Massimo 56 

von Haehling, Stefan 

P029 

Vongooru, Haree 

P121 

Voors, A. 

P193 

Voors, A.A. 

P245 

Wagman, Gabriel 

P268 

Walsh, Mary N. 91, 100 

Wan, Chingping 

P176 

Wang, Da-Zhi 42 

Wang, Tiannan 

P101 

Wang, Yibin 51 

198 

AUTHOR INDEX 

Wang, Zeneng 

P088, P090 

Warren, S. 

P129 

Wasilewski, Jaroslaw 52 

Waters, Benjamin 

P136 

Watson, Ronald R. 

P056 

Wawrzyniak, Andrew J. 

P325 

Waxman, Aaron B. 108 

Webster, Tracy A. 

P248 

Webster, Tracy L. 

102, P169, P171 

Weder, Alan B. 55 

Wehrens, Xander 

P101 

Wehrens, Xander H.T. 

98, P042, P293 

Weintraub, Andrew R. 91 

Weintraub, Joanne 

P323 

Weintraub, Neal 

P272 

Weissman, Irvig L. 

P099 

Wells, Joanna M. 55 

Wencker, Detlef 

44, P105, P114, P141, P287 

Westlake, Cheryl 

P335 

Wever Pinzon, Omar 

P155 

Whellan, David J. 

87, 91, P250, P259, P344 

White, Brenda 

P080 

White, Matthew 

P331 

White-Williams, Connie L. 87 

Whooley, Mary A. 

P044 

Wilkoff, Bruce 

P175 

Wilkoff, Bruce L. 

P165, P172 

Williams, Celeste 

P310 

Williams, Janice 

P217 

Wilson, Debra 

P347 

Wilson-McManus, Janet 

P137 

Windle, John 

P135 

Windle, John R. 

P061 

Wisloff, Ulrik 

P042 

Wiste, Heather 

P248 

Witteles, Ronald M. 

103, 142, P145 

Wodnar-Filipowicz, Aleksandra 101, P084 

Wojdyla, D. 

P245, P280 

Wolf, Kelly 33 

Wolf, Matthew J. 32 

Won, Hoyoun 

P238, P244 

Wong, Shirley 

P252 

Woo, Y. Joseph 

P157 

Wroblewski, Megan 

P156 

Wu, Alan H.B. 

44, P066 

Wu, Yuping 

P072, P075, P086, P097, P278 

Xiao, Chunyang 56 

Xu, Haiyong 

P273 

Xu, Yi-Zhou 

P169 

199

AUTHOR INDEX 

Xue, Yang 

55, P185, P219, P302 

Yadav, Rakesh 52 

Yamada, Gregg 

P332 

Yamamoto, Takeshi 

P154 

Yancy, Clyde W. 86, 143 

Yang, B.F. 

P286 

Yang, Fang 

P182 

Yang, James 

45, P198 

Yang, Jonathan 

P130, P149 

Yang, Michael 

P036 

Yang, N. 

P201 

Yang, Ning 

P094 

Yao, Atsushi 

P307 

Yedlapati, Neeraja 

P032 

Yeo, Daniel 

P352 

Yoshikawa, Tsutomu 

P211 

Youker, Keith A. 

56, P111, P112 

Young, Courtney A. 

P305 

Young, James B. 

106, P292 

Young, Malia 

P227 

Young, Michelle 

P323 

Yu, Shengbo 

P188, P191, P194 

Yu, Shuiqing 

P117, P131, P151 

Yun, Hae Eun 

P284, P346 

Yun, Soo-Hyeon 

P209, P324 

Zaeem, Faisal 

P105, P114 

Zakhary, Daniel 

P052 

Zambroski, Cheryl H. 

P192 

Zampini, Giorgio 

P082 

Zareba, Wojciech 

P183 

Zarella, Frances 

P351 

Zavin, A. 

P024, P046, P055 

Zaw, Ma Wai Wai 

P218 

Zeldenrust, Steven 

P180 

Zelin, Kathleen 

P164 

Zeng, Dewan 

P208 

Zhang, Renliang 

P089 

Zhang, Yan 

P205 

Zhang, Yi 

P340 

Zhao, Qingyan 

P188, P191, P194 

Zhao, Wang V. 56 

Zheng, Hanqiao 

56, P050, P173 

Zhong, Hongyan 

P208 

Zhong, Wei 

P107 

Zhou, Peng 

P199 

Zhou, Xiaoyan 

P103 

Zibadi, Sherma 

P056 

Zielke, Sayeh 

P305 

Zieroth, Shelley 

P353 

200 

AUTHOR INDEX 

Zile, Michael 

P250 

Zile, Michael R. 56 

Zolty, Ronald P113, P177, P210, P213, P231, 

P232, P266, P309 

201

Hynes AUTHOR Convention INDEXCenter 

Second Level 

hynes AUTHOR convention INDEXcenter 

Third Level 

201 

207 

REGISTRATION 

CME 

208 209 

202 203 204 205 

Entrance 

REGISTRATION 

202 

203

HFSA DATES TO REMEMBER 

October 21-23, 2011 

The Practical Management of HF: 

From Prevention to Advanced Disease 

Chicago, IL 

April 9, 2012 (Monday) 

Abstract Deadline 

16th HFSA Annual Scientific Meeting 

September 9-12 , 2012 

HFSA Annual Scientific Meeting 

Seattle, WA 

Advanced HF/Transplant Cardiology Certification 

• May 1, 2012 

ABIM Exam Registration Deadline 

• September 29-30, 2012 

HFSA Board Review 


• October 23, 2012 

ABIM Certifying Exam

16th Annual Scientific Meeting 

September 9 – 12, 2012 

Washington State Convention and Trade Center 

Seattle, WA 

Abstract Deadline: April 9, 2012 

www.hfsa.org

15th Annual Scientific Meeting - Heart Failure Society of America

Create successful ePaper yourself

Delete template?

Save as template?